<SEC-DOCUMENT>0001493152-23-035706.txt : 20231004
<SEC-HEADER>0001493152-23-035706.hdr.sgml : 20231004
<ACCEPTANCE-DATETIME>20231004172745
ACCESSION NUMBER:		0001493152-23-035706
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20231002
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231004
DATE AS OF CHANGE:		20231004

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTELLIGENT BIO SOLUTIONS INC.
		CENTRAL INDEX KEY:			0001725430
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				821512711
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39825
		FILM NUMBER:		231308992

	BUSINESS ADDRESS:	
		STREET 1:		142 WEST 57TH ST FL11
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		646-233-6971

	MAIL ADDRESS:	
		STREET 1:		142 WEST 57TH ST FL11
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GBS Inc.
		DATE OF NAME CHANGE:	20190919

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Glucose Biosensor Systems (Greater China) Holdings, Inc.
		DATE OF NAME CHANGE:	20171214
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:INBS="http://ibs.inc/20231002">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_INBS_ibs.inc_20231002 -->
<!-- Field: Set; Name: xdx; ID: xdx_047_20231002_20231002 -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0001725430 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0wNi0zMA== -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:EntityCentralIndexKey">0001725430</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:CurrentFiscalYearEndDate">--06-30</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="inbs-20231002.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2023-10-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001725430</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-02</xbrli:startDate>
        <xbrli:endDate>2023-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_907_edei--DocumentType_c20231002__20231002_zc543nXUaTL9"><ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the
Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of Earliest Event Reported): <b><span id="xdx_906_edei--DocumentPeriodEndDate_c20231002__20231002_z9Hwk74W3fK7"><ix:nonNumeric contextRef="AsOf2023-10-02" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">October 2, 2023</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_901_edei--EntityRegistrantName_c20231002__20231002_zm3zBwru6ZK5"><ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:EntityRegistrantName">INTELLIGENT
BIO SOLUTIONS INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20231002__20231002_zO0w4y94A6Vj"><ix:nonNumeric contextRef="AsOf2023-10-02" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityFileNumber_c20231002__20231002_zJt1pg7YcWLh"><ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:EntityFileNumber">001-39825</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20231002__20231002_zk9c6O9PRbu4"><ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:EntityTaxIdentificationNumber">82-1512711</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            of</span></p>
                                                                             <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
                                                                             <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
                                            Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
                                            employer</span></p>
                                                                             <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identification
                                            no.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="xdx_903_edei--EntityAddressAddressLine1_c20231002__20231002_zAcDphoAEiV1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:EntityAddressAddressLine1">142
West, 57<sup>th</sup> Street</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_902_edei--EntityAddressAddressLine2_c20231002__20231002_znx0V4GZFlOc"><ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:EntityAddressAddressLine2">11th
Floor</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressCityOrTown_c20231002__20231002_zwM9EneJ93G8"><ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:EntityAddressCityOrTown">New
York</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressStateOrProvince_c20231002__20231002_zK1SKwFjIoZ8"><ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:EntityAddressStateOrProvince">NY</ix:nonNumeric></span> <span id="xdx_90E_edei--EntityAddressPostalZipCode_c20231002__20231002_zg9aOsxt6TD8"><ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:EntityAddressPostalZipCode">10019</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices, including zip code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_908_edei--CityAreaCode_c20231002__20231002_zpU4lgvHr6T7"><ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:CityAreaCode">(646)</ix:nonNumeric></span> <span id="xdx_908_edei--LocalPhoneNumber_c20231002__20231002_zzGFvwE2f0rb"><ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:LocalPhoneNumber">828-8258</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N/A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--WrittenCommunications_c20231002__20231002_zNCpD2ld5Rz6"><ix:nonNumeric contextRef="AsOf2023-10-02" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--SolicitingMaterial_c20231002__20231002_zwuSWhQLBIQ9"><ix:nonNumeric contextRef="AsOf2023-10-02" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--PreCommencementTenderOffer_c20231002__20231002_zYSw4q5s1L21"><ix:nonNumeric contextRef="AsOf2023-10-02" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20231002__20231002_zth9HpJWgYL5"><ix:nonNumeric contextRef="AsOf2023-10-02" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--Security12bTitle_c20231002__20231002_zOm87gRHTNxd"><ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:Security12bTitle">Common
    Stock, $0.01 par value</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--TradingSymbol_c20231002__20231002_zvKv0xUi3rv3"><ix:nonNumeric contextRef="AsOf2023-10-02" name="dei:TradingSymbol">INBS</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--SecurityExchangeName_c20231002__20231002_zOjRmSa9Gg6c"><ix:nonNumeric contextRef="AsOf2023-10-02" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_903_edei--EntityEmergingGrowthCompany_c20231002__20231002_zPvpWaXmUBLe"><ix:nonNumeric contextRef="AsOf2023-10-02" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_90B_edei--EntityExTransitionPeriod_c20231002__20231002_zQansQXby1v6"><ix:nonNumeric contextRef="AsOf2023-10-02" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01. Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 2, 2023, Intelligent Bio Solutions Inc. (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting
Agreement&#8221;) with Ladenburg Thalmann &amp; Co. Inc., as representative (the &#8220;Representative&#8221;) of the underwriters named
in Schedule I thereto (collectively, the &#8220;Underwriters&#8221;), pursuant to which the Company agreed to issue and sell, in a registered
public offering by the Company (the &#8220;Public Offering&#8221;): (a) 1,544,004 Class A Units, with each Class A Unit consisting of
one share of the Company&#8217;s common stock, par value $0.01 per share (&#8220;Common Stock&#8221;), one warrant to purchase one share
of Common Stock at an exercise price of $0.55 per share (subject to one-time reset provision described below) that will expire on the
five-and-a-half-year anniversary of the original issuance date (the &#8220;Series E Warrants&#8221;), and one warrant to purchase one
share of Common Stock at an exercise price of $0.55 per share, or pursuant to alternate cashless exercise option, which warrant will
expire on the one-and-a-half-year anniversary of the original issuance date (the &#8220;Series F Warrants&#8221; and together with the
Series E Warrants, the &#8220;Warrants&#8221;) (the &#8220;Class A Units&#8221;); and (b) 5,728,723 Class B Units, with each Class B
Unit consisting of one share of our Series E Convertible Preferred Stock (which is convertible into Common Stock) (the &#8220;Series
E Preferred Stock&#8221;), one Series E Warrant and one Series F Warrant (the &#8220;Class B Units&#8221; and, together with the Class
A Units, the &#8220;Units&#8221;) at a public offering price of $0.55 per Class B Unit. Under the one-time reset provision of the Series
E Warrants, the exercise price of the Series E Warrants will reset to a price equal to the lesser of (i) the then exercise price and
(ii) 90% of the five-day volume weighted average price for the five trading days immediately following the date the Company effects a
reverse stock split. Under the alternate cashless exercise option of the Series F Warrants, the holder of the Series F Warrant (beginning
on the date the Warrant Stockholder Approval is effective (described below)), has the right to receive an aggregate number of shares
of Common Stock on a one-for-one basis (subject to adjustment). The Warrants will be exercisable beginning on the effective date of such
stockholder approvals as may be required by the applicable rules and regulations of the Nasdaq Capital Market (or any successor entity)
to permit the exercise of the Warrants (&#8220;Warrant Stockholder Approval&#8221;).&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Underwriting Agreement, the Company also granted the Underwriter a 45-day option (the &#8220;Overallotment Option&#8221;) to purchase
up to 1,090,909 additional shares of Common Stock, and/or Series E Warrants to purchase up to 1,090,909 additional shares of Common Stock,
and/or Series F Warrants to purchase up to 1,090,909 additional shares of Common Stock. The Underwriter partially exercised the Overallotment
Option on October 2, 2023, and purchased 688,217 additional shares of Common Stock, Series E Warrants to purchase an additional 688,217
shares of Common Stock, and Series F Warrants to purchase an additional 688,217 shares of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Units were offered by the Company pursuant to the registration statement on Form S-1 (File No. 333-273219), as amended, which was initially
filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on July 12, 2023, and declared effective by the SEC on September
29, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 4, 2023, the Public Offering closed and the Company issued and sold: (i) 2,232,221 shares of Common Stock (which includes 688,217
shares of Common Stock sold pursuant to the partial exercise of the Overallotment Option), (ii) 5,728,723 shares of Series E Preferred
Stock, (iii) Series E Warrants to purchase 7,960,944 shares of Common Stock (which includes Series E Warrants to purchase 688,217 shares
sold pursuant to the partial exercise of the Overallotment Option), and (iv) Series F Warrants to purchase 7,960,944 shares of Common
Stock (which includes Series F Warrants to purchase 688,217 shares sold pursuant to the partial exercise of the Overallotment Option).
The net proceeds to the Company, after deducting the underwriting discounts and commissions and estimated offering expenses payable by
the Company, were approximately $3.35 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spiro
Sakiris, our Chief Financial Officer, purchased 112,727 Class A Units on the same terms as the other purchasers in the Public Offering.
Mr. Christopher Towers, a member of our Board of Directors (the &#8220;Board&#8221;), purchased 9,090 Class A Units on the same terms
as the other purchasers in the Public Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriting Agreement contains representations, warranties and covenants made by the Company that are customary for transactions of
this type. Under the terms of the Underwriting Agreement, the Company has agreed to indemnify the Underwriters against certain liabilities,
including certain liabilities arising under the Securities Act, or to contribute to payments that the Underwriters may be required to
make for these liabilities. In addition, pursuant to the terms of the Underwriting Agreement, the Company and its executive officers
and directors and certain stockholders have entered into lock-up agreements providing that the Company and each of these persons may
not, without the prior written approval of the Underwriter, subject to limited exceptions, offer, sell, transfer or otherwise dispose
of the Company&#8217;s securities for a period from the date of the Underwriting Agreement until the later of (i) ninety (90) days following
the date of the Underwriting Agreement and (ii) fifteen (15) days following the date of the Warrant Stockholder Approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Underwriting Agreement, the Representative received an underwriting discount of 8.0% to the public offering price for the Units.
In addition, the Company agreed to pay the Representative a management fee equal to 1.0% of the aggregate gross proceeds received from
the sale of the securities in the Public Offering and to reimburse the accountable expenses of the Representative up to a maximum of
$145,000. The Company also agreed to issue to the Representative, or its designees, warrants (the &#8220;Representative Warrants&#8221;)
to purchase up to a number of shares of Common Stock equal to 5.0% of the shares of common stock (or common stock equivalents) sold in
the Public Offering (which equaled 398,047 shares of Common Stock), which warrants have an exercise price of $0.6875 per share and will
terminate on October 2, 2028.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 4, 2023, the Company entered into a warrant agency agreement with the Company&#8217;s transfer agent, Continental Stock Transfer
&amp; Trust Company (&#8220;Continental&#8221;), which will also act as the warrant agent for the Company, setting forth the terms and
conditions of the Warrants sold in the Public Offering (the &#8220;Warrant Agency Agreement&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
after the Public Offering, there will be 4,562,620 shares of Common Stock outstanding (reflecting the partial exercise of the Overallotment
Option, but assuming no conversion of the Series E Preferred Stock and no exercise of the Warrants).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing summaries of the Underwriting Agreement, the form of Series E Warrant, the form of Series F Warrant, form of Representative
Warrant, and the Warrant Agency Agreement do not purport to be complete and are subject to, and qualified in their entirety by, such
documents attached as Exhibits 1.1, 4.1, 4.2, 4.3 and 4.4 respectively, to this Current Report on Form 8-K, which are incorporated herein
by reference.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Public Offering, the Company filed the Certificate of Designation of Preferences, Rights and Limitations of the Series
E Convertible Preferred Stock (the &#8220;Certificate of Designation&#8221;) with the Secretary of State of the State of Delaware on
October 3, 2023. The Certificate of Designation specifies that 5,728,723 shares have been designated Series E Preferred Stock, all of
which were issued in the Public Offering. The following summary of certain terms and provisions of the Series E Preferred Stock is qualified
in its entirety by reference to, the terms and provisions set forth in Certificate of Designation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Series E Preferred Stock have no voting rights, except as required by law. The Company may not disproportionally alter
or change adversely the powers, preferences and rights of the Series E Preferred Stock or amend the Certificate of Designation or amend
our Certificate of Incorporation or Bylaws in any manner that disproportionally adversely affect any right of the holders of the Series
E Preferred Stock without the affirmative vote of the holders of a majority of the shares of Series E Preferred Stock then outstanding,
or increase the number of authorized shares of Series E Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of Series E Preferred Stock are not entitled to receive any dividends, unless and until specifically declared by the Board. However,
holders of Series E Preferred Stock are entitled to receive dividends on shares of Series E Preferred Stock equal (on an as-if-converted-to-common-stock
basis) to and in the same form as dividends actually paid on shares of Common Stock when such dividends are specifically declared by
the Board, except for stock dividends or distributions payable in shares of common stock on shares of common stock or any other common
stock equivalents for which the conversion price will be adjusted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of the liquidation, dissolution, or winding-up of the Company, holders of our Series E Preferred Stock will be entitled to
receive out of the assets, whether capital or surplus, of the Corporation the same amount to which such holder would be entitled to receive
with respect to such shares of Series E Preferred Stock if such shares had been converted to common stock immediately prior to such event
(without giving effect for such purposes to the 4.99% or 9.99% beneficial ownership limitation, as applicable) subject to the preferential
rights of holders of any class or series of our capital stock specifically ranking by its terms senior to the Series E Preferred Stock
as to distributions of assets upon such event, whether voluntarily or involuntarily.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of Series E Preferred Stock is convertible at any time at the holder&#8217;s option into one share of common stock (subject to
the beneficial ownership limitations as provided in the Certificate of Designation), subject to adjustment as provided in the Certificate
of Designation, provided that the holder will be prohibited from converting Series E Preferred Stock into shares of Common Stock if,
as a result of such conversion, the holder, together with its affiliates, would own more than 4.99%, or 9.99%, of the total number of
shares of our common stock then issued and outstanding. However, any holder may increase or decrease such percentage to any other percentage
not in excess of 9.99%, provided that any increase in such percentage shall not be effective until the 61st day after such notice to
us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing summary of the Certificate of Designation does not purport to be complete and is subject to, and qualified in its entirety
by, such document attached as Exhibit 3.1 to this Current Report on Form 8-K, which is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01 Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 2, 2023, the Company issued a press release announcing that it had priced the Public Offering, a copy of which is attached as
Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 4, 2023, the Company issued a press release announcing the closing of the Public Offering and the partial exercise of the Overallotment
Option, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex1-1.htm">Underwriting Agreement dated as of October 2, 2023, by and between Intelligent Bio Solutions Inc. and Ladenburg Thalmann &amp; Co. Inc.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex3-1.htm">Certificate of Designation of Preferences, Rights and Limitations of the Series E Convertible Preferred Stock, filed with the Delaware Secretary of State on October 3, 2023</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-1.htm">Form
    of Series E Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Series F Warrant</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-3.htm">Form of Representative Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-4.htm">Warrant Agency Agreement, dated as of October 4, 2023, between Intelligent Bio Solutions Inc. and Continental Stock Transfer &amp; Trust Company.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release dated October 2, 2023</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-2.htm">Press Release dated October 4, 2023</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
October 4, 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INTELLIGENT
    BIO SOLUTIONS INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Spiro Sakiris</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spiro
    Sakiris</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZS42xbrq0qIhVShFxG+xUgm2mTOJPj+QtjS3iMDAM733vCTERG1qbBhnOyzKHI7Zdoz1CiTUy2gsGR7bdpRBuiVfjPGvrh/cHZhQYDMwiVlIHYbA+jMMqhZmcymSq5iBVmsyh2Ivoq2dka1Oh9UY3oG0FBVPHBr3mfkw46hdZavuh6oTsDNkQF8tRfoOSMwUHeugn8c1BnmcimgwTiQ3TvfvW3J2nFlYNtqHLjeh/ow8SxElB -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
1.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1,544,004
SHARES <FONT STYLE="text-transform: uppercase">of Common Stock</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>5,728,723
Shares of Series E Convertible preferred stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>7,272,727
SERIES E Warrants (Exercisable for 7,272,727 Shares of</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Common
stock) AND</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>7,272,727
SERIES F Warrants (Exercisable for 7,272,727 Shares of</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Common
stock) of</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTELLIGENT
BIO SOLUTIONS INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNDERWRITING
AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
October 2, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladenburg
Thalmann &amp; Co. Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the Representative of the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Several
underwriters, if any, named in <U>Schedule I</U> hereto</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">640
Fifth Avenue, 4<SUP>th</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Intelligent Bio Solutions Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and
affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or
affiliates of Intelligent Bio Solutions Inc., the &ldquo;<U>Company</U>&rdquo;), hereby confirms its agreement (this &ldquo;<U>Agreement</U>&rdquo;)
with the several underwriters (such underwriters, including the Representative (as defined below), the &ldquo;<U>Underwriters</U>&rdquo;
and each an &ldquo;<U>Underwriter</U>&rdquo;) named in <U>Schedule I</U> hereto for which Ladenburg Thalmann &amp; Co. Inc. is acting
as representative to the several Underwriters (the &ldquo;<U>Representative</U>&rdquo; and if there are no Underwriters other than the
Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same
meaning as Underwriter) on the terms and conditions set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is understood that the several Underwriters are to make a public offering of the Public Securities as soon as the Representative deems
it advisable to do so. The Public Securities are to be initially offered to the public at the public offering price set forth in the
Prospectus Supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is further understood that you will act as the Representative for the Underwriters in the offering and sale of the Closing Securities
and, if any, the Option Securities in accordance with this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, (a) capitalized terms that are not otherwise defined
herein have the meanings given to such terms in the Certificate of Designation (as defined below) and (b), the following terms have the
meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(k).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls or is controlled
by or is under common control with such Person as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Certificate
of Designation</U>&rdquo; means the Certificate of Designation to be filed prior to the Closing by the Company with the Secretary of
State of Delaware in the form of <U>Exhibit A</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Closing Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the hour and the date on the Trading Day on which all conditions precedent to (i) the Underwriters&rsquo; obligations
to pay the Closing Purchase Price and (ii) the Company&rsquo;s obligations to deliver the Closing Securities, in each case, have been
satisfied or waived, but in no event later than 10:00 a.m. (New York City time) on the second (2<SUP>nd</SUP>) Trading Day following
the date hereof or at such earlier time as shall be agreed upon by the Representative and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(b), which aggregate purchase price shall be net
of the underwriting discounts and commissions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Securities</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(a)(iv).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Shares</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(a)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Preferred Shares</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(a)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Warrants</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(a)(iv).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Combined
Preferred Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Combined
Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Auditor</U>&rdquo; means UHY LLP, with offices located at 201 Old Country Road, Suite 202, Melville, NY 11747.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means ArentFox Schiff LLP, with offices located at 1717 K Street NW, Washington, DC 20006.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Price</U>&rdquo; shall have the meaning ascribed to such term in the Certificate of Designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Shares</U>&rdquo; shall have the meaning ascribed to such term in the Certificate of Designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(f).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>EGS</U>&rdquo;
means Ellenoff Grossman &amp; Schole LLP, with offices located at 1345 Avenue of the Americas, New York, New York 10105.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Execution
Date</U>&rdquo; shall mean the date on which the parties execute and enter into this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant
to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities
upon the exercise or exchange of or conversion of any Securities issued hereunder, warrants to the Representative in connection with
the transactions pursuant to this Agreement and any securities upon exercise of warrants to the Representative and/or other securities
exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided
that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease
the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations)
or to extend the term of such securities, (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority
of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined
in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith
during the prohibition period in Section 4.20(a) herein, and provided that any such issuance shall only be to a Person (or to the equityholders
of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with
the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not
include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary
business is investing in securities, and (d) approximately 75,000 shares of Common Stock issuable upon the conversion of the Series C
Convertible Preferred Stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended &ldquo;<U>Fee Cap</U>&rdquo; shall have the meaning ascribed to such term
in Section 4.6(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FINRA</U>&rdquo;
means the Financial Industry Regulatory Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Former
Company Auditor</U>&rdquo; means BDO Audit Pty Ltd., with offices located at Level 11, 1 Margaret Street, Sydney NSW 2000 Australia.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
means (a) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the
ordinary course of business), (b) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others,
whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties
by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (c)
the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lock-Up
Agreements</U>&rdquo; means the lock-up agreements that are delivered on the date hereof by each of the Company&rsquo;s officers and
directors and each holder of Common Stock and Common Stock Equivalents listed on Schedule 1.1 holding, on a fully diluted basis, more
than 5% of the Company&rsquo;s issued and outstanding Common Stock, in the form of <U>Exhibit B</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; means (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document,
(ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the
Company and the Subsidiaries, taken as a whole or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Offering</U>&rdquo;
shall have the meaning ascribed to such term in Section 2.1(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Option</U>&rdquo;
shall have the meaning ascribed to such term in Section 2.2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Option
Closing Date</U>&rdquo; shall have the meaning ascribed to such term in Section 2.2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Option
Closing Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section 2.2(b), which aggregate purchase price shall
be net of the underwriting discounts and commissions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Option
Securities</U>&rdquo; shall have the meaning ascribed to such term in Section 2.2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Option
Shares</U>&rdquo; shall have the meaning ascribed to such term in Section 2.2(a)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Option
Warrants</U>&rdquo; shall have the meaning ascribed to such term in Section 2.2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preferred
Share Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preferred
Stock</U>&rdquo; means up to 5,728,723 shares of the Company&rsquo;s Series E Convertible Preferred Stock issued or issuable pursuant
to Section 2.1(a)(ii), and having the rights, preferences and privileges set forth in the Certificate of Designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preferred
Stock Agency Agreement</U>&rdquo; means the addendum to the Company&rsquo;s Transfer Agency Agreement with the Transfer Agent, pursuant
to which the Transfer Agent agrees to act as transfer agent and conversion agent for the Preferred Stock, in the form of <U>Exhibit C
</U>attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preliminary
Prospectus</U>&rdquo; means, if any, any preliminary prospectus relating to the Securities included in the Registration Statement or
filed with the Commission pursuant to Rule 424(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means, if any, any supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed
with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Securities</U>&rdquo; means, collectively, the Closing Securities and, if any, the Option Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means, collectively, the various parts of the registration statement prepared by the Company on Form S-1 (File No.
333-273219) with respect to the Securities, each as amended as of the date hereof, including the Prospectus and Prospectus Supplement,
if any, the Preliminary Prospectus, if any, and all exhibits filed with or incorporated by reference into such registration statement,
and includes any Rule 462(b) Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
462(b) Registration Statement</U>&rdquo; means any registration statement prepared by the Company registering additional Public Securities,
which was filed with the Commission on or prior to the date hereof and became automatically effective pursuant to Rule 462(b) promulgated
by the Commission pursuant to the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Closing Securities, the Option Securities and the Underlying Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
E Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Series E Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
E Warrants</U>&rdquo; means, collectively, the Series E Common Stock purchase warrants delivered to the Underwriters in accordance with
Section 2.1(a)(iii) and Section 2.2, which Series E Warrants shall be exercisable at any time on or after the date Shareholder Approval
is received and effective and have a term of exercise equal to five and one half (5.5) years from issuance, in the form of <U>Exhibit
J</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
F Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Series F Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
F Warrants</U>&rdquo; means, collectively, the Series F Common Stock purchase warrants delivered to the Underwriters in accordance with
Section 2.1(a)(iv) and Section 2.2, which Series F Warrants shall be exercisable at any time on or after the date Shareholder Approval
is received and effective and have a term of exercise equal to one and one half (1.5) years from issuance, in the form of <U>Exhibit
K</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Share
Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shareholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Capital Market (or any
successor entity) from the shareholders of the Company to permit the exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means, collectively, the shares of Common Stock delivered to the Underwriters in accordance with Section 2.1(a)(i) and Section 2.2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof, but shall not include any entity of which the Company owns less than 51%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Certificate of Designation, the Warrants, the Preferred Stock Agency Agreement, the Warrant
Agency Agreement, the Lock Up Agreements, the Voting Agreements, and any other documents or agreements executed in connection with the
transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust Company, the current transfer agent of the Company, with a mailing address
of 1 State Street 30th Floor, New York, NY 10004-1561, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Underlying
Shares</U>&rdquo; means, collectively, the Conversion Shares and Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Voting
Agreement</U>&rdquo; shall have the meaning ascribed to such term in Section 2.4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Agency Agreement</U>&rdquo; means the warrant agency agreement dated on or about the Closing Date, among the Company and the Transfer
Agent in the form of <U>Exhibit D</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Series E Warrants and the Series F Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASE
AND SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Upon the terms and subject to the conditions set forth herein, the Company agrees to sell in the aggregate 1,544,004 shares of Common
Stock, 5,728,723 shares of Preferred Stock, , Series E Warrants exercisable for an aggregate of 7,272,727 shares of Common Stock and
Series F Warrants exercisable for an aggregate of 7,272,727 shares of Common Stock, and each Underwriter agrees to purchase, severally
and not jointly, at the Closing, the following securities of the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the number of shares of Common Stock (the &ldquo;<U>Closing Shares</U>&rdquo;) set forth opposite the name of such Underwriter on <U>Schedule
I</U> hereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the number of shares of Preferred Stock (the &ldquo;<U>Closing Preferred Shares</U>&rdquo;) set forth opposite the name of such Underwriter
on Schedule I hereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Series E Warrants to purchase up to the number of shares of Common Stock set forth opposite the name of such Underwriter on <U>Schedule
I</U> hereof (the &ldquo;<U>Closing E Warrants</U>&rdquo;), which Series E Warrants shall have an exercise price of $0.55, subject to
adjustment as provided therein</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Series F Warrants to purchase up to the number of shares of Common Stock set forth opposite the name of such Underwriter on <U>Schedule
I</U> hereof (the &ldquo;<U>Closing F Warrants</U>&rdquo;, collectively with the Closing E Warrants, the &ldquo;<U>Closing Warrants</U>&rdquo;
and collectively with the Closing Shares and Closing Preferred Shares, the &ldquo;<U>Closing Securities</U>&rdquo;), which Series F Warrants
shall have an exercise price of $0.55, subject to adjustment as provided therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The aggregate purchase price for the Closing Securities shall equal the amount set forth opposite the name of such Underwriter on <U>Schedule
I</U> hereto (the &ldquo;<U>Closing Purchase Price</U>&rdquo;). The combined purchase price for one Share, one Series E Warrant and one
Series F Warrant shall be $0.506 (the &ldquo;<U>Combined Purchase Price</U>&rdquo;) which shall be allocated $0.4876 per Share (the &ldquo;<U>Share
Purchase Price</U>&rdquo;), $0.0092 per Series E Warrant and $0.0092 per Series F Warrant (the &ldquo;<U>Warrant Purchase Price</U>&rdquo;).
The purchase price for one Preferred Share, one Series E Warrant and one Series F Warrant shall be $0.506 (the &ldquo;<U>Combined Preferred
Purchase Price</U>&rdquo;), which shall be allocated as $0.4876 per Preferred Share (the &ldquo;<U>Preferred Share Purchase Price</U>&rdquo;),
$0.0092 per Series E Warrant and $0.0092 per Series F Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
On the Closing Date, each Underwriter shall deliver or cause to be delivered to the Company, via wire transfer, immediately available
funds equal to such Underwriter&rsquo;s Closing Purchase Price and the Company shall deliver to, or as directed by, such Underwriter
its respective Closing Securities and the Company shall deliver the other items required pursuant to Section 2.3 deliverable at the Closing.
Upon satisfaction of the covenants and conditions set forth in Sections 2.3 and 2.4, the Closing shall occur at the offices of EGS or
such other location as the Company and Representative shall mutually agree. The Public Securities are to be offered initially to the
public at the offering price set forth on the cover page of the Prospectus (the &ldquo;<U>Offering</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company acknowledges and agrees that, with respect to any Notice(s) of Conversion (as defined in the Certificate of Designation)
delivered by a Holder (as defined in the Certificate of Designation) on or prior to 12:00 pm (New York City time) on the Closing Date,
which Notice(s) of Conversion may be delivered at any time after the time of execution of this Agreement, the Company shall deliver the
Conversion Shares (as defined in the Certificate of Designation) subject to notice(s) to the Holder by 4:00 pm (New York City time) on
the Closing Date and the Closing Date shall be the Share Delivery Date (as defined in the Certificate of Designation) under the Certificate
of Designation. The Company acknowledges and agrees that the Holders are third party beneficiaries of this covenant of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Option to Purchase Additional Securities</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative
is hereby granted an option (the &ldquo;<U>Option</U>&rdquo;) to purchase, in the aggregate, up to 1,090,909 shares of Common Stock (the
&ldquo;<U>Option Shares</U>&rdquo;), Series E Warrants to purchase up to 1,090,909 shares of Common Stock and Series F Warrants to purchase
up to 1,090,909 shares of Common Stock (the &ldquo;<U>Option Warrants</U>&rdquo; and, collectively with the Option Shares, the &ldquo;<U>Option
Securities</U>&rdquo;) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price
and/or Warrant Purchase Price, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In connection with an exercise of the Option, (a) the purchase price to be paid for the Option Shares is equal to the product of the
Share Purchase Price multiplied by the number of Option Shares to be purchased and (b) the purchase price to be paid for the Option Warrants
is equal to the product of the Warrant Purchase Price multiplied by the number of Option Warrants to be purchased (the aggregate purchase
price to be paid on an Option Closing Date, the &ldquo;<U>Option Closing Purchase Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Option granted pursuant to this Section 2.2 may be exercised by the Representative as to all (at any time) or any part (from time
to time) of the Option Securities within forty-five (45) days after the Execution Date. An Underwriter will not be under any obligation
to purchase any Option Securities prior to the exercise of the Option by the Representative. The Option granted hereby may be exercised
by the giving of oral notice to the Company from the Representative, which must be confirmed in writing by overnight mail or electronic
transmission setting forth the number of Option Shares and/or Option Warrants to be purchased and the date and time for delivery of and
payment for the Option Securities (each, an &ldquo;<U>Option Closing Date</U>&rdquo;), which will not be later than two (2) full Business
Days after the date of the notice or such other time as shall be agreed upon by the Company and the Representative, at the offices of
EGS or at such other place (including remotely by other electronic transmission) as shall be agreed upon by the Company and the Representative.
If such delivery and payment for the Option Securities does not occur on the Closing Date, each Option Closing Date will be as set forth
in the notice. Upon exercise of the Option, the Company will become obligated to convey to the Underwriters, and, subject to the terms
and conditions set forth herein, the Underwriters will become obligated to purchase, the number of Option Shares and/or Option Warrants
specified in such notice. The Representative may cancel the Option at any time prior to the expiration of the Option by written notice
to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Deliveries</U>. The Company shall deliver or cause to be delivered to each Underwriter (if applicable) the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
At the Closing Date, the Closing Shares and, as to each Option Closing Date, if any, the applicable Option Shares, which shares shall
be delivered via The Depository Trust Company Deposit or Withdrawal at Custodian system for the accounts of the several Underwriters;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
At the Closing Date, the Closing Preferred Shares, which shares shall be delivered via The Depository Trust Company Deposit or Withdrawal
at Custodian system for the accounts of the several Underwriters;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
At the Closing Date, the Closing E Warrants and, as to each Option Closing Date, if any, the applicable Option Warrants via The Depository
Trust Company Deposit or Withdrawal at Custodian system for the accounts of the several Underwriters;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
At the Closing Date, the Closing F Warrants and, as to each Option Closing Date, if any, the applicable Option Warrants via The Depository
Trust Company Deposit or Withdrawal at Custodian system for the accounts of the several Underwriters</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
At the Closing Date, and each Option Closing Date, if any, to the Representative only, a warrant (the &ldquo;<U>Representative Warrant</U>&rdquo;)
in the form attached hereto as <U>Exhibit E</U>, to purchase up to a number of shares of Common Stock equal to 5.0% of the Closing Shares,
Preferred Shares and Option Shares issued on such Closing Date and Option Closing Date, as applicable, for the account of the Representative
(or its designees), which Representative Warrant shall have an exercise price of $0.6875, subject to adjustment therein, and registered
in the name of the Representative, otherwise on substantially the same terms as the Closing E Warrants;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
At the Closing Date, the Preferred Stock Agency Agreement and Warrant Agency Agreement duly executed by the parties thereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
At the Closing Date, evidence of the filing and acceptance of the Certificate of Designation from the Secretary of State of the State
of Delaware;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
At the Closing Date, a legal opinion of Company Counsel addressed to the Underwriters, including, without limitation, a negative assurance
letter, substantially in the form of <U>Exhibit F</U> attached hereto and as to each Option Closing Date, if any, a bring-down opinion
and negative assurance letter from Company Counsel in form and substance reasonably satisfactory to the Representative to the Company,
including, without limitation, a negative assurance letter, addressed to the Underwriters and in form and substance satisfactory to the
Representative;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
At the Closing Date, a cold comfort letter, addressed to the Underwriters and in form and substance satisfactory in all respects to the
Representative from the Former Company Auditor dated, respectively, as of the date of this Agreement and a bring-down letter dated as
of each Option Closing Date, if any;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
On the Closing Date and on each Option Closing Date, the duly executed and delivered Officer&rsquo;s Certificate, substantially in the
form required by <U>Exhibit G</U> attached hereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)
On the date hereof, the duly executed and delivered Lock Up Agreements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)
On the date hereof, the duly executed and delivered Voting Agreements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)
On the Closing Date and on each Option Closing Date, the duly executed and delivered Secretary&rsquo;s Certificate, substantially in
the form required by <U>Exhibit H</U> attached hereto; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)
On the Closing Date and on each Option Closing Date, the duly executed and delivered Chief Financial Officer&rsquo;s Certificate, substantially
in the form required by <U>Exhibit I</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4
<U>Closing Conditions</U>. The respective obligations of each Underwriter hereunder in connection with the Closing and each Option Closing
Date are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects when made and on the date in question (other than representations and warranties of the Company
already qualified by materiality, which shall be true and correct in all respects) of the representations and warranties of the Company
contained herein (unless as of a specific date therein);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the date in question shall have been
performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.3 of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the delivery by the Company of a voting agreement, in the form of <U>Exhibit L</U> (the &ldquo;<U>Voting Agreement</U>&rdquo;) attached
hereto, duly executed by each of the parties listed on Schedule 1.2 hereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
the Registration Statement shall be effective on the date of this Agreement and at each of the Closing Date and each Option Closing Date,
if any, no stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose
shall have been instituted or shall be pending or contemplated by the Commission and any request on the part of the Commission for additional
information shall have been complied with to the reasonable satisfaction of the Representative;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
by the Execution Date, if required by FINRA, the Underwriters shall have received clearance from FINRA as to the amount of compensation
allowable or payable to the Underwriters as described in the Registration Statement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
the Closing Shares, the Option Shares and the Underlying Shares have been approved for listing on the Trading Market; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
prior to and on each of the Closing Date and each Option Closing Date, if any: (i) there shall have been no material adverse change or
development involving a prospective material adverse change in the condition or prospects or the business activities, financial or otherwise,
of the Company from the latest dates as of which such condition is set forth in the Registration Statement and Prospectus; (ii) no action
suit or proceeding, at law or in equity, shall have been pending or threatened against the Company or any Affiliate of the Company before
or by any court or federal or state commission, board or other administrative agency wherein an unfavorable decision, ruling or finding
may materially adversely affect the business, operations, prospects or financial condition or income of the Company, except as set forth
in the Registration Statement and Prospectus; (iii) no stop order shall have been issued under the Securities Act and no proceedings
therefor shall have been initiated or threatened by the Commission; and (iv) the Registration Statement and the Prospectus and any amendments
or supplements thereto shall contain all material statements which are required to be stated therein in accordance with the Securities
Act and the rules and regulations thereunder and shall conform in all material respects to the requirements of the Securities Act and
the rules and regulations thereunder, and neither the Registration Statement nor the Prospectus nor any amendment or supplement thereto
shall contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
AND WARRANTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall
be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the
corresponding section of the Disclosure Schedules, the Company represents and warrants to the Underwriters as of the Execution Date,
as of the Closing Date and as of each Option Closing Date, if any, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect Subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. Except as set
forth on <U>Schedule 3.1(a)</U>, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each
Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly
issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company
has no Subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in a Material Adverse Effect and no Proceeding has been instituted in any such jurisdiction
revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents to which the Company is a party and otherwise to carry out
its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by
the Company, the filing of the Certificate of Designation with the Secretary of State of the State of Delaware, and the consummation
by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action on the part of
the Company and no further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection
herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which
the Company is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with
the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the filing of the Certificate of Designation with the Secretary of State of the State of Delaware, the issuance
and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict
with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation, bylaws or other
organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or
both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary,
or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without
notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt
or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company
or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law,
rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company
or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company
or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected
to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. Except as set forth on <U>Schedule 3.1(e)</U>, the Company is not required to obtain any consent,
waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local
or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction
Documents, other than: (i) the filings required pursuant to Section 4.16 of this Agreement, (ii) the filing with the Commission of the
Prospectus, (iii) application(s) to each applicable Trading Market for the listing of the Shares and Warrant Shares for trading thereon
in the time and manner required thereby, (iv) Shareholder Approval, and (v) such filings as are required to be made under applicable
state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Registration Statement</U>. The Company has filed with the Commission the Registration Statement, including any related Prospectus
or Prospectuses, for the registration of the Securities under the Securities Act, which Registration Statement has been prepared by the
Company in all material respects in conformity with the requirements of the Securities Act and the rules and regulations of the Commission
under the Securities Act. The Registration Statement has been declared effective by the Commission on September 29, 2023 (the &ldquo;<U>Effective
Date</U>&rdquo;). The Company has advised the Representative of all further information (financial and other) with respect to the Company
required to be set forth therein in the Registration Statement and Prospectus. Any reference in this Agreement to the Registration Statement,
the Prospectus or the Prospectus Supplement shall be deemed to refer to and include the documents incorporated by reference therein,
if any, which were filed under the Exchange Act, on or before the date of this Agreement, or the issue date of the Prospectus or the
Prospectus Supplement, as the case may be; and any reference in this Agreement to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo;
or &ldquo;supplement&rdquo; with respect to the Registration Statement, the Prospectus or the Prospectus Supplement shall be deemed to
refer to and include the filing of any document under the Exchange Act after the date of this Agreement, or the issue date of the Prospectus
or the Prospectus Supplement, as the case may be, deemed to be incorporated therein by reference. All references in this Agreement to
financial statements and schedules and other information which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo; &ldquo;described,&rdquo;
&ldquo;referenced,&rdquo; &ldquo;set forth&rdquo; or &ldquo;stated&rdquo; in the Registration Statement, the Prospectus or the Prospectus
Supplement (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules
and other information which is or is deemed to be incorporated by reference in the Registration Statement, the Prospectus or the Prospectus
Supplement, as the case may be. No stop order suspending the effectiveness of the Registration Statement or the use of the Prospectus
or the Prospectus Supplement has been issued, and no proceeding for any such purpose is pending or has been initiated or, to the Company&rsquo;s
knowledge, is threatened by the Commission. For purposes of this Agreement, &ldquo;<U>free writing prospectus</U>&rdquo; has the meaning
set forth in Rule 405 under the Securities Act. The Company will not, without the prior consent of the Representative, prepare, use or
refer to, any free writing prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Issuance of Securities</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Underlying
Shares, when issued in accordance with the terms of the Transaction Documents, will be validly issued, fully paid and nonassessable,
free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the maximum number
of shares of Common Stock issuable pursuant to this Agreement, the Warrants the Representative Warrant, and has reserved from its duly
authorized preferred stock the maximum number of Series E Convertible Preferred Stock issuable pursuant to this Agreement. The holder
of the Securities will not be subject to personal liability by reason of being such holders. The Securities are not and will not be subject
to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company. All corporate
action required to be taken for the authorization, issuance and sale of the Securities has been duly and validly taken. The Securities
conform in all material respects to all statements with respect thereto contained in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(h)</U>, which <U>Schedule
3.1(h)</U> shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as
of the date hereof. Except as set forth on <U>Schedule 3.1(h)</U>, the Company has not issued any capital stock since its most recently
filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s
stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans
or stock plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently
filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or
any similar right to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and
sale of the Securities and as set forth on <U>Schedule 3.1(h)</U>, there are no outstanding options, warrants, scrip rights to subscribe
to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable
or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or capital stock of any Subsidiary,
or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional
shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not
obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Underwriters).
There are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion,
exchange or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no
outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are
no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security
of the Company or such Subsidiary. The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements
or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued,
fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding
shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval
or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. Except
for the Shareholder Approval and as set forth on <U>Schedule 3.1(h)</U>, there are no stockholders agreements, voting agreements or other
similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company,
between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and
the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received
a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their
respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act,
as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements
of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and
regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in
accordance with United States generally accepted accounting principles, consistently applied, during the periods involved (&ldquo;<U>GAAP</U>&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. The agreements and documents described
in the Registration Statement, the Prospectus, the Prospectus Supplement and the SEC Reports conform to the descriptions thereof contained
therein and there are no agreements or other documents required by the Securities Act and the rules and regulations thereunder to be
described in the Registration Statement, the Prospectus, the Prospectus Supplement or the SEC Reports or to be filed with the Commission
as exhibits to the Registration Statement, that have not been so described or filed. Each agreement or other instrument (however characterized
or described) to which the Company is a party or by which it is or may be bound or affected and (i) that is referred to in the Registration
Statement, the Prospectus, the Prospectus Supplement or the SEC Reports, or (ii) is material to the Company&rsquo;s business, has been
duly authorized and validly executed by the Company, is in full force and effect in all material respects and is enforceable against
the Company and, to the Company&rsquo;s knowledge, the other parties thereto, in accordance with its terms, except (x) as such enforceability
may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally, (y) as enforceability
of any indemnification or contribution provision may be limited under the federal and state securities laws, and (z) that the remedy
of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion
of the court before which any proceeding therefore may be brought. None of such agreements or instruments has been assigned by the Company,
and neither the Company nor, to the best of the Company&rsquo;s knowledge, any other party is in default thereunder and, to the best
of the Company&rsquo;s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute
a default thereunder. To the best of the Company&rsquo;s knowledge, performance by the Company of the material provisions of such agreements
or instruments will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental
agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses, including, without limitation,
those relating to environmental laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, except as set forth on <U>Schedule 3.1(j)</U>, (i) there has been no event, occurrence or development that has
had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock, (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company stock and option plans, and (vi) no officer or director of the Company has resigned from any position with the Company.
The Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance
of the Securities contemplated by this Agreement or as set forth on <U>Schedule 3.1(j)</U>, no event, liability, fact, circumstance,
occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries
or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed
by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed
at least 1 Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
                                            <U>Litigation</U>. Except as set forth on <U>Schedule 3.1(k)</U>, there is no action, suit,
                                            inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of
                                            the Company, threatened against or affecting the Company, any Subsidiary or any of their
                                            respective properties before or by any court, arbitrator, governmental or administrative
                                            agency or regulatory authority (federal, state, county, local or foreign) (collectively,
                                            an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(k)</U>
                                            (i) adversely affects or challenges the legality, validity or enforceability of any of the
                                            Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision,
                                            have or reasonably be expected to result in a Material Adverse Effect. Neither the Company
                                            nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any
                                            Action involving a claim of violation of or liability under federal or state securities laws
                                            or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company,
                                            there is not pending or contemplated, any investigation by the Commission involving the Company
                                            or any current or former director or officer of the Company. The Commission has not issued
                                            any stop order or other order suspending the effectiveness of any registration statement
                                            filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Compliance</U>. Except as set forth on <U>Schedule 3.1(m)</U>, neither the Company nor any Subsidiary: (i) is in default under or
in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default
by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under
or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or
by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any
judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute,
rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws
relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters,
except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (each, a &ldquo;<U>Material
Permit</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification
of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP, and the payment of
which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which
the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). Except
as set forth on <U>Schedule 3.1(p)</U>, none of, and neither the Company nor any Subsidiary has received a notice (written or otherwise)
that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be
abandoned, within two (2) years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date
of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge
that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected
to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there
is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken
reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where
failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage in an amount deemed prudent by the Company. Neither the Company nor any
Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires
or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Transactions With Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of
the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently
a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal
property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from, any
officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee
has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other
than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company
and (iii) other employee benefits, including stock option agreements under any stock or option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. Except as set forth on <U>Schedule 3.1(s)</U>, (i) the Company and the Subsidiaries
are in compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the
date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date
hereof and as of the Closing Date; (ii) the Company and the Subsidiaries maintain a system of internal accounting controls sufficient
to provide reasonable assurance that: (a) transactions are executed in accordance with management&rsquo;s general or specific authorizations,
(b) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset
accountability, (c) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (d)
the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with
respect to any differences; (iii) the Company and the Subsidiaries have established disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures
to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded,
processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms; and (iv) the Company&rsquo;s
certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as
of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation
Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since
the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange
Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control
over financial reporting of the Company and its Subsidiaries, except as set forth on <U>Schedule 3.1(s)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Certain Fees</U>. Except as set forth in the Prospectus, no brokerage or finder&rsquo;s fees or commissions are or will be payable
by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or
other Person with respect to the transactions contemplated by the Transaction Documents. To the Company&rsquo;s knowledge, there are
no other arrangements, agreements or understandings of the Company or, to the Company&rsquo;s knowledge, any of its stockholders that
may affect the Underwriters&rsquo; compensation, as determined by FINRA. The Company has not made any direct or indirect payments (in
cash, securities or otherwise) to: (i) any person, as a finder&rsquo;s fee, consulting fee or otherwise, in consideration of such person
raising capital for the Company or introducing to the Company persons who raised or provided capital to the Company; (ii) any FINRA member;
or (iii) any person or entity that has any direct or indirect affiliation or association with any FINRA member, within the twelve months
prior to the Execution Date, other than the prior payment to the Representative in connection with the March 2023 public offering of
Common Stock and warrants. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or
its affiliates, except as specifically authorized herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Registration Rights</U>. Except as set forth on <U>Schedule 3.1(v)</U>, no Person has any right to cause the Company or any Subsidiary
to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as set forth on <U>Schedule 3.1(w)</U>, the Company has not, in the 12 months preceding the date hereof, received
notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance
with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in
the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently
eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is
current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such
electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable as a result of the Underwriters and the Company fulfilling their
obligations or exercising their rights under the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Disclosure; 10b-5</U>. The Registration Statement (and any further documents to be filed with the Commission) contains all exhibits
and schedules as required by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, if any,
at the time it became effective, complied in all material respects with the Securities Act and the Exchange Act and the applicable rules
and regulations under the Securities Act and did not and, as amended or supplemented, if applicable, will not, contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.
The Preliminary Prospectus, Prospectus and the Prospectus Supplement, each as of its respective date, comply in all material respects
with the Securities Act and the Exchange Act and the applicable rules and regulations. Each of the Preliminary Prospectus, Prospectus
and the Prospectus Supplement, as amended or supplemented, did not and will not contain as of the date thereof any untrue statement of
a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under
which they were made, not misleading. The SEC Reports, when they were filed with the Commission, conformed in all material respects to
the requirements of the Exchange Act and the applicable rules and regulations, and none of such documents, when they were filed with
the Commission, contained any untrue statement of a material fact or omitted to state a material fact necessary to make the statements
therein (with respect to the SEC Reports incorporated by reference in the Preliminary Prospectus, Prospectus or Prospectus Supplement),
in light of the circumstances under which they were made not misleading; and any further documents so filed and incorporated by reference
in the Preliminary Prospectus, Prospectus or Prospectus Supplement, when such documents are filed with the Commission, will conform in
all material respects to the requirements of the Exchange Act and the applicable rules and regulations, as applicable, and will not contain
any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances
under which they were made not misleading. No post-effective amendment to the Registration Statement reflecting any facts or events arising
after the date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein is
required to be filed with the Commission. There are no documents required to be filed with the Commission in connection with the transaction
contemplated hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be filed within the requisite
time period. There are no contracts or other documents required to be described in the Preliminary Prospectus, Prospectus or Prospectus
Supplement, or to be filed as exhibits or schedules to the Registration Statement, which have not been described or filed as required.
The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not
contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made and when made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>No Integrated Offering</U>. Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause
this offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval
provisions of any Trading Market on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date. <U>Schedule 3.1(aa)</U> sets forth as of the date hereof all outstanding
secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments, and
all other qualifications, if any, to which the representations set forth in this Section 3.1(aa) are subject. Neither the Company nor
any Subsidiary is in default with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Tax Status</U>. Except as set forth on <U>Schedule 3.1(bb)</U> and except for matters that would not, individually or in the aggregate,
have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all
United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by
any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in
amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably
adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply.
There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the
Company or of any Subsidiary know of no basis for any such claim. The provisions for taxes payable, if any, shown on the financial statements
filed with or as part of the Registration Statement are sufficient for all accrued and unpaid taxes, whether or not disputed, and for
all periods to and including the dates of such consolidated financial statements. The term &ldquo;taxes&rdquo; mean all federal, state,
local, foreign, and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease,
service, service use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs,
duties or other taxes, fees, assessments, or charges of any kind whatsoever, together with any interest and any penalties, additions
to tax, or additional amounts with respect thereto. The term &ldquo;returns&rdquo; means all returns, declarations, reports, statements,
and other documents required to be filed in respect to taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Accountants</U>. To the knowledge and belief of the Company, the Company Auditor (i) is an independent registered public accounting
firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the
Company&rsquo;s Annual Report for the fiscal year ending June 30, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>FDA</U>. As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (&ldquo;<U>FDA</U>&rdquo;) under
the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&ldquo;<U>FDCA</U>&rdquo;) that is manufactured,
packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a &ldquo;<U>Pharmaceutical
Product</U>&rdquo;), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed
by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration,
investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices,
good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure
to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company&rsquo;s knowledge, threatened,
action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation)
against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter
or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration,
or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and
promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws
or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical
hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company
or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of
its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries,
and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of
the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations
of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United
States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving
or clearing for marketing any product being developed or proposed to be developed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or
prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Representative&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total
equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its
Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject
to the BHCA and to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>D&amp;O Questionnaires</U>. To the Company&rsquo;s knowledge, all information contained in the questionnaires completed by each of
the Company&rsquo;s directors and officers immediately prior to the Offering is true and correct in all respects and the Company has
not become aware of any information which would cause the information disclosed in such questionnaires become inaccurate and incorrect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>FINRA Affiliation</U>. No officer, director or any beneficial owner of 5% or more of the Company&rsquo;s unregistered securities has
any direct or indirect affiliation or association with any FINRA member (as determined in accordance with the rules and regulations of
FINRA) that is participating in the Offering. The Company will advise the Representative and EGS if it learns that any officer, director
or owner of 5% or more of the Company&rsquo;s outstanding shares of Common Stock or Common Stock Equivalents is or becomes an affiliate
or associated person of a FINRA member firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Officers&rsquo; Certificate</U>. Any certificate signed by any duly authorized officer of the Company and delivered to the Representative
or EGS shall be deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Board of Directors</U>. The Board of Directors is comprised of the persons set forth under the SEC Reports. The qualifications of
the persons serving as board members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act of 2002
and the rules promulgated thereunder applicable to the Company and the rules of the Trading Market. At least one member of the Board
of Directors qualifies as a &ldquo;financial expert&rdquo; as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules
promulgated thereunder and the rules of the Trading Market. In addition, at least a majority of the persons serving on the Board of Directors
qualify as &ldquo;independent&rdquo; as defined under the rules of the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>Cybersecurity</U>. There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s
information technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees,
suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems
and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition
that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and Data; (ii) the Company
and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations
of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy
and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation
or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries
have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and
the integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have
implemented backup and disaster recovery technology consistent with industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or
toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTHER
AGREEMENTS OF THE PARTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Amendments to Registration Statement</U>. The Company has delivered, or will as promptly as practicable deliver, to the Underwriters
complete conformed copies of the Registration Statement and of each consent and certificate of experts, as applicable, filed as a part
thereof, and conformed copies of the Registration Statement (without exhibits), the Prospectus and the Prospectus Supplement, as amended
or supplemented, in such quantities and at such places as an Underwriter reasonably requests. Neither the Company nor any of its directors
and officers has distributed and none of them will distribute, prior to the Closing Date, any offering material in connection with the
offering and sale of the Securities other than the Prospectus, the Prospectus Supplement, the Registration Statement, and copies of the
documents incorporated by reference therein. The Company shall not file any such amendment or supplement to which the Representative
shall reasonably object in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Federal Securities Laws</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Compliance</U>. During the time when a Prospectus is required to be delivered under the Securities Act, the Company will use its best
efforts to comply with all requirements imposed upon it by the Securities Act and the rules and regulations thereunder and the Exchange
Act and the rules and regulations thereunder, as from time to time in force, so far as necessary to permit the continuance of sales of
or dealings in the Securities in accordance with the provisions hereof and the Prospectus. If at any time when a Prospectus relating
to the Securities is required to be delivered under the Securities Act, any event shall have occurred as a result of which, in the opinion
of counsel for the Company or counsel for the Underwriters, the Prospectus, as then amended or supplemented, includes an untrue statement
of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they were made, not misleading, or if it is necessary at any time to amend the Prospectus to comply
with the Securities Act, the Company will notify the Underwriters promptly and prepare and file with the Commission, subject to Section
4.1 hereof, an appropriate amendment or supplement in accordance with Section 10 of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Filing of Final Prospectus Supplement</U>. The Company will file the Prospectus Supplement (in form and substance satisfactory to
the Representative) with the Commission pursuant to the requirements of Rule 424.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Exchange Act Registration</U>. For a period of three years from the Execution Date, the Company will use its best efforts to maintain
the registration of the Common Stock under the Exchange Act. The Company will not deregister the Common Stock under the Exchange Act
without the prior written consent of the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Free Writing Prospectuses</U>. The Company represents and agrees that it has not made and will not make any offer relating to the
Securities that would constitute an issuer free writing prospectus, as defined in Rule 433 of the rules and regulations under the Securities
Act, without the prior written consent of the Representative. Any such free writing prospectus consented to by the Representative is
herein referred to as a <B>&ldquo;</B><U>Permitted Free Writing Prospectus</U>.&rdquo; The Company represents that it will treat each
Permitted Free Writing Prospectus as an &ldquo;issuer free writing prospectus&rdquo; as defined in rule and regulations under the Securities
Act, and has complied and will comply with the applicable requirements of Rule 433 of the Securities Act, including timely Commission
filing where required, legending and record keeping.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Delivery to the Underwriters of Prospectuses</U>. The Company will deliver to the Underwriters, without charge, from time to time
during the period when the Prospectus is required to be delivered under the Securities Act or the Exchange Act such number of copies
of each Prospectus as the Underwriters may reasonably request and, as soon as the Registration Statement or any amendment or supplement
thereto becomes effective, deliver to you two original executed Registration Statements, including exhibits, and all post-effective amendments
thereto and copies of all exhibits filed therewith or incorporated therein by reference and all original executed consents of certified
experts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Effectiveness and Events Requiring Notice to the Underwriters</U>. The Company will use its best efforts to cause the Registration
Statement to remain effective with a current prospectus until the later of nine (9) months from the Execution Date and the date on which
the Warrants are no longer outstanding, and will notify the Underwriters and holders of the Warrants immediately and confirm the notice
in writing: (i) of the effectiveness of the Registration Statement and any amendment thereto; (ii) of the issuance by the Commission
of any stop order or of the initiation, or the threatening, of any proceeding for that purpose; (iii) of the issuance by any state securities
commission of any proceedings for the suspension of the qualification of the Securities for offering or sale in any jurisdiction or of
the initiation, or the threatening, of any proceeding for that purpose; (iv) of the mailing and delivery to the Commission for filing
of any amendment or supplement to the Registration Statement or Prospectus; (v) of the receipt of any comments or request for any additional
information from the Commission; and (vi) of the happening of any event during the period described in this Section 4.4 that, in the
judgment of the Company, makes any statement of a material fact made in the Registration Statement or the Prospectus untrue or that requires
the making of any changes in the Registration Statement or the Prospectus in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. If the Commission or any state securities commission shall enter a stop order or suspend
such qualification at any time, the Company will make every reasonable effort to obtain promptly the lifting of such order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Review of Financial Statements</U>. For a period of five (5) years from the Execution Date, the Company, at its expense, shall cause
its regularly engaged independent registered public accountants to review (but not audit) the Company&rsquo;s financial statements for
each of the first three fiscal quarters prior to the announcement of quarterly financial information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Expenses of the Offering</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>General Expenses Related to the Offering</U>. The Company hereby agrees to pay on each of the Closing Date and each Option Closing
Date, if any, to the extent not paid at the Closing Date, all expenses incident to the performance of the obligations of the Company
under this Agreement, including, but not limited to: (a) all filing fees and communication expenses relating to the registration of the
Securities to be sold in the Offering (including the Option Securities) with the Commission; (b) all FINRA Public Offering Filing System
fees associated with the review of the Offering by FINRA; all fees and expenses relating to the listing of such Closing Shares, Option
Shares and Underlying Shares on the Trading Market and such other stock exchanges as the Company and the Representative together determine;
(c) all fees, expenses and disbursements relating to the registration or qualification of such Securities under the &ldquo;blue sky&rdquo;
securities laws of such states and other foreign jurisdictions as the Representative may reasonably designate (including, without limitation,
all filing and registration fees, and the fees and expenses of Blue Sky counsel); (d) the costs of all mailing and printing of the underwriting
documents (including, without limitation, the Underwriting Agreement, any Blue Sky Surveys and, if appropriate, any Agreement Among Underwriters,
Selected Dealers&rsquo; Agreement, Underwriters&rsquo; Questionnaire and Power of Attorney), Registration Statements, Prospectuses and
all amendments, supplements and exhibits thereto and as many preliminary and final Prospectuses as the Representative may reasonably
deem necessary; (e) the costs and expenses of the Company&rsquo;s public relations firm; (f) the costs of preparing, printing and delivering
the Securities; (g) fees and expenses of the Transfer Agent for the Securities (including, without limitation, any fees required for
same-day processing of any instruction letter delivered by the Company, and fees and expenses pursuant to the Warrant Agency Agreement);
(h) stock transfer and/or stamp taxes, if any, payable upon the transfer of securities from the Company to the Underwriters; (i) the
fees and expenses of the Company&rsquo;s accountants; (j) the fees and expenses of the Company&rsquo;s legal counsel and other agents
and representatives; (k) the Underwriters&rsquo; costs of mailing prospectuses to prospective investors; (l) the costs associated with
advertising the Offering in the national editions of the Wall Street Journal and New York Times after the Closing Date; (m) the costs
of the Underwriters&rsquo; use of i-Deal&rsquo;s book-building, prospectus tracking and compliance software (or other similar software)
for the Offering; and (n) the expenses of the Underwriters&rsquo; actual &ldquo;road show&rdquo; expenses for the Offering. The Underwriters
may also deduct from the net proceeds of the Offering payable to the Company on the Closing Date, or each Option Closing Date, if any,
the expenses set forth herein to be paid by the Company to the Underwriters. Notwithstanding anything herein to the contrary, the expenses
payable to the Representative under this Section 4.6(a) shall be subject to, and shall be limited to, the Fee Cap set forth in Section
4.6(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Expenses of the Representative</U>. The Company further agrees that on the Closing Date and each Option Closing Date (if any), the
Company will (i) pay the Representative a management fee equal to 1.0% of the total gross proceeds raised in the Offering on the Closing
Date and each Option Closing Date, if any, (ii) reimburse the Representative up to $145,000 for fees and expenses of legal counsel and
other out-of-pocket expenses, by deduction from the proceeds of the Offering contemplated herein (the &ldquo;<U>Fee Cap</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Application of Net Proceeds</U>. The Company will apply the net proceeds from the Offering received by it in a manner consistent with
the application described under the caption &ldquo;Use of Proceeds&rdquo; in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Delivery of Earnings Statements to Security Holders</U>. The Company will make generally available to its security holders as soon
as practicable, but not later than the first day of the fifteenth full calendar month following the Execution Date, an earnings statement
(which need not be certified by independent public or independent certified public accountants unless required by the Securities Act
or the Rules and Regulations under the Securities Act, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the
Securities Act) covering a period of at least twelve consecutive months beginning after the Execution Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Stabilization</U>. Neither the Company, nor, to its knowledge, any of its employees, directors or shareholders (without the consent
of the Representative) has taken or will take, directly or indirectly, any action designed to or that has constituted or that might reasonably
be expected to cause or result in, under the Exchange Act, or otherwise, stabilization or manipulation of the price of any security of
the Company to facilitate the sale or resale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Internal Controls</U>. Subject to the success of the remediation efforts described in the SEC Reports, the Company will maintain a
system of internal accounting controls sufficient to provide reasonable assurances that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorization; (ii) transactions are recorded as necessary in order to permit preparation
of financial statements in accordance with GAAP and to maintain accountability for assets; (iii) access to assets is permitted only in
accordance with management&rsquo;s general or specific authorization; and (iv) the recorded accountability for assets is compared with
existing assets at reasonable intervals and appropriate action is taken with respect to any differences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>Accountants</U>. The Company shall continue to retain a nationally recognized independent certified public accounting firm for a period
of at least three years after the Execution Date. The Underwriters acknowledge that the Company Auditor is acceptable to the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>FINRA</U>. The Company shall advise the Underwriters (who shall make an appropriate filing with FINRA) if it is aware that any 5%
or greater shareholder of the Company becomes an affiliate or associated person of an Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>No Fiduciary Duties</U>. The Company acknowledges and agrees that the Underwriters&rsquo; responsibility to the Company is solely
contractual and commercial in nature, based on arms-length negotiations and that neither the Underwriters nor their affiliates or any
selected dealer shall be deemed to be acting in a fiduciary capacity, or otherwise owes any fiduciary duty to the Company or any of its
affiliates in connection with the Offering and the other transactions contemplated by this Agreement. Notwithstanding anything in this
Agreement to the contrary, the Company acknowledges that the Underwriters may have financial interests in the success of the Offering
that are not limited to the difference between the price to the public and the purchase price paid to the Company by the Underwriters
for the shares and the Underwriters have no obligation to disclose, or account to the Company for, any of such additional financial interests.
The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters
with respect to any breach or alleged breach of fiduciary duty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Underlying Shares</U>. The Shares of Common Stock underlying the Preferred Stock shall be issued free of legends. If all or any portion
of a Warrant is exercised at a time when there is an effective registration statement to cover the issuance of the Warrant Shares or
if the Warrant is exercised via cashless exercise, the Warrant Shares issued pursuant to any such exercise shall be issued free of all
restrictive legends. If at any time following the date hereof the Registration Statement (or any subsequent registration statement registering
the sale or resale of the Warrant Shares) is not effective or is not otherwise available for the sale of the Warrant Shares, the Company
shall immediately notify the holders of the Warrants in writing that such registration statement is not then effective and thereafter
shall promptly notify such holders when the registration statement is effective again and available for the sale of the Warrant Shares
(it being understood and agreed that the foregoing shall not limit the ability of the Company to issue, or any holder thereof to sell,
any of the Warrant Shares in compliance with applicable federal and state securities laws).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
<U>Board Composition and Board Designations</U>. The Company shall ensure that: (i) the qualifications of the persons serving as board
members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder
and with the listing requirements of the Trading Market and (ii) if applicable, at least one member of the Board of Directors qualifies
as a &ldquo;financial expert&rdquo; as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16
<U>Securities Laws Disclosure; Publicity</U>. At the request of the Representative, by 9:00 a.m. (New York City time) on the date hereof,
the Company shall issue a press release disclosing the material terms of the Offering. The Company and the Representative shall consult
with each other in issuing any other press releases with respect to the Offering, and neither the Company nor any Underwriter shall issue
any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press
release of such Underwriter, or without the prior consent of such Underwriter, with respect to any press release of the Company, which
consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party
shall promptly provide the other party with prior notice of such public statement or communication. The Company will not issue press
releases or engage in any other publicity, without the Representative&rsquo;s prior written consent, for a period ending at 5:00 p.m.
(New York City time) on the first business day following the 45th day following the Closing Date, other than normal and customary releases
issued in the ordinary course of the Company&rsquo;s business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Underwriter of the Securities is an &ldquo;Acquiring Person&rdquo; under any control share acquisition, business combination,
poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter
adopted by the Company, or that any Underwriter of Securities could be deemed to trigger the provisions of any such plan or arrangement,
by virtue of receiving Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18
<U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep
available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company
to issue Shares and Conversion Option Shares pursuant to this Agreement and shall reserve and keep available at all times, free of preemptive
rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue common stock pursuant to the conversion
of Series E Convertible Preferred Stock, and Warrant Shares pursuant to any exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19
<U>Listing of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock
on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all
of the Closing Shares, Option Shares and Underlying Shares on such Trading Market and promptly secure the listing of all of the Closing
Shares, Option Shares and Underlying Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common
Stock traded on any other Trading Market, it will then include in such application all of the Closing Shares, Option Shares and Underlying
Shares, and will take such other action as is necessary to cause all of the Closing Shares, Option Shares and Underlying Shares to be
listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to
continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s reporting,
filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common
Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation,
by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic
transfer. In addition, the Company shall hold an annual or special meeting of stockholders on or prior to December 4, 2023 for the purpose
of obtaining Shareholder Approval, with the recommendation of the Company&rsquo;s Board of Directors that such proposal is approved,
and the Company shall solicit proxies from its stockholders in connection therewith in the same manner as all other management proposals
in such proxy statement and all management-appointed proxyholders shall vote their proxies in favor of such proposal. If the Company
does not obtain Shareholder Approval at the first meeting, the Company shall call a meeting within every forty-five (45) day period thereafter
to seek Shareholder Approval until the earlier of the date on which Shareholder Approval is obtained or the Warrants are no longer outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20
<U>Subsequent Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until the later of (i) ninety (90) days after the Closing Date and (ii) fifteen (15) days following the date Shareholder
Approval is received and effective, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce
the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
From the date hereof until the one (1) year anniversary of the Closing Date, the Company shall be prohibited from effecting or entering
into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a
combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction
in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or
include the right to receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or
other price that is based upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after
the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being
reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent
events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects
a transaction under, any agreement, including, but not limited to, an equity line of credit or an &ldquo;at-the-market offering&rdquo;,
whereby the Company may issue securities at a future determined price regardless of whether shares pursuant to such agreement have actually
been issued and regardless of whether such agreement is subsequently canceled; <U>provided</U>, <U>however</U>, that, ninety (90) days
after the Closing Date, the entry into and/or issuance of shares of Common Stock in an &ldquo;at the market&rdquo; offering with the
Representative as sales agent shall not be deemed a Variable Rate Transaction. Any Underwriter shall be entitled to obtain injunctive
relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding the foregoing, this Section 4.20 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction
shall be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.21
<U>Research Independence</U>. The Company acknowledges that each Underwriter&rsquo;s research analysts and research departments, if any,
are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal
policies, and that such Underwriter&rsquo;s research analysts may hold and make statements or investment recommendations and/or publish
research reports with respect to the Company and/or the offering that differ from the views of its investment bankers. The Company hereby
waives and releases, to the fullest extent permitted by law, any claims that the Company may have against such Underwriter with respect
to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research
departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriter&rsquo;s investment
banking divisions. The Company acknowledges that the Representative is a full service securities firm and as such from time to time,
subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short
position in debt or equity securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.22
<U>Record Date</U>. The Company agrees to set the record date (the &ldquo;<U>Record Date</U>&rdquo;) for purposes of obtaining Shareholder
Approval on September 28, 2023. The Company covenants it will not change or amend the Record Date unless agreed to by the Representative;
<U>provided that</U>, if any such change is made to the Record Date, the Company will obtain additional duly executed Voting Agreements
in form and substance deemed acceptable by the Representative, representing shares at least equal to the shares originally represented
by the Voting Agreements delivered on the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFAULT
BY UNDERWRITERS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">If
on the Closing Date or any Option Closing Date, if any, any Underwriter shall fail to purchase and pay for the portion of the Closing
Securities or Option Securities, as the case may be, which such Underwriter has agreed to purchase and pay for on such date (otherwise
than by reason of any default on the part of the Company), the Representative, or if the Representative is the defaulting Underwriter,
the non-defaulting Underwriters, shall use their reasonable efforts to procure within 36 hours thereafter one or more of the other Underwriters,
or any others, to purchase from the Company such amounts as may be agreed upon and upon the terms set forth herein, the Closing Securities
or Option Securities , as the case may be, which the defaulting Underwriter or Underwriters failed to purchase. If during such 36 hours
the Representative shall not have procured such other Underwriters, or any others, to purchase the Closing Securities or Option Securities,
as the case may be, agreed to be purchased by the defaulting Underwriter or Underwriters, then (a) if the aggregate number of Closing
Securities or Option Securities, as the case may be, with respect to which such default shall occur does not exceed 10% of the Closing
Securities or Option Securities, as the case may be, covered hereby, the other Underwriters shall be obligated, severally, in proportion
to the respective numbers of Closing Securities or Option Securities, as the case may be, which they are obligated to purchase hereunder,
to purchase the Closing Securities or Option Securities, as the case may be, which such defaulting Underwriter or Underwriters failed
to purchase, or (b) if the aggregate number of Closing Securities or Option Securities, as the case may be, with respect to which such
default shall occur exceeds 10% of the Closing Securities or Option Securities, as the case may be, covered hereby, the Company or the
Representative will have the right to terminate this Agreement without liability on the part of the non-defaulting Underwriters or of
the Company except to the extent provided in Article VI hereof. In the event of a default by any Underwriter or Underwriters, as set
forth in this Article V, the applicable Closing Date may be postponed for such period, not exceeding seven days, as the Representative,
or if the Representative is the defaulting Underwriter, the non-defaulting Underwriters, may determine in order that the required changes
in the Prospectus or in any other documents or arrangements may be effected. The term &ldquo;Underwriter&rdquo; includes any Person substituted
for a defaulting Underwriter. Any action taken under this Section shall not relieve any defaulting Underwriter from liability in respect
of any default of such Underwriter under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VI.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEMNIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
<U>Indemnification of the Underwriters</U>. Subject to the conditions set forth below, the Company agrees to indemnify and hold harmless
the Underwriters, and each dealer selected by each Underwriter that participates in the offer and sale of the Securities (each a &ldquo;<U>Selected
Dealer</U>&rdquo;) and each of their respective directors, officers and employees and each Person, if any, who controls such Underwriter
or any Selected Dealer (&ldquo;<U>Controlling Person</U>&rdquo;) within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act, against any and all loss, liability, claim, damage and expense whatsoever (including but not limited to any and
all legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, commenced or threatened,
or any claim whatsoever, whether arising out of any action between such Underwriter and the Company or between such Underwriter and any
third party or otherwise) to which they or any of them may become subject under the Securities Act, the Exchange Act or any other statute
or at common law or otherwise or under the laws of foreign countries, arising out of or based upon any untrue statement or alleged untrue
statement of a material fact contained in (i) any Preliminary Prospectus, if any, the Registration Statement or the Prospectus (as from
time to time each may be amended and supplemented); (ii) any materials or information provided to investors by, or with the approval
of, the Company in connection with the marketing of the offering of the Securities, including any &ldquo;road show&rdquo; or investor
presentations made to investors by the Company (whether in person or electronically); or (iii) any application or other document or written
communication (in this Article VI, collectively called &ldquo;<U>application</U>&rdquo;) executed by the Company or based upon written
information furnished by the Company in any jurisdiction in order to qualify the Securities under the securities laws thereof or filed
with the Commission, any state securities commission or agency, Trading Market or any securities exchange; or the omission or alleged
omission therefrom of a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading, unless such statement or omission was made in reliance upon and in conformity with written
information furnished to the Company with respect to the applicable Underwriter by or on behalf of such Underwriter expressly for use
in any Preliminary Prospectus, if any, the Registration Statement or Prospectus, or any amendment or supplement thereto, or in any application,
as the case may be. With respect to any untrue statement or omission or alleged untrue statement or omission made in the Preliminary
Prospectus, if any, the indemnity agreement contained in this Section 6.1 shall not inure to the benefit of an Underwriter to the extent
that any loss, liability, claim, damage or expense of such Underwriter results from the fact that a copy of the Prospectus was not given
or sent to the Person asserting any such loss, liability, claim or damage at or prior to the written confirmation of sale of the Securities
to such Person as required by the Securities Act and the rules and regulations thereunder, and if the untrue statement or omission has
been corrected in the Prospectus, unless such failure to deliver the Prospectus was a result of non-compliance by the Company with its
obligations under this Agreement. The Company agrees promptly to notify each Underwriter of the commencement of any litigation or proceedings
against the Company or any of its officers, directors or Controlling Persons in connection with the issue and sale of the Public Securities
or in connection with the Registration Statement or Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
<U>Procedure</U>. If any action is brought against an Underwriter, a Selected Dealer or a Controlling Person in respect of which indemnity
may be sought against the Company pursuant to Section 6.1, such Underwriter, such Selected Dealer or Controlling Person, as the case
may be, shall promptly notify the Company in writing of the institution of such action and the Company shall assume the defense of such
action, including the employment and fees of counsel (subject to the reasonable approval of such Underwriter or such Selected Dealer,
as the case may be) and payment of actual expenses. Such Underwriter, such Selected Dealer or Controlling Person shall have the right
to employ its or their own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of such Underwriter,
such Selected Dealer or Controlling Person unless (i) the employment of such counsel at the expense of the Company shall have been authorized
in writing by the Company in connection with the defense of such action, or (ii) the Company shall not have employed counsel to have
charge of the defense of such action, or (iii) such indemnified party or parties shall have reasonably concluded that there may be defenses
available to it or them which are different from or additional to those available to the Company (in which case the Company shall not
have the right to direct the defense of such action on behalf of the indemnified party or parties), in any of which events the reasonable
fees and expenses of not more than one additional firm of attorneys selected by such Underwriter (in addition to local counsel), Selected
Dealer and/or Controlling Person shall be borne by the Company. Notwithstanding anything to the contrary contained herein, if any Underwriter,
Selected Dealer or Controlling Person shall assume the defense of such action as provided above, the Company shall have the right to
approve the terms of any settlement of such action which approval shall not be unreasonably withheld.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
<U>Indemnification of the Company</U>. Each Underwriter severally and not jointly agrees to indemnify and hold harmless the Company,
its directors, officers and employees and agents who control the Company within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act against any and all loss, liability, claim, damage and expense described in the foregoing indemnity from the Company
to such Underwriter, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions
made in any Preliminary Prospectus, if any, the Registration Statement or Prospectus or any amendment or supplement thereto or in any
application, in reliance upon, and in strict conformity with, written information furnished to the Company with respect to such Underwriter
by or on behalf of such Underwriter expressly for use in such Preliminary Prospectus, if any, the Registration Statement or Prospectus
or any amendment or supplement thereto or in any such application. In case any action shall be brought against the Company or any other
Person so indemnified based on any Preliminary Prospectus, if any, the Registration Statement or Prospectus or any amendment or supplement
thereto or any application, and in respect of which indemnity may be sought against such Underwriter, such Underwriter shall have the
rights and duties given to the Company, and the Company and each other Person so indemnified shall have the rights and duties given to
such Underwriter by the provisions of this Article VI. Notwithstanding the provisions of this Section 6.3, no Underwriter shall be required
to indemnify the Company for any amount in excess of the underwriting discounts and commissions applicable to the Securities purchased
by such Underwriter. The Underwriters&rsquo; obligations in this Section 6.3 to indemnify the Company are several in proportion to their
respective underwriting obligations and not joint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4
<U>Contribution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Contribution Rights</U>. In order to provide for just and equitable contribution under the Securities Act in any case in which (i)
any Person entitled to indemnification under this Article VI makes a claim for indemnification pursuant hereto but it is judicially determined
(by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of
the last right of appeal) that such indemnification may not be enforced in such case notwithstanding the fact that this Article VI provides
for indemnification in such case, or (ii) contribution under the Securities Act, the Exchange Act or otherwise may be required on the
part of any such Person in circumstances for which indemnification is provided under this Article VI, then, and in each such case, the
Company and each Underwriter, severally and not jointly, shall contribute to the aggregate losses, liabilities, claims, damages and expenses
of the nature contemplated by said indemnity agreement incurred by the Company and such Underwriter, as incurred, in such proportions
that such Underwriter is responsible for that portion represented by the percentage that the underwriting discount appearing on the cover
page of the Prospectus bears to the initial offering price appearing thereon and the Company is responsible for the balance; provided,
that, no Person guilty of a fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled
to contribution from any Person who was not guilty of such fraudulent misrepresentation. For purposes of this Section, each director,
officer and employee of such Underwriter or the Company, as applicable, and each Person, if any, who controls such Underwriter or the
Company, as applicable, within the meaning of Section 15 of the Securities Act shall have the same rights to contribution as such Underwriter
or the Company, as applicable. Notwithstanding the provisions of this Section 6.4, no Underwriter shall be required to contribute any
amount in excess of the underwriting discounts and commissions applicable to the Securities purchased by such Underwriter. The Underwriters&rsquo;
obligations in this Section 6.4 to contribute are several in proportion to their respective underwriting obligations and not joint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Contribution Procedure</U>. Within fifteen days after receipt by any party to this Agreement (or its representative) of notice of
the commencement of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof is to be made against
another party (&ldquo;<U>contributing party</U>&rdquo;), notify the contributing party of the commencement thereof, but the failure to
so notify the contributing party will not relieve it from any liability which it may have to any other party other than for contribution
hereunder. In case any such action, suit or proceeding is brought against any party, and such party notifies a contributing party or
its representative of the commencement thereof within the aforesaid fifteen days, the contributing party will be entitled to participate
therein with the notifying party and any other contributing party similarly notified. Any such contributing party shall not be liable
to any party seeking contribution on account of any settlement of any claim, action or proceeding affected by such party seeking contribution
without the written consent of such contributing party. The contribution provisions contained in this Section 6.4 are intended to supersede,
to the extent permitted by law, any right to contribution under the Securities Act, the Exchange Act or otherwise available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VII.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
<U>Termination</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Termination Right</U>. The Representative shall have the right to terminate this Agreement at any time prior to any Closing Date,
by notice to the Company: (i) if any domestic or international event or act or occurrence has materially disrupted, or in its opinion
will in the immediate future materially disrupt, general securities markets in the United States; or (ii) if trading on any Trading Market
shall have been suspended or materially limited, or minimum or maximum prices for trading shall have been fixed, or maximum ranges for
prices for securities shall have been required by FINRA or by order of the Commission or any other government authority having jurisdiction,
or (iii) if the United States shall have become involved in a new war or an increase in major hostilities, or (iv) if a banking moratorium
has been declared by a New York State or federal authority, or (v) if a moratorium on foreign exchange trading has been declared which
materially adversely impacts the United States securities markets, or (vi) if the Company shall have sustained a material loss by fire,
flood, accident, hurricane, earthquake, theft, sabotage or other calamity or malicious act which, whether or not such loss shall have
been insured, will, in the Representative&rsquo;s opinion, make it inadvisable to proceed with the delivery of the Securities, or (vii)
if the Company is in material breach of any of its representations, warranties or covenants hereunder, or (viii) if the Representative
shall have become aware after the date hereof of such a material adverse change in the conditions or prospects of the Company, or such
adverse material change in general market conditions as in the Representative&rsquo;s judgment would make it impracticable to proceed
with the offering, sale and/or delivery of the Securities or to enforce contracts made by the Underwriters for the sale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Expenses</U>. In the event this Agreement shall be terminated pursuant to Section 7.1(a), within the time specified herein or any
extensions thereof pursuant to the terms herein, the Company shall be obligated to pay to the Representative its actual and accountable
out of pocket expenses related to the transactions contemplated herein then due and payable, including the fees and disbursements of
EGS up to $50,000 (<U>provided</U>, <U>however</U>, that such expense cap in no way limits or impairs the indemnification and contribution
provisions of this Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Indemnification</U>. Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination
of this Agreement, and whether or not this Agreement is otherwise carried out, the provisions of Article VI shall not be in any way effected
by such election or termination or failure to carry out the terms of this Agreement or any part hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus
Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior
agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules. Notwithstanding anything herein to the contrary, the Investment Banking Agreement, dated February
26, 2022 (the &ldquo;<U>Engagement Agreement</U>&rdquo;), as amended, by and between the Company and the Representative, shall continue
to be effective and the terms therein, including, without limitation, Section 4(b) and Section 5 with respect to any future offerings,
shall continue to survive and be enforceable by the Representative in accordance with its terms, provided that, in the event of a conflict
between the terms of the Engagement Agreement and this Agreement, the terms of this Agreement shall prevail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via e-mail attachment at the email address set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York
City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via
e-mail attachment at the e-mail address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if
sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required
to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and the Representative. No waiver of any default with respect to any provision, condition
or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver
of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder
in any manner impair the exercise of any such right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflict of laws thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient
venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If either party shall commence an Action or Proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company under Article VI, the prevailing party in such Action or Proceeding shall
be reimbursed by the other party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.8
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the Option Closing, if any, and the
delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.9
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.10
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.11
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
the Underwriters and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary
damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents
and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at
law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.12
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.13
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.14
<B><U>WAIVER OF JURY TRIAL</U>. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY ARISING
OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST
EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVE FOREVER ANY RIGHT TO TRIAL BY
JURY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing correctly sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided
below for that purpose, whereupon this letter shall constitute a binding agreement among the Company and the several Underwriters in
accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTELLIGENT
    BIO SOLUTIONS INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Spiro Sakiris</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spiro
    Sakiris</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Notice:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intelligent
    Bio Solutions Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">142
    West 57<SUP>th</SUP> Street, Floor 11</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, NY 10019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
    spiro.sakiris@ibs.com</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    Spiro Sakiris</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Copy
    to:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Arent
    Fox Schiff LLP</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1717
    K Street NW, Washington, DC 20006</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
    ralph.demartino@afslaw.com</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    Ralph De Martino</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
    on the date first above written.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladenburg
    Thalmann &amp; Co. Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    the Representative of the several</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriters
    listed on Schedule I</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    Ladenburg Thalmann &amp; Co. Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Nicholas Stergis</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas
    Stergis</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing
    Director-Investment Banking</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Notice:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">640
    Fifth Avenue, 4<SUP>th</SUP> Floor</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, NY 10019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Copy
    to:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ellenoff
    Grossman &amp; Schole LLP</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1345
    Avenue of the Americas</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, NY 10105</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
    capmkts@egsllp.com</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    Michael Nertney, Esq.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">Schedule
of Underwriters</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 30%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underwriters</B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Closing</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares</B></FONT></P></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Closing</B></FONT></P>
                                                                                                                                                   <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares</B></FONT></P></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Closing
                                            E</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrants</B></FONT></P></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Closing
                                            F</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrants</B></FONT></P></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Closing</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purchase</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price</B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladenburg
    Thalmann &amp; Co. Inc.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,544,004</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,728,723</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,272,727</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,272,727</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,679,999.86</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1,544,004</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5,728,723</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7,272,727</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7,272,727</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3,679,999.86</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
1.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
Agreement Signatories</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven
    Boyages</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrence
    Fisher</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jonathan
    Hurd</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason
    Isenberg</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Jenkins</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spiro
    Sakiris</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harry
    Simeonidis</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher
    Towers</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Gary W. Rollins Foundation</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Ma-Ran Foundation</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
1.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Voting
Agreement Signatories</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven
    Boyages</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrence
    Fisher</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jonathan
    Hurd</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason
    Isenberg</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Jenkins</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spiro
    Sakiris</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harry
    Simeonidis</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher
    Towers</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phillip
    Hand</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Gary W. Rollins Foundation</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Ma-Ran Foundation</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>3
<FILENAME>ex3-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Intelligent
Bio Solutions Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF DESIGNATION OF PREFERENCES,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RIGHTS
AND LIMITATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
E CONVERTIBLE PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">PURSUANT
TO SECTION 151 OF THE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">delaware
GENERAL CORPORATION LAW</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Spiro Sakiris, does hereby certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
He is the Chief Financial Officer of Intelligent Bio Solutions Inc., a Delaware corporation (the &ldquo;<U>Corporation</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The Corporation is authorized to issue 10,000,000 shares of preferred stock, none of which are outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
The following resolutions were duly adopted by the board of directors of the Corporation (the &ldquo;<U>Board of Directors</U>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the certificate of incorporation of the Corporation provides for a class of its authorized stock known as preferred stock, consisting
of 10,000,000 shares, $0.01 par value per share, issuable from time to time in one or more series;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Board of Directors is authorized to designate and establish the number of shares to be included in each such series of preferred
stock, and to fix the powers, designation, preferences and rights of the shares of each such series and the qualifications, limitations
or restrictions thereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions and
other matters relating to a series of the preferred stock, which shall consist of 5,728,723 shares of the preferred stock which the Corporation
has the authority to issue, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, BE IT RESOLVED, that the Board of Directors does hereby provide for the issuance of a series of preferred stock for cash or
exchange of other securities, rights or property and does hereby fix and determine the rights, preferences, restrictions and other matters
relating to such series of preferred stock as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERMS
OF PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. For the purposes hereof, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Alternate
Consideration</U>&rdquo; shall have the meaning set forth in Section 7(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall have the meaning set forth in Section 6(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Buy-In</U>&rdquo;
shall have the meaning set forth in Section 6(c)(iv).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Corporation&rsquo;s common stock, par value $0.01 per share, and stock of any other class of securities into
which such securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Corporation or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Amount</U>&rdquo; means the sum of the Stated Value at issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Date</U>&rdquo; shall have the meaning set forth in Section 6(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Price</U>&rdquo; shall have the meaning set forth in Section 6(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Shares</U>&rdquo; means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance
with the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Fundamental
Transaction</U>&rdquo; shall have the meaning set forth in Section 7(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
means United States generally accepted accounting principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Holder</U>&rdquo;
shall have the meaning given such term in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liquidation</U>&rdquo;
shall have the meaning set forth in Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>New
York Courts</U>&rdquo; shall have the meaning set forth in Section 8(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Notice
of Conversion</U>&rdquo; shall have the meaning set forth in Section 6(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Original
Issue Date</U>&rdquo; means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers
of any particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such Preferred
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preferred
Stock</U>&rdquo; shall have the meaning set forth in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Share
Delivery Date</U>&rdquo; shall have the meaning set forth in Section 6(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stated
Value</U>&rdquo; shall have the meaning set forth in Section 2, as the same may be increased pursuant to Section 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any direct or indirect subsidiary of the Corporation and shall, where applicable, also include any direct or indirect subsidiary
of the Corporation formed or acquired after the date Original Issue Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Successor
Entity</U>&rdquo; shall have the meaning set forth in Section 7(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust, the current transfer agent of the Corporation, with a mailing address
of 1 State Street 30th Floor, New York, NY 10004-1561, and any successor transfer agent of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Preferred Stock then outstanding and reasonably acceptable to
the Corporation, the fees and expenses of which shall be paid by the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Designation, Amount and Par Value</U>. The series of preferred stock shall be designated as its Series E Convertible Preferred
Stock (the &ldquo;<U>Preferred Stock</U>&rdquo;) and the number of shares so designated shall be 5,728,723 (which shall not be subject
to increase without the written consent of the holders of a majority of the then outstanding shares of the Preferred Stock (each, a &ldquo;<U>Holder</U>&rdquo;
and collectively, the &ldquo;<U>Holders</U>&rdquo;)). Each share of Preferred Stock shall have a par value of $0.01 per share and a stated
value equal to $0.55 (the &ldquo;<U>Stated Value</U>&rdquo;). The Preferred Stock will initially be issued in book-entry form and shall
initially be represented only by one or more global certificates deposited with the Depository Trust Company (&ldquo;<U>DTC</U>&rdquo;)
and registered in the name of Cede &amp; Co., a nominee of DTC, or as otherwise directed by DTC. As between the Corporation and a beneficial
owner of Preferred Stock shall have all of the rights and remedies of a Holder hereunder. In addition, a beneficial owner of Preferred
Stock has the right, upon written notice by such beneficial owner to the Corporation, to request the exchange of some or all of such
beneficial owner&rsquo;s interest in Preferred Stock represented by one or more global Preferred Stock certificates deposited with Cede
&amp; Co. (or its successor) for a physical Preferred Stock certificate (a &ldquo;<U>Preferred Stock Certificate Request Notice</U>&rdquo;
and the date of delivery of such Preferred Stock Certificate Request Notice by a beneficial owner, the &ldquo;<U>Preferred Stock Certificate
Request Notice Date</U>&rdquo; and the deemed surrender upon delivery by the beneficial owner of a number of global shares of Preferred
Stock for the same number of shares of Preferred Stock represented by a physical stock certificate, a &ldquo;<U>Preferred Stock Exchange</U>&rdquo;,
and such physical certificate(s), a &ldquo;<U>Preferred Stock Certificate</U>&rdquo;). Upon delivery of a Preferred Stock Certificate
Request Notice, the Corporation shall promptly effect the Preferred Stock Exchange and shall promptly issue and deliver to the beneficial
owner a physical Preferred Stock Certificate for such number of shares of Preferred Stock represented by its interest in such global
certificates in the name of the beneficial owner. Such Preferred Stock Certificate shall be dated the Original Issue Date and shall be
executed by an authorized signatory of the Corporation. In connection with a Preferred Stock Exchange, the Corporation agrees to deliver
the Preferred Stock Certificate to the Holder within two (2) Business Days of the delivery of a properly completed and executed Preferred
Stock Certificate Request Notice pursuant to the delivery instructions in the Preferred Stock Certificate Request Notice. The Corporation
covenants and agrees that, upon the date of delivery of the properly completed and executed Preferred Stock Certificate Request Notice,
the Holder shall be deemed to be the holder of the Preferred Stock Certificate and further, for purposes of Regulation SHO, a Holder
whose interest in this Preferred Stock is a beneficial interest in certificate(s) representing this Preferred Stock held in book-entry
form through DTC shall be deemed to have converted its interest in this Preferred Stock upon instructing its broker that is a DTC participant
to convert its interest in this Preferred Stock, and, notwithstanding anything to the contrary set forth herein, the Preferred Stock
Certificate shall be deemed for all purposes to represent all of the terms and conditions of the Preferred Stock evidenced by such global
Preferred Stock certificates and the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Dividends</U>. Except for stock dividends or distributions for which adjustments are to be made pursuant to Section 7, Holders
shall be entitled to receive, and the Corporation shall pay, dividends on shares of Preferred Stock equal (on an as-if-converted-to-Common-Stock
basis calculated using the then current Conversion Price for the Preferred Stock on the record date for such dividend, disregarding for
such purpose any conversion limitations hereunder) to and in the same form as dividends actually paid on shares of the Common Stock when,
as and if such dividends are paid on shares of the Common Stock. No other dividends shall be paid on shares of Preferred Stock. The Corporation
shall not pay any dividends on the Common Stock unless the Corporation simultaneously complies with this provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Voting Rights</U>. Except as otherwise provided herein or as otherwise required by law, the Preferred Stock shall have no voting
rights. However, as long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of
the Holders of a majority of the then outstanding shares of the Preferred Stock, (a) alter or change adversely the powers, preferences
or rights given to the Preferred Stock or alter or amend this Certificate of Designation, (b) amend its certificate of incorporation
or other charter documents in any manner that adversely affects any rights of the Holders, (c) increase the number of authorized shares
of Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Liquidation</U>. Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a &ldquo;<U>Liquidation</U>&rdquo;),
the Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Corporation the same amount that a holder
of Common Stock would receive if the Preferred Stock were fully converted (disregarding for such purposes any conversion limitations
hereunder) to Common Stock which amounts shall be paid <U>pari passu</U> with all holders of Common Stock. The Corporation shall mail
written notice of any such Liquidation, not less than 30 days prior to the payment date stated therein, to each Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6</U>. <U>Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Conversions at Option of Holder</U>. Each share of Preferred Stock shall be convertible, at any time and from time to time on or after
the Original Issue Date, at the option of the Holder thereof, into that number of shares of Common Stock (subject to the limitations
set forth in Section 6(d)) determined by dividing the Stated Value of such share of Preferred Stock by the Conversion Price. Holders
shall effect conversions by providing the Corporation with the form of conversion notice attached hereto as <U>Annex A</U> (a &ldquo;<U>Notice
of Conversion</U>&rdquo;). Each Notice of Conversion shall specify the number of shares of Preferred Stock to be converted, the number
of shares of Preferred Stock owned prior to the conversion at issue, the number of shares of Preferred Stock owned subsequent to the
conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the date the applicable Holder
delivers by email such Notice of Conversion to the Corporation (such date, the &ldquo;<U>Conversion Date</U>&rdquo;). If no Conversion
Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to the Corporation
is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other type
of guarantee or notarization) of any Notice of Conversion form be required. The calculations and entries set forth in the Notice of Conversion
shall control in the absence of manifest or mathematical error. To effect conversions of shares of Preferred Stock, a Holder shall not
be required to surrender the certificate(s) representing the shares of Preferred Stock to the Corporation unless all of the shares of
Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares
of Preferred Stock promptly following the Conversion Date at issue. Shares of Preferred Stock converted into Common Stock or redeemed
in accordance with the terms hereof shall be canceled and shall not be reissued. Notwithstanding the foregoing in this Section 6(a),
a holder whose interest in the Preferred Stock is a beneficial interest in certificate(s) representing the Preferred Stock held in book-entry
form through DTC (or another established clearing corporation performing similar functions), shall effect conversions made pursuant to
this Section 6(a) by delivering to DTC (or such other clearing corporation, as applicable) the appropriate instruction form for conversion,
complying with the procedures to effect conversions that are required by DTC (or such other clearing corporation, as applicable), subject
to a Holder&rsquo;s right to elect to receive Preferred Stock in certificated form pursuant to Section 2, in which case this sentence
shall not apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Conversion Price</U>. The conversion price for the Preferred Stock shall equal $0.55 (the &ldquo;<U>Conversion Price</U>&rdquo;),
subject to adjustment as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Mechanics of Conversion</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Conversion Shares Upon Conversion</U>. Not later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading
Days comprising the Standard Settlement Period (as defined below) after each Conversion Date (the &ldquo;<U>Share Delivery Date</U>&rdquo;),
the Corporation shall deliver, or cause to be delivered, to the converting Holder (A) Conversion Shares which shall be free of restrictive
legends and trading restrictions representing the number of Conversion Shares being acquired upon the conversion of the Preferred Stock,
and (B) a bank check in the amount of accrued and unpaid dividends, if any. The Corporation shall use its best efforts to deliver the
Conversion Shares required to be delivered by the Corporation under this Section 6 electronically through the Depository Trust Company
or another established clearing corporation performing similar functions. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Corporation&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Conversion. Notwithstanding the foregoing, with respect to
any Notice(s) of Conversion delivered by 12:00 p.m. (New York City time) on the Original Issue Date, the Corporation agrees to deliver
the Conversion Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Original Issue Date, and the Original Issue
Date being deemed the &ldquo;Share Delivery Date&rdquo; with respect to any such Notice(s) of Conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Failure to Deliver Conversion Shares</U>. If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to
or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Corporation
at any time on or before its receipt of such Conversion Shares, to rescind such Conversion, in which event the Corporation shall promptly
return to the Holder any original Preferred Stock certificate delivered to the Corporation and the Holder shall promptly return to the
Corporation the Conversion Shares issued to such Holder pursuant to the rescinded Notice of Conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Obligation Absolute; Partial Liquidated Damages</U>. The Corporation&rsquo;s obligation to issue and deliver the Conversion Shares
upon conversion of Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of any action or
inaction by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against
any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged
breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged violation of law by such Holder
or any other person, and irrespective of any other circumstance which might otherwise limit such obligation of the Corporation to such
Holder in connection with the issuance of such Conversion Shares; <U>provided</U>, <U>however</U>, that such delivery shall not operate
as a waiver by the Corporation of any such action that the Corporation may have against such Holder. In the event a Holder shall elect
to convert any or all of the Stated Value of its Preferred Stock, the Corporation may not refuse conversion based on any claim that such
Holder or anyone associated or affiliated with such Holder has been engaged in any violation of law, agreement or for any other reason,
unless an injunction from a court, on notice to Holder, restraining and/or enjoining conversion of all or part of the Preferred Stock
of such Holder shall have been sought and obtained, and the Corporation posts a surety bond for the benefit of such Holder in the amount
of 125% of the Stated Value of Preferred Stock which is subject to the injunction, which bond shall remain in effect until the completion
of arbitration/litigation of the underlying dispute and the proceeds of which shall be payable to such Holder to the extent it obtains
judgment. In the absence of such injunction, the Corporation shall issue Conversion Shares and, if applicable, cash, upon a properly
noticed conversion. If the Corporation fails to deliver to a Holder such Conversion Shares pursuant to Section 6(c)(i) by the Share Delivery
Date applicable to such conversion, the Corporation shall pay to such Holder, in cash, as liquidated damages and not as a penalty, for
each $5,000 of Stated Value of Preferred Stock being converted, $50 per Trading Day (increasing to $100 per Trading Day on the third
Trading Day and increasing to $200 per Trading Day on the sixth Trading Day after such damages begin to accrue) for each Trading Day
after the Share Delivery Date until such Conversion Shares are delivered or Holder rescinds such conversion. Notwithstanding anything
herein to the contrary, the Corporation shall not be responsible for the payment of liquidated damages resulting from the failure to
issue or deliver Conversion Shares if such failure is caused by any action or inaction of the Holder. Nothing herein shall limit a Holder&rsquo;s
right to pursue actual damages for the Corporation&rsquo;s failure to deliver Conversion Shares within the period specified herein and
such Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit a Holder from seeking to
enforce damages pursuant to any other Section hereof or under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Conversion Shares Upon Conversion</U>. In addition to any other rights available
to the Holder, if the Corporation fails for any reason to deliver to a Holder the applicable Conversion Shares by the Share Delivery
Date pursuant to Section 6(c)(i), and if after such Share Delivery Date such Holder is required by its brokerage firm to purchase (in
an open market transaction or otherwise), or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive upon the conversion relating
to such Share Delivery Date (a &ldquo;<U>Buy-In</U>&rdquo;), then the Corporation shall (A) pay in cash to such Holder (in addition to
any other remedies available to or elected by such Holder) the amount, if any, by which (x) such Holder&rsquo;s total purchase price
(including any brokerage commissions) for the Common Stock so purchased exceeds (y) the product of (1) the aggregate number of shares
of Common Stock that such Holder was entitled to receive from the conversion at issue multiplied by (2) the actual sale price at which
the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B) at the option of such
Holder, either reissue (if surrendered) the shares of Preferred Stock equal to the number of shares of Preferred Stock submitted for
conversion (in which case, such conversion shall be deemed rescinded) or deliver to such Holder the number of shares of Common Stock
that would have been issued if the Corporation had timely complied with its delivery requirements under Section 6(c)(i). For example,
if a Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted
conversion of shares of Preferred Stock with respect to which the actual sale price of the Conversion Shares (including any brokerage
commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A) of the immediately preceding sentence, the
Corporation shall be required to pay such Holder $1,000. The Holder shall provide the Corporation written notice indicating the amounts
payable to such Holder in respect of the Buy-In and, upon request of the Corporation, evidence of the amount of such loss. Nothing herein
shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief with respect to the Corporation&rsquo;s failure to timely deliver Conversion
Shares upon conversion of the shares of Preferred Stock as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>Reservation of Shares Issuable Upon Conversion</U>. The Corporation covenants that it will at all times reserve and keep available
out of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Preferred Stock as
herein provided, free from preemptive rights or any other actual contingent purchase rights of Persons other than the Holder (and the
other holders of the Preferred Stock), not less than such aggregate number of shares of the Common Stock as shall be issuable (taking
into account the adjustments and restrictions of Section 7) upon the conversion of the then outstanding shares of Preferred Stock. The
Corporation covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued,
fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Fractional Shares</U>. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Preferred
Stock. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Corporation shall
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Conversion Price or round up to the next whole share. Notwithstanding anything to the contrary contained herein, but consistent with
the provisions of this subsection with respect to fractional Conversion Shares, nothing shall prevent any Holder from converting fractional
shares of Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Transfer Taxes and Expenses</U>. The issuance of Conversion Shares on conversion of this Preferred Stock shall be made without charge
to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares,
provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance
and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares of Preferred Stock
and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting
the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation
that such tax has been paid. The Corporation shall pay all Transfer Agent fees required for same-day processing of any Notice of Conversion
and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for
same-day electronic delivery of the Conversion Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Beneficial Ownership Limitation</U>. The Corporation shall not effect any conversion of the Preferred Stock, and a Holder shall not
have the right to convert any portion of the Preferred Stock, to the extent that, after giving effect to the conversion set forth on
the applicable Notice of Conversion, such Holder (together with such Holder&rsquo;s Affiliates, and any Persons acting as a group together
with such Holder or any of such Holder&rsquo;s Affiliates (such Persons, &ldquo;Attribution Parties&rdquo;)) would beneficially own in
excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common
Stock beneficially owned by such Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock
issuable upon conversion of the Preferred Stock with respect to which such determination is being made, but shall exclude the number
of shares of Common Stock which are issuable upon (i) conversion of the remaining, unconverted Preferred Stock beneficially owned by
such Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion
of any other securities of the Corporation subject to a limitation on conversion or exercise analogous to the limitation contained herein
(including, without limitation, the Preferred Stock) beneficially owned by such Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 6(d), beneficial ownership shall be calculated in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained
in this Section 6(d) applies, the determination of whether the Preferred Stock is convertible (in relation to other securities owned
by such Holder together with any Affiliates and Attribution Parties) and of how many shares of Preferred Stock are convertible shall
be in the sole discretion of such Holder, and the submission of a Notice of Conversion shall be deemed to be such Holder&rsquo;s determination
of whether the shares of Preferred Stock may be converted (in relation to other securities owned by such Holder together with any Affiliates
and Attribution Parties) and how many shares of the Preferred Stock are convertible, in each case subject to the Beneficial Ownership
Limitation. To ensure compliance with this restriction, each Holder will be deemed to represent to the Corporation each time it delivers
a Notice of Conversion that such Notice of Conversion has not violated the restrictions set forth in this paragraph and the Corporation
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 6(d), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as stated in the most recent of the following: (i) the Corporation&rsquo;s most recent
periodic or annual report filed with the Commission, as the case may be, (ii) a more recent public announcement by the Corporation or
(iii) a more recent written notice by the Corporation or the Transfer Agent setting forth the number of shares of Common Stock outstanding.
Upon the written or oral request (which may be via email) of a Holder, the Corporation shall within two Trading Days confirm orally and
in writing to such Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common
Stock shall be determined after giving effect to the conversion or exercise of securities of the Corporation, including the Preferred
Stock, by such Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common
Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by a Holder prior to the
issuance of any shares of Preferred Stock, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock held by the applicable Holder. A Holder, upon notice
to the Corporation, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 6(d) applicable to its Preferred
Stock provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock upon conversion of this Preferred Stock held by the Holder
and the provisions of this Section 6(d) shall continue to apply. Any such increase in the Beneficial Ownership Limitation will not be
effective until the 61<SUP>st</SUP> day after such notice is delivered to the Corporation and shall only apply to such Holder and no
other Holder. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 6(d) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation contained herein or to make changes or supplements necessary or desirable to properly give effect to
such limitation. The limitations contained in this paragraph shall apply to a successor holder of Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
7</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Stock Splits</U>. If the Corporation, at any time while this Preferred Stock is outstanding: (i) pays a stock
dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any other
Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation upon
conversion of, or payment of a dividend on, this Preferred Stock), (ii) subdivides outstanding shares of Common Stock into a larger number
of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares,
or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Corporation, then
the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding
any treasury shares of the Corporation) outstanding immediately before such event, and of which the denominator shall be the number of
shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section 7(a) shall become effective
immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become
effective immediately after the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 7(a) above, if at any time the Corporation grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete conversion of such Holder&rsquo;s Preferred Stock (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however,
to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Preferred Stock is outstanding, if the Corporation declares or makes any dividend
or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Preferred Stock, then, in each such case, the Holder shall be entitled to participate in such
Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common
Stock acquirable upon complete conversion of this Preferred Stock (without regard to any limitations on conversion hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution,
or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation
in such Distribution (<U>provided</U>, <U>however</U>, to the extent that the Holder&rsquo;s right to participate in any such Distribution
would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such
Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent)
and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto
would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Preferred Stock is outstanding, (i) the Corporation, directly or indirectly,
in one or more related transactions effects any merger or consolidation of the Corporation with or into another Person, (ii) the Corporation,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Corporation or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock, (iv) the Corporation, directly or indirectly, in one or more related transactions effects any reclassification, reorganization
or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (v) the Corporation, directly or indirectly, in one or more related transactions
consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of
Common Stock (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent conversion of this Preferred Stock, the
Holder shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior
to the occurrence of such Fundamental Transaction (without regard to any limitation in Section 6(d) on the conversion of this Preferred
Stock), the number of shares of Common Stock of the successor or acquiring corporation or of the Corporation, if it is the surviving
corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental
Transaction by a holder of the number of shares of Common Stock for which this Preferred Stock is convertible immediately prior to such
Fundamental Transaction (without regard to any limitation in Section 6(d) on the conversion of this Preferred Stock). For purposes of
any such conversion, the determination of the Conversion Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Corporation shall apportion the Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative
value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities,
cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any conversion of this Preferred Stock following such Fundamental Transaction. To the extent necessary to effectuate
the foregoing provisions, any successor to the Corporation or surviving entity in such Fundamental Transaction shall file a new Certificate
of Designation with the same terms and conditions and issue to the Holders new preferred stock consistent with the foregoing provisions
and evidencing the Holders&rsquo; right to convert such preferred stock into Alternate Consideration. The Corporation shall cause any
successor entity in a Fundamental Transaction in which the Corporation is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Corporation under this Certificate of Designation in accordance with the provisions
of this Section 7(d) pursuant to written agreements in customary form and shall, at the option of the holder of this Preferred Stock,
deliver to the Holder in exchange for this Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Preferred Stock which is convertible for a corresponding number of shares of capital stock of such
Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of this Preferred
Stock (without regard to any limitations on the conversion of this Preferred Stock) prior to such Fundamental Transaction, and with a
conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative value
of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of
shares of capital stock and such conversion price being for the purpose of protecting the economic value of this Preferred Stock immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from
and after the date of such Fundamental Transaction, the provisions of this Certificate of Designation referring to the &ldquo;Corporation&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Corporation and shall assume all of the obligations
of the Corporation under this Certificate of Designation with the same effect as if such Successor Entity had been named as the Corporation
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to the Holders</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Conversion Price</U>. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 7, the Corporation
shall promptly deliver to each record Holder by email a notice setting forth the Conversion Price after such adjustment and setting forth
a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Conversion by Holder</U>. If (A) the Corporation shall declare a dividend (or any other distribution in whatever form)
on the Common Stock, (B) the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C)
the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any
shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Corporation shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer
of all or substantially all of the assets of the Corporation, or any compulsory share exchange whereby the Common Stock is converted
into other securities, cash or property or (E) the Corporation shall authorize the voluntary or involuntary dissolution, liquidation
or winding up of the affairs of the Corporation, then, in each case, the Corporation shall cause to be delivered by email to each record
Holder at its last email address as it shall appear upon the stock books of the Corporation, at least ten (10) calendar days prior to
the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the
purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders
of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or
(y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares
of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect
the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder constitutes,
or contains, material, non-public information regarding the Corporation or any of the Subsidiaries, the Corporation shall simultaneously
file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to convert the Conversion
Amount of this Preferred Stock (or any part hereof) during the 10-day period commencing on the date of such notice through the effective
date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
8</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Conversion, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight
courier service, addressed to the Corporation, at the address set forth above Attention: Spiro Sakiris, Chief Financial Officer, e-mail
address: spiro.sakiris@ibs.inc, or such other e-mail address or address as the Corporation may specify for such purposes by notice to
the Holders delivered in accordance with this Section 8. Any and all notices or other communications or deliveries to be provided by
the Corporation hereunder shall be in writing and delivered personally, e-mail, or sent by a nationally recognized overnight courier
service addressed to each Holder at the e-mail address or address of such Holder appearing on the books of the Corporation. Any notice
or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if
such notice or communication is delivered via e-mail at the e-mail address set forth in this Section 8 prior to 5:30 p.m. (New York City
time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail
at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any
Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service,
or (iv) upon actual receipt by the party to whom such notice is required to be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Absolute Obligation</U>. Except as expressly provided herein, no provision of this Certificate of Designation shall alter or impair
the obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages and accrued dividends, as applicable,
on the shares of Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Lost or Mutilated Preferred Stock Certificate</U>. If a Holder&rsquo;s Preferred Stock certificate shall be mutilated, lost, stolen
or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate,
or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Preferred Stock so
mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and of
the ownership hereof reasonably satisfactory to the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designation
shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the
principles of conflict of laws thereof. All legal proceedings concerning the interpretation, enforcement and defense of the transactions
contemplated by this Certificate of Designation (whether brought against a party hereto or its respective Affiliates, directors, officers,
shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City
of New York, Borough of Manhattan (the &ldquo;<U>New York Courts</U>&rdquo;). The Corporation and each Holder hereby irrevocably submits
to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action
or proceeding, any claim that it is not personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper
or inconvenient venue for such proceeding. The Corporation and each Holder hereby irrevocably waives personal service of process and
consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or
overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Certificate of Designation
and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall
be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. The Corporation and each Holder
hereto hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding
arising out of or relating to this Certificate of Designation or the transactions contemplated hereby. If any party shall commence an
action, suit or proceeding to enforce any provisions of this Certificate of Designation, then the prevailing party in such action or
proceeding shall be reimbursed by the other party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred in the
investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Waiver</U>. Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designation shall not operate
as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of
Designation or a waiver by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term
of this Certificate of Designation on one or more occasions shall not be considered a waiver or deprive that party (or any other Holder)
of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designation on any other
occasion. Any waiver by the Corporation or a Holder must be in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Severability</U>. If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of this Certificate
of Designation shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain
applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder
violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the
maximum rate of interest permitted under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Next Business Day</U>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment
shall be made on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Headings</U>. The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation
and shall not be deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Status of Converted or Redeemed Preferred Stock</U>. If any shares of Preferred Stock shall be converted, redeemed or reacquired by
the Corporation, such shares shall resume the status of authorized but unissued shares of preferred stock and shall no longer be designated
as Series E Convertible Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESOLVED,
FURTHER, that the Chairman, the president or any vice-president, and the secretary or any assistant secretary, of the Corporation be
and they hereby are authorized and directed to prepare and file this Certificate of Designation of Preferences, Rights and Limitations
in accordance with the foregoing resolution and the provisions of Delaware law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have executed this Certificate of Designation this 3rd day of October, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Spiro Sakiris</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spiro
    Sakiris</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANNEX
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF CONVERSION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">(To
be Executed by the Registered Holder in order to Convert Shares of Preferred Stock)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby elects to convert the number of shares of Series E Convertible Preferred Stock indicated below into shares of common
stock, par value $0.01 per share (the &ldquo;<U>Common Stock</U>&rdquo;), of Intelligent Bio Solutions Inc., a Delaware corporation (the
&ldquo;<U>Corporation</U>&rdquo;), according to the conditions hereof, as of the date written below. If shares of Common Stock are to
be issued in the name of a Person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto.
No fee will be charged to the Holders for any conversion, except for any such transfer taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
calculations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date to Effect Conversion: _____________________________________________</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of shares of Preferred Stock owned prior to Conversion: _______________</FONT></P>

<P STYLE="margin-left: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of shares of Preferred Stock to be Converted: ________________________</FONT></P>

<P STYLE="margin-left: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stated Value of shares of Preferred Stock to be Converted: ____________________</FONT></P>

<P STYLE="margin-left: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of shares of Common Stock to be Issued: ___________________________</FONT></P>

<P STYLE="margin-left: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable Conversion Price:____________________________________________</FONT></P>

<P STYLE="margin-left: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of shares of Preferred Stock subsequent to Conversion: ________________</FONT></P>

<P STYLE="margin-left: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address for Delivery: ______________________</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U></U></FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>or</U></FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U></U></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DWAC Instructions:</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker no: _________</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account no: ___________</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[HOLDER]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>4
<FILENAME>ex4-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
E COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>intelligent
bio solutions INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: 8,363,636</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: October 4, 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CUSIP:
    36151G147</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISIN:
    US36151G1470</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SERIES E COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, CEDE &amp; CO., or its
assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date Shareholder Approval is received and effective (the &ldquo;<U>Initial Exercise Date</U>&rdquo;)
and on or prior to 5:00 p.m. (New York City time) on the five-and-a-half year anniversary of the Issue Date (the &ldquo;<U>Termination
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
up to 8,363,636 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price
of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall
initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee
(&ldquo;<U>DTC</U>&rdquo;) shall initially be the sole registered holder of this Warrant, subject to a Holder&rsquo;s right to elect
to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in which case this sentence shall not
apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
(based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading
Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form S-1 (File No. 333-273219).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Reverse
Stock Split Date</U>&rdquo; means the first date following the Issue Date on which a reverse stock split of the Common Stock is approved
and deemed effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shareholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Capital Market (or any
successor entity) from the shareholders of the Company to permit the exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust Company, the current transfer agent of the Company, with a mailing address
of 1 State Street 30th Floor, New York, NY 10004-1561, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trigger
Date</U>&rdquo; means the 6th Trading Day immediately following the Reverse Stock Split Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Underwriting
Agreement</U>&rdquo; means the underwriting agreement, dated as of October 2, 2023, among the Company and Ladenburg Thalmann &amp; Co.
Inc. as representative of the underwriters named therein, as amended, modified or supplemented from time to time in accordance with its
terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Agency Agreement</U>&rdquo; means that certain warrant agency agreement, dated on or about the Issue Date, between the Company and the
Warrant Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Agent</U>&rdquo; means the Transfer Agent and any successor warrant agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Series E Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable of the date
on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares
purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain
records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any
Notice of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant,
acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares
hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the
face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing in this Section 2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing this
Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect
exercises made pursuant to this Section 2(a) by delivering to DTC (or such other clearing corporation, as applicable) the appropriate
instruction form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation,
as applicable), subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant
Agency Agreement, in which case this sentence shall not apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be $0.55, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;). In addition, on the Trigger Date, the Exercise Price shall be reduced, and only reduced, to
the lesser of (i) the then Exercise Price and (ii) 90% of the average of the VWAPs for the five (5) Trading Day period immediately prior
to the Trigger Date (the &ldquo;<U>Reset Exercise Price</U>&rdquo;, which shall thereafter be the new Exercise Price, subject to further
adjustment hereunder, and such five (5) Trading Day period shall be referred to herein as a &ldquo;<U>Reset Measurement Period</U>&rdquo;).
The Company shall notify each Holder of the applicable adjustment to the Exercise Price as of such date (each notice, a &ldquo;<U>Trigger
Date Adjustment Notice</U>&rdquo;). For purposes of clarification, whether or not the Company provides a Trigger Date Adjustment Notice
pursuant to this Section 2(b), each Holder shall only be required to pay the Reset Exercise Price with respect to such exercise, regardless
of whether a Holder accurately refers to such price in any Notice of Exercise. If the aggregate Exercise Price paid by the Holder exceeds
the amount that should have been paid based on the Reset Exercise Price, the Company shall promptly return any excess aggregate Exercise
Price to the Holder. Any adjustment to the Exercise Price pursuant to this Section shall be effective retroactively to the first Trading
Day of such Reset Measurement Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in
whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A) =</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as applicable: (i) the VWAP
  on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed
  and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section
  2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS
  promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading
  Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading
  Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice
  of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter
  (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof
  or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such
  Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo;
  on such Trading Day;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B) =</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Exercise Price of this
  Warrant, as adjusted hereunder; and</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X) =</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of Warrant Shares
  that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of
  a cash exercise rather than a cashless exercise.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics
                                            of Exercise</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a
certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares
to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date
that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day
after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement
Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier
of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant
Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant
Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading
Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such
Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. Notwithstanding anything herein
to the contrary, the Company shall not be responsible for the payment of liquidated damages resulting from the failure to issue or deliver
Warrant Shares if such failure is caused by any action or inaction of the Holder. The Company agrees to maintain a transfer agent that
is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of
this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that
the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for
the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one
or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v)
the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another
Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or
more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such
exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation
in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of
the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary,
in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option,
exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the
date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder
an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date
of the consummation of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within
the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive
from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value
of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection
with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the
holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental
Transaction; <U>provided</U>, <U>further</U>, that if holders of Common Stock of the Company are not offered or paid any consideration
in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which
Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo;
means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg
determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free
interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the
applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and
the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading
Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per
share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value
of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period beginning
on the Trading Day immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation
of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section
3(d), (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated Fundamental
Transaction and the Termination Date, and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer
of immediately available funds (or such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s election
and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction
in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the
Company under this Warrant in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance
reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and
shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by
a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares
of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon
exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and
with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under
this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this
Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the
Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally
with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall
assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect
as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market on which the Common Stock is then
listed, the Company may at any time during the term of this Warrant reduce the then current Exercise Price to any amount and for any
period of time deemed appropriate by the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be divided
or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying
the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance
with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a
new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants
issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with this Warrant except as to
the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Warrant Agent shall register this Warrant, upon records to be maintained by the Warrant Agent for that purpose
(the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company and the Warrant Agent
may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflict
of laws thereof. All legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by this
Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders, partners, members,
employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York, Borough of Manhattan
(the &ldquo;<U>New York Courts</U>&rdquo;). Each party hereby irrevocably submits to the exclusive jurisdiction of the New York Courts
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein,
and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject
to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient venue for such proceeding. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by
mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, then the prevailing party
in such action, suit or proceeding shall be reimbursed by the other party for its reasonable attorneys&rsquo; fees and other costs and
expenses incurred in the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight
courier service, addressed to the Company, at 142 West 57<SUP>th</SUP> Street, Floor 9, New York, NY 10019, Attention: Spiro Sakiris,
email address: spiro.sakiris@ibs.inc, or such other email address or address as the Company may specify for such purposes by notice to
the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and
delivered personally, by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail
address or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall
be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via e-mail
at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after
the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section on
a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following
the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom
such notice is required to be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public
information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant
to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)
<U>Warrant Agency Agreement.</U> If this Warrant is held in global form through DTC (or any successor depositary), this Warrant is issued
subject to the Warrant Agency Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant
Agency Agreement, the provisions of this Warrant shall govern and be controlling.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>INTELLIGENT
    BIO SOLUTIONS INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Spiro Sakiris</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spiro
    Sakiris</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:
INTELLIGENT BIO SOLUTIONS INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
&nbsp;&nbsp; ] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
&nbsp;&nbsp; ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set
forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the
cashless exercise procedure set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: ____________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: _____________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>5
<FILENAME>ex4-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
F COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>intelligent
bio solutions INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: 8,363,636</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: October 4, 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CUSIP:
    36151G154</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISIN:
    US36151G1546</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SERIES F COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, CEDE &amp; CO., or its
assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date Shareholder Approval is received and effective (the &ldquo;<U>Initial Exercise Date</U>&rdquo;)
and on or prior to 5:00 p.m. (New York City time) on the one-and-a-half year anniversary of the Issue Date (the &ldquo;<U>Termination
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
up to 8,363,636 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price
of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall
initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee
(&ldquo;<U>DTC</U>&rdquo;) shall initially be the sole registered holder of this Warrant, subject to a Holder&rsquo;s right to elect
to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in which case this sentence shall not
apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
(based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading
Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form S-1 (File No. 333-273219).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shareholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Capital Market (or any
successor entity) from the shareholders of the Company to permit the exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust Company, the current transfer agent of the Company, with a mailing address
of 1 State Street 30th Floor, New York, NY 10004-1561, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Underwriting
Agreement</U>&rdquo; means the underwriting agreement, dated as of October 2, 2023, among the Company and Ladenburg Thalmann &amp; Co.
Inc. as representative of the underwriters named therein, as amended, modified or supplemented from time to time in accordance with its
terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Agency Agreement</U>&rdquo; means that certain warrant agency agreement, dated on or about the Issue Date, between the Company and the
Warrant Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Agent</U>&rdquo; means the Transfer Agent and any successor warrant agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Series F Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable of the date
on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares
purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain
records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any
Notice of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant,
acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares
hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the
face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing in this Section 2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing this
Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect
exercises made pursuant to this Section 2(a) by delivering to DTC (or such other clearing corporation, as applicable) the appropriate
instruction form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation,
as applicable), subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant
Agency Agreement, in which case this sentence shall not apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $0.55, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    = </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
    either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of
    the Common Stock on the principal Trading Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution of the applicable
    Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered
    within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading
    Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice
    of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the
    close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    = </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    = </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything to the contrary herein, the Holder may also effect an &ldquo;alternative cashless exercise&rdquo; on or after the Initial Exercise
Date. In such event, the aggregate number of Warrant Shares issuable in such alternative cashless exercise pursuant to any given Notice
of Exercise electing to effect an alternative cashless exercise shall equal the product of (x) the aggregate number of Warrant Shares
that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a
cash exercise rather than a cashless exercise and (y) 1.00.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics
                                            of Exercise</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. Notwithstanding anything herein to the contrary, the Company shall not be responsible for the payment of liquidated damages resulting from the failure to issue or deliver Warrant Shares if such failure is caused by any action or inaction of the Holder. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of
this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares
for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or
more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the common
equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the
Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to
the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the
exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is
the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company&rsquo;s
control, including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company
or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised
portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental
Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock
are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>,
<U>further</U>, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction,
such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following
such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant
based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of
consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding
to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental
Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from
the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public
announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation shall
be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if
any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period beginning on the Trading Day immediately
preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental
Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section 3(d), (D) a remaining option
time equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination
Date, and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds
(or such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation
of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not
the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant
in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to
the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of
the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies
the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation
of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market on which the Common Stock is then listed, the Company
may at any time during the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed
appropriate by the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Transferability</U>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of
this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay
any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>New
Warrants</U>. If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be divided or combined
with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names
and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section
4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or
Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers
or exchanges shall be dated the Issue Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant
Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Warrant
Register</U>. The Warrant Agent shall register this Warrant, upon records to be maintained by the Warrant Agent for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company and the Warrant Agent
may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflict of
laws thereof. All legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by this Warrant
(whether brought against a party hereto or their respective affiliates, directors, officers, shareholders, partners, members, employees
or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York, Borough of Manhattan (the
&ldquo;<U>New York Courts</U>&rdquo;). Each party hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for
the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein,
and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject
to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient venue for such proceeding. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by
mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, then the prevailing party
in such action, suit or proceeding shall be reimbursed by the other party for its reasonable attorneys&rsquo; fees and other costs and
expenses incurred in the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any
Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service,
addressed to the Company, at 142 West 57<SUP>th</SUP> Street, Floor 9, New York, NY 10019, Attention: Spiro Sakiris, email address: spiro.sakiris@ibs.inc,
or such other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or
other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or
sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing
on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest
of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section
prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication
is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any
notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o) <U>Warrant
Agency Agreement.</U> If this Warrant is held in global form through DTC (or any successor depositary), this Warrant is issued subject
to the Warrant Agency Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant Agency
Agreement, the provisions of this Warrant shall govern and be controlling.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>INTELLIGENT
    BIO SOLUTIONS INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Spiro Sakiris</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spiro
    Sakiris</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To: INTELLIGENT
BIO SOLUTIONS INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp; ] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set
forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the
cashless exercise procedure set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT>____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT>____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT>____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT>___</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: __________________________<U> </U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: ___________________________<U> </U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>6
<FILENAME>ex4-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIVE
COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>intelligent
bio solutions INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: October 4, 2023</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
REPRESENTATIVE COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, or its assigns (the
&ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York
City time) on October 2, 2028 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Intelligent
Bio Solutions Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares (as subject to adjustment hereunder,
the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Underwriting Agreement (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
(based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading
Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form S-1 (File No. 333-273219).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust Company, the current transfer agent of the Company, with a mailing address
of 1 State Street 30th Floor, New York, NY 10004-1561, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Underwriting
Agreement</U>&rdquo; means the underwriting agreement, dated as of October 2, 2023, among the Company and Ladenburg Thalmann &amp; Co.
Inc. as representative of the underwriters named therein, as amended, modified or supplemented from time to time in accordance with its
terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Representative Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable of the date
on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares
purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain
records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any
Notice of Exercise within one (1) Business Day of receipt of such notice. Notwithstanding the foregoing, with respect to any Notice(s)
of Exercise delivered on or prior to 4:00 p.m. (New York City time) on the Trading Date prior to the Initial Exercise Date, which may
be delivered at any time after the time of execution of the Underwriting Agreement, the Company agrees to deliver the Warrant Shares
subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant
Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless
exercise) is received by such Warrant Share Delivery Date. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $0.6875, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and
delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in
Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either
(y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common
Stock on the principal Trading Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution of the applicable Notice
of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within
two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant
to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a
Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular
trading hours&rdquo; on such Trading Day;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
= the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics
                                            of Exercise</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery
                                            of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased
                                            hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account
                                            of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
                                            through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the
                                            Company is then a participant in such system and either (A) there is an effective registration
                                            statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares
                                            by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by
                                            physical delivery of a certificate, registered in the Company&rsquo;s share register in the
                                            name of the Holder or its designee, for the number of Warrant Shares to which the Holder
                                            is entitled pursuant to such exercise to the address specified by the Holder in the Notice
                                            of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery
                                            to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
                                            aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the
                                            Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such
                                            date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
                                            of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder
                                            of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective
                                            of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise
                                            Price (other than in the case of a cashless exercise) is received within the earlier of (i)
                                            two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement
                                            Period following delivery of the Notice of Exercise. If the Company fails for any reason
                                            to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant
                                            Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages
                                            and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on
                                            the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading
                                            Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery
                                            Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares
                                            are delivered or Holder rescinds such exercise. Notwithstanding anything herein to the contrary,
                                            the Company shall not be responsible for the payment of liquidated damages resulting from
                                            the failure to issue or deliver Warrant Shares if such failure is caused by any action or
                                            inaction of the Holder. The Company agrees to maintain a transfer agent that is a participant
                                            in the FAST program so long as this Warrant remains outstanding and exercisable. As used
                                            herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period,
                                            expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with
                                            respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of
this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise, other
than cash (including, without limitation, any distribution of stock or other securities, property or options by way of a dividend, spin
off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares
for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or
more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the common
equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the
Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to
the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the
exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is
the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company&rsquo;s
control, including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company
or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised
portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental
Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock
are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>,
<U>further</U>, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction,
such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following
such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant
based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of
consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding
to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental
Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from
the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public
announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation shall
be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if
any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period beginning on the Trading Day immediately
preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental
Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section 3(d), (D) a remaining option
time equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination
Date, and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds
(or such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation
of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not
the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant
in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to
the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of
the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies
the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation
of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market on which the Common Stock is then listed, the Company
may at any time during the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed
appropriate by the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Transferability</U>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of
this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay
any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date of this Warrant and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflict of
laws thereof. All legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by this Warrant
(whether brought against a party hereto or their respective affiliates, directors, officers, shareholders, partners, members, employees
or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York, Borough of Manhattan (the
&ldquo;<U>New York Courts</U>&rdquo;). Each party hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for
the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein,
and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject
to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient venue for such proceeding. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by
mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, then the prevailing party
in such action, suit or proceeding shall be reimbursed by the other party for its reasonable attorneys&rsquo; fees and other costs and
expenses incurred in the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any
Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service,
addressed to the Company, at 142 West 57<SUP>th</SUP> Street, Floor 9, New York, NY 10019, Attention: Spiro Sakiris, email address: spiro.sakiris@ibs.inc,
or such other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or
other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or
sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing
on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest
of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section
prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication
is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any
notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>INTELLIGENT
    BIO SOLUTIONS INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spiro
Sakiris</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">INTELLIGENT
    BIO SOLUTIONS INC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-bottom: 1.5pt; text-align: center; padding-left: 10pt; text-indent: -0.01pt; width: 20%">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; padding-left: 10pt; text-indent: -0.01pt; width: 35%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 45%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT>____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT>____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT>____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT>___</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
_______________ __, ______</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;____________________________</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;____________________________</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>7
<FILENAME>ex4-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INTELLIGENT
BIO SOLUTIONS INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTINENTAL
STOCK TRANSFER &amp; TRUST COMPANY, as</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
Agent</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
Agency Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated
as of October 4, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>WARRANT
AGENCY AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANT
AGENCY AGREEMENT, dated as of October 4, 2023 (&ldquo;<U>Agreement</U>&rdquo;), by and between Intelligent Bio Solutions Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), and Continental Stock Transfer &amp; Trust Company, a Delaware limited liability company
(&ldquo;<U>CST</U>&rdquo; or the &ldquo;<U>Warrant Agent</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">W
I T N E S S E T H</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
pursuant to an offering by the Company of Warrants (as defined below), the Company wishes to issue Warrants in book entry form entitling
the respective holders of the Warrants (the &ldquo;<U>Holders</U>&rdquo;, which term shall include a Holder&rsquo;s transferees, successors
and assigns and &ldquo;Holder&rdquo; shall include, if the Warrants are held in &ldquo;street name&rdquo;, a Participant (as defined
below) or a designee appointed by such Participant) to purchase an aggregate of up to 16,727,272 shares of Common Stock underlying the
Warrants (as defined below) upon the terms and subject to the conditions hereinafter set forth (the &ldquo;<U>Offering</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company wishes the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to act on behalf of the Company,
in connection with the issuance, registration, transfer, exchange, exercise and replacement of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the premises and the mutual agreements herein set forth, the parties hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. <U>Certain Definitions</U>. For purposes of this Agreement, the following terms have the meanings indicated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<U>Affiliate</U>&rdquo; has the meaning ascribed to it in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the
&ldquo;<U>Exchange Act</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;<U>Business Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United
States or any day on which the Nasdaq Stock Market is authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<U>Close of Business</U>&rdquo; on any given date means 5:00 p.m., New York City time, on such date; <U>provided</U>, <U>however</U>,
that if such date is not a Business Day, it means 5:00 p.m., New York City time, on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<U>Person</U>&rdquo; means an individual, corporation, association, partnership, limited liability company, joint venture, trust,
unincorporated organization, government or political subdivision thereof or governmental agency or other entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;<U>Series E Warrants</U>&rdquo; means Series E Common Stock Purchase Warrants of the Company with a term of exercise of five (5)
years following the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&ldquo;<U>Series F Warrants</U>&rdquo; means Series F Common Stock Purchase Warrants of the Company with a term of exercise of one (1)
year following the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
&ldquo;<U>Warrants</U>&rdquo; means, collectively, the Series E Warrants and Series F Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&ldquo;<U>Warrant Certificate</U>&rdquo; means a certificate in substantially the form attached as <U>Exhibit 1-A</U> hereto (as it relates
to the Series E Warrants) or <U>Exhibit 1-B</U> hereto (as it relates to the Series F Warrants), representing such number of Warrant
Shares (as defined below) as is indicated therein, provided that any reference to the delivery of a Warrant Certificate in this Agreement
shall include delivery of notice from the Depository or a Participant (each as defined below) of the transfer or exercise of the Warrant
in the form of a Global Warrant (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
&ldquo;<U>Warrant Shares</U>&rdquo; means the shares of Common Stock underlying the Warrants and issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
other capitalized terms used but not otherwise defined herein shall have the meaning ascribed to such terms in the Warrant Certificates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2. <U>Appointment of Successor Warrant Agent</U>. The Company hereby appoints the Warrant Agent to act as agent for the Company in accordance
with the express terms or conditions hereof (and no implied terms and conditions), and the Warrant Agent hereby accepts such appointment.
The Company may from time to time appoint such Co-Warrant Agents as it may, in its sole discretion, deem necessary or desirable upon
ten (10) calendar days&rsquo; prior written notice to the Warrant Agent. The Warrant Agent shall have no duty to supervise, and shall
in no event be liable for, the acts or omissions of any such Co-Warrant Agent. In the event the Company appoints one or more co-Warrant
Agents, the respective duties of the Warrant Agent and any Co-Warrant Agent shall be as the Company shall reasonably determine, provided
that such duties and determination are consistent with the terms and provisions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3. <U>Global Warrants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Warrants shall be issuable in book entry form. All of the Warrants shall initially be represented by one or more Global Warrants
(the &ldquo;<U>Global Warrants</U>&rdquo; and, each, a &ldquo;<U>Global Warrant</U>&rdquo;), deposited with the Warrant Agent and registered
in the name of Cede &amp; Co., a nominee of The Depository Trust Company (the &ldquo;<U>Depository</U>&rdquo;), or as otherwise directed
by the Depository. Ownership of beneficial interests in the Warrants, shall be shown on, and the transfer of such ownership shall be
effected through, records maintained by (i) the Depository or its nominee for each Global Warrant or (ii) institutions that have accounts
with the Depository (such institution, with respect to a Warrant in its account, a &ldquo;<U>Participant</U>&rdquo;). For purposes of
Regulation SHO, a holder whose interest in a Global Warrant is a beneficial interest in certificate(s) representing such Warrant held
in book-entry form through the Depository shall be deemed to have exercised its interest in such Warrant upon instructing its broker
that is a Participant to exercise its interest in such Warrant, provided that in each such case payment of the applicable aggregate Exercise
Price (other than in the case of a cashless exercise) is delivered by such Participant within the earlier of (i) two trading days and
(ii) the number of trading days comprising the Standard Settlement Period, in each case following such instruction. As used herein, &ldquo;Standard
Settlement Period&rdquo; means the standard settlement period, expressed in a number of trading days, on the Company&rsquo;s primary
trading market with respect to the Common Stock as in effect on the date of delivery of the Exercise Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If the Depository subsequently ceases to make its book-entry settlement system available for the Warrants, the Company may instruct the
Warrant Agent regarding other arrangements for book-entry settlement. In the event that the Warrants are not eligible for, or it is no
longer necessary to have the Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the Depository
to deliver to the Warrant Agent for cancellation each Global Warrant, and the Company shall instruct the Warrant Agent in writing to
deliver to each Holder a Warrant Certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
A Holder has the right to elect at any time or from time to time a Warrant Exchange (as defined below) pursuant to a Warrant Certificate
Request Notice (as defined below). Upon written notice by a Holder to the Warrant Agent for the exchange of some or all of such Holder&rsquo;s
Global Warrants for a Warrant Certificate, evidencing the same number of Warrants, which request shall be in the form attached hereto
as <U>Annex A</U> (a &ldquo;<U>Warrant Certificate Request Notice</U>&rdquo; and the date of delivery of such Warrant Certificate Request
Notice by the Holder, the &ldquo;<U>Warrant Certificate Request Notice Date</U>&rdquo; and the deemed surrender upon delivery by the
Holder of a number of Global Warrants for the same number of Warrants evidenced by a Warrant Certificate, a &ldquo;<U>Warrant Exchange</U>&rdquo;),
the Warrant Agent shall promptly effect the Warrant Exchange and shall promptly issue and deliver, at the expense of the Company, to
the Holder a Warrant Certificate, for such number of Warrants in the name set forth in the Warrant Certificate Request Notice. Such Warrant
Certificate shall be dated the original issue date of the Warrants, shall be executed by manual signature by an authorized signatory
of the Company, and shall be in the form attached hereto as <U>Exhibit 1-A</U> or <U>Exhibit 1-B</U>, as the case may be. In connection
with a Warrant Exchange, the Company agrees to deliver, or to direct the Warrant Agent to deliver, the Warrant Certificate, to the Holder
within three (3) Business Days of the Warrant Certificate Request Notice pursuant to the delivery instructions in the Warrant Certificate
Request Notice (&ldquo;<U>Warrant Certificate Delivery Date</U>&rdquo;). Notwithstanding anything herein to the contrary, the Company
shall act as warrant agent with respect to any physical Warrant Certificate issued pursuant to this section. If the Company fails for
any reason to deliver to the Holder the Warrant Certificate subject to the Warrant Certificate Request Notice by the Warrant Certificate
Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares
evidenced by such Warrant Certificate (based on the VWAP (as defined in the Warrants) of the Common Stock on the Warrant Certificate
Request Notice Date), $10 per Business Day for each Business Day after such Warrant Certificate Delivery Date until such Warrant Certificate
is delivered or, prior to delivery of such Warrant Certificate, the Holder rescinds such Warrant Exchange. In no event shall the Warrant
Agent be liable for the Company&rsquo;s failure to deliver the Warrant Certificate by the Warrant Certificate Delivery Date. The Company
covenants and agrees that, upon the date of delivery of the Warrant Certificate Request Notice, the Holder shall be deemed to be the
holder of the Warrant Certificate, as applicable, and, notwithstanding anything to the contrary set forth herein, the Warrant Certificate
shall be deemed for all purposes to contain all of the terms and conditions of the Warrants, evidenced by such Warrant Certificate, and
the terms of this Agreement, other than Sections 3(c) and 9 herein, shall not apply to the Warrants evidenced by the Warrant Certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4. <U>Form of Warrant Certificates</U>. The Warrant Certificate, together with the form of election to purchase Common Stock (&ldquo;<U>Exercise
Notice</U>&rdquo;) and the form of assignment to be printed on the reverse thereof, shall be in the form of <U>Exhibit 1-A</U> or <U>Exhibit
1-B</U>, as the case may be, hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5. <U>Countersignature and Registration</U>. The Warrant Certificates shall be executed on behalf of the Company by its Chief Executive
Officer, Chief Financial Officer or Vice President, either manually or by .pdf via email signature. The Warrant Certificates shall be
countersigned by the Warrant Agent either manually or by .pdf via email signature and shall not be valid for any purpose unless so countersigned.
In case any officer of the Company who shall have signed any of the Warrant Certificates shall cease to be such officer of the Company
before countersignature by the Warrant Agent and issuance and delivery by the Company, such Warrant Certificates, nevertheless, may be
countersigned by the Warrant Agent, issued and delivered with the same force and effect as though the Person who signed such Warrant
Certificate had not ceased to be such officer of the Company; and any Warrant Certificate may be signed on behalf of the Company by any
Person who, at the actual date of the execution of such Warrant Certificate, shall be a proper officer of the Company to sign such Warrant
Certificate, although at the date of the execution of this Agreement any such Person was not such an officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Agent will keep or cause to be kept, at its office designated for such purposes, books for registration and transfer of the Warrant
Certificates issued hereunder. Such books shall show the names and addresses of the respective Holders of the Warrant Certificates, the
number of warrants evidenced on the face of each such Warrant Certificate and the date of each such Warrant Certificate. The Warrant
Agent will create a special account for the issuance of Warrant Certificates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6. <U>Transfer, Split Up, Combination and Exchange of Warrant Certificates; Mutilated, Destroyed, Lost or Stolen Warrant Certificates</U>.
With respect to the Global Warrant, subject to the provisions of the Warrant Certificate, and the last sentence of this first paragraph
of Section 6 and subject to applicable law, rules or regulations, or any &ldquo;stop transfer&rdquo; instructions the Company may give
to the Warrant Agent, at any time after the closing date of the Offering, and at or prior to the Close of Business on the Termination
Date (as such term is defined in the Warrant Certificate), any Warrant Certificate or Warrant Certificates or Global Warrant or Global
Warrants may be transferred, split up, combined or exchanged for another Warrant Certificate or Warrant Certificates or Global Warrant
or Global Warrants, entitling the Holder to purchase a like number of shares of Common Stock as the Warrant Certificate or Warrant Certificates
or Global Warrant or Global Warrants surrendered then entitled such Holder to purchase. Any Holder desiring to transfer, split up, combine
or exchange any Warrant Certificate or Global Warrant shall make such request in writing delivered to the Warrant Agent and shall surrender
the Warrant Certificate or Warrant Certificates, together with the required form of assignment and certificate duly executed and properly
completed and such other documentation as the Warrant Agent may reasonably request, to be transferred, split up, combined or exchanged
at the office of the Warrant Agent designated for such purpose, provided that no such surrender is applicable to the Holder of a Global
Warrant. Any requested transfer of Warrants, whether in book-entry form or certificate form, shall be accompanied by evidence of authority
of the party making such request that may be reasonably required by the Warrant Agent. Thereupon the Warrant Agent shall, subject to
the last sentence of this first paragraph of Section 6, countersign and deliver to the Person entitled thereto a Warrant Certificate
or Warrant Certificates, as the case may be, as so requested. The Company may require payment from the Holder of a sum sufficient to
cover any tax or governmental charge that may be imposed in connection with any transfer, split up, combination or exchange of Warrant
Certificates. The Warrant Agent shall not have any duty or obligation to take any action under any section of this Agreement that requires
the payment of taxes and/or charges unless and until it is satisfied that all such payments have been made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
receipt by the Warrant Agent of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of a Warrant Certificate,
which evidence shall include an affidavit of loss, or in the case of mutilated certificates, the certificate or portion thereof remaining,
and, in case of loss, theft or destruction, of indemnity or security reasonably acceptable to the Company and the Warrant Agent, and
satisfaction of any other reasonable requirements established by Section 8-405 of the Uniform Commercial Code as in effect in the State
of Delaware, and reimbursement to the Company and the Warrant Agent of all reasonable expenses incidental thereto, and upon surrender
to the Warrant Agent and cancellation of the Warrant Certificate if mutilated, the Company will make and deliver a new Warrant Certificate
of like tenor to the Warrant Agent for delivery to the Holder in lieu of the Warrant Certificate so lost, stolen, destroyed or mutilated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7. <U>Exercise of Warrants; Exercise Price; Termination Date</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Warrants shall be exercisable commencing on the Initial Exercise Date. The Warrants shall cease to be exercisable and the right to
exercise such Warrants shall terminate and become void as set forth in the Warrant Certificate. Subject to the foregoing and to Section
7(b) below, the Holder of a Warrant may exercise the Warrant, in whole or in part pursuant to Section 2 of the Warrant Certificate. Payment
of the Exercise Price (unless exercised via a cashless exercise) may be made, at the option of the Holder, by wire transfer or by certified
or official bank check in United States dollars, to the Warrant Agent at the office of the Warrant Agent designated for such purposes.
In the case of the Holder of a Global Warrant, the Holder shall deliver the duly executed Exercise Notice and the payment of the Exercise
Price as described herein. Notwithstanding any other provision in this Agreement, a holder whose interest in a Global Warrant is a beneficial
interest in a Global Warrant held in book-entry form through the Depository (or another established clearing corporation performing similar
functions) shall effect exercises by delivering to the Depository (or such other clearing corporation, as applicable) the appropriate
instruction form for exercise, complying with the procedures to effect exercise that is required by the Depository (or such other clearing
corporation, as applicable). The Company acknowledges that the bank accounts maintained by the Warrant Agent in connection with the services
provided under this Agreement will be in its name and that the Warrant Agent may receive investment earnings in connection with the investment
at Warrant Agent risk and for its benefit of funds held in those accounts from time to time. Neither the Company nor the Holders will
receive interest on any deposits or Exercise Price. No ink-original Exercise Notice shall be required, nor shall any medallion guarantee
(or other type of guarantee or notarization) of any Exercise Notice be required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Upon receipt of an Exercise Notice for a Cashless Exercise, the Warrant Agent shall deliver a copy of the Exercise Notice to the Company
and request from the Company, and the Company shall promptly calculate and transmit to the Warrant Agent in writing, the number of Warrant
Shares issuable in connection with such Cashless Exercise. The Warrant Agent shall have no obligation under this Agreement to calculate,
the number of Warrant Shares issuable in connection with a Cashless Exercise, nor shall the Warrant Agent have any duty or obligation
to investigate or confirm whether the Company&rsquo;s determination of the number of Warrant Shares issuable upon such exercise, pursuant
to this Section 7, is accurate or correct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Upon the Warrant Agent&rsquo;s receipt of a Warrant Certificate, at or prior to the Close of Business on the Termination Date set forth
in such Warrant Certificate, with the executed Exercise Notice and payment of the Exercise Price for the shares to be purchased (other
than in the case of a Cashless Exercise) and an amount equal to any applicable tax, or governmental charge referred to in Section 6 by
wire transfer, or by certified check or bank draft payable to the order of the Company (or, in the case of the Holder of a Global Warrant,
the delivery of the executed Exercise Notice and the payment of the Exercise Price (other than in the case of a Cashless Exercise) and
any other applicable amounts as set forth herein), the Warrant Agent shall cause the Warrant Shares underlying such Warrant Certificate,
or Global Warrant, to be delivered to or upon the order of the Holder of such Warrant Certificate, or Global Warrant, registered in such
name or names as may be designated by such Holder, no later than the Warrant Share Delivery Date (as such term is defined in the Warrant
Certificate). If the Company is then a participant in the DWAC system of the Depository and either (A) there is an effective registration
statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) the Warrant is being exercised
via Cashless Exercise, then the certificates for Warrant Shares shall be transmitted by the Warrant Agent to the Holder by crediting
the account of the Holder&rsquo;s broker with the Depository through its DWAC system. For the avoidance of doubt, if the Company becomes
obligated to pay any amounts to any Holders pursuant to Sections 2(d)(i) or 2(d)(iv) of the Warrant Certificate, such obligation shall
be solely that of the Company and not that of the Warrant Agent. Notwithstanding anything else to the contrary in this Agreement, except
in the case of a Cashless Exercise, if any Holder fails to duly deliver payment to the Warrant Agent of an amount equal to the aggregate
Exercise Price of the Warrant Shares to be purchased upon exercise of such Holder&rsquo;s Warrant as set forth in Section 7(a) hereof
by the Warrant Share Delivery Date, the Warrant Agent will not be obligated to deliver such Warrant Shares (via DWAC or otherwise) until
following receipt of such payment, and the applicable Warrant Share Delivery Date shall be deemed extended by one day for each day (or
part thereof) until such payment is delivered to the Warrant Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Warrant Agent shall deposit all funds received by it in payment of the Exercise Price for all Warrants in the account of the Company
maintained with the Warrant Agent for such purpose (or to such other account as directed by the Company in writing) and shall advise
the Company via email at the end of each day on which exercise notices are received, or funds for the exercise of any Warrant are received,
of the amount so deposited to its account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
In case the Holder of any Warrant Certificate shall exercise fewer than all Warrants evidenced thereby, upon the request of the Holder,
a new Warrant Certificate evidencing the number of Warrants equivalent to the number of Warrants remaining unexercised may be issued
by the Warrant Agent to the Holder of such Warrant Certificate or to his duly authorized assigns in accordance with Section 2(d)(ii)
of the Warrant Certificate, subject to the provisions of Section 6 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
8. <U>Cancellation and Destruction of Warrant Certificates</U>. All Warrant Certificates surrendered for the purpose of exercise, transfer,
split up, combination or exchange shall, if surrendered to the Company or to any of its agents, be delivered to the Warrant Agent for
cancellation or in canceled form, or, if surrendered to the Warrant Agent, shall be canceled by it, and no Warrant Certificates shall
be issued in lieu thereof except as expressly permitted by any of the provisions of this Agreement. The Company shall deliver to the
Warrant Agent for cancellation and retirement, and the Warrant Agent shall so cancel and retire any other Warrant Certificate purchased
or acquired by the Company otherwise than upon the exercise thereof. The Warrant Agent shall deliver all canceled Warrant Certificates
to the Company, or shall, at the written request of the Company, destroy such canceled Warrant Certificates, and in such case shall deliver
a certificate of destruction thereof to the Company, subject to any applicable law, rule or regulation requiring the Warrant Agent to
retain such canceled certificates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9. <U>Certain Representations; Reservation and Availability of Shares of Common Stock or Cash</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
This Agreement has been duly authorized, executed and delivered by the Company and, assuming due authorization, execution and delivery
hereof by the Warrant Agent, constitutes a valid and legally binding obligation of the Company enforceable against the Company in accordance
with its terms, and the Warrants have been duly authorized, executed and issued by the Company and, assuming due execution thereof by
the Warrant Agent pursuant hereto and payment therefor by the Holders, constitute valid and legally binding obligations of the Company
enforceable against the Company in accordance with their terms and entitled to the benefits hereof; in each case except as enforceability
may be limited by bankruptcy, insolvency, reorganization, moratorium and other similar laws relating to or affecting creditors&rsquo;
rights generally or by general equitable principles (regardless of whether such enforceability is considered in a proceeding in equity
or at law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
As of the date hereof, the authorized capital stock of the Company consists of (i) 100,000,000 shares of Common Stock, of which 2,330,399
shares of Common Stock are issued and outstanding, and up to 16,727,272 shares of Common Stock are reserved for issuance upon exercise
of the Warrants, and up to 418,182 shares of Common Stock are reserved for issuance upon exercise of the warrants issued to the underwriter
in connection with the Offering, 426,521 shares of Common Stock reserved for issuance upon exercise of the other warrants and up to 8,363,636
shares are reserved for issuance in connection with the Offering; (ii) 10,000,000 shares of preferred stock, 500,000 of which are issued
or reserved for future issuance and convertible into 75,000 shares of Common Stock upon conversion, subject to rounding (represents shares
of preferred stock held back in connection with potential indemnification claims by the Company); and (iii) 125,000 shares of Common
Stock are authorized for issuance to employees, consultants and directors pursuant to the Company&rsquo;s stock plan, under which awards
for 25,000 shares are issued and outstanding. There are no other outstanding obligations, warrants, options or other rights to subscribe
for or purchase from the Company any class of capital stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company covenants and agrees that it will cause to be reserved and kept available out of its authorized and unissued shares of Common
Stock or its authorized and issued shares of Common Stock held in its treasury, free from preemptive rights, the number of shares of
Common Stock that will be sufficient to permit the exercise in full of all outstanding Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Warrant Agent will create a special account for the issuance of Common Stock upon the exercise of Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The Company further covenants and agrees that it will pay when due and payable any and all federal and state transfer taxes and charges
which may be payable in respect of the original issuance or delivery of the Warrant Certificates or certificates evidencing Common Stock
upon exercise of the Warrants. The Company shall not, however, be required to pay any tax or governmental charge which may be payable
in respect of any transfer involved in the transfer or delivery of Warrant Certificates or the issuance or delivery of certificates for
Common Stock in a name other than that of the Holder of the Warrant Certificate evidencing Warrants surrendered for exercise or to issue
or deliver any certificate for shares of Common Stock upon the exercise of any Warrants until any such tax or governmental charge shall
have been paid (any such tax or governmental charge being payable by the Holder of such Warrant Certificate at the time of surrender)
or until it has been established to the Company&rsquo;s and the Warrant Agent&rsquo;s reasonable satisfaction that no such tax or governmental
charge is due.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10. <U>Common Stock Record Date</U>. Each Person in whose name any certificate for shares of Common Stock is issued (or to whose broker&rsquo;s
account is credited shares of Common Stock through the DWAC system) upon the exercise of Warrants shall for all purposes be deemed to
have become the holder of record for the Common Stock represented thereby on, and such certificate shall be dated, the date on which
submission of the Exercise Notice was made, provided that the Warrant Certificate evidencing such Warrant was duly surrendered (but only
if required herein) and payment of the Exercise Price (and any applicable transfer taxes) was received on or prior to the Warrant Share
Delivery Date; <U>provided</U>, <U>however</U>, that, if the date of submission of the Exercise Notice is a date upon which the Common
Stock transfer books of the Company are closed, such Person shall be deemed to have become the record holder of such shares on, and such
certificate shall be dated, the next succeeding day on which the Common Stock transfer books of the Company are open.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
11. <U>Adjustment of Exercise Price, Number of Shares of Common Stock or Number of the Company Warrants</U>. The Exercise Price, the
number of shares covered by each Warrant and the number of Warrants outstanding are subject to adjustment from time to time as provided
in Section 3 of the Warrant Certificate. In the event that at any time, as a result of an adjustment made pursuant to Section 3 of the
Warrant Certificate, the Holder of any Warrant thereafter exercised shall become entitled to receive any shares of capital stock of the
Company other than shares of Common Stock, thereafter the number of such other shares so receivable upon exercise of any Warrant shall
be subject to adjustment from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect
to the shares contained in Section 3 of the Warrant Certificate, and the provisions of Sections 7, 9 and 13 of this Agreement with respect
to the shares of Common Stock shall apply on like terms to any such other shares. All Warrants originally issued by the Company subsequent
to any adjustment made to the Exercise Price pursuant to the Warrant Certificate shall evidence the right to purchase, at the adjusted
Exercise Price, the number of shares of Common Stock purchasable from time to time hereunder upon exercise of the Warrants, all subject
to further adjustment as provided herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
12. <U>Certification of Adjusted Exercise Price or Number of Shares of Common Stock</U>. Whenever the Exercise Price or the number of
shares of Common Stock issuable upon the exercise of each Warrant Certificate is adjusted as provided in Section 11 or 13, the Company
shall (a) promptly prepare a certificate setting forth the Exercise Price of each Warrant Certificate, as so adjusted, and a brief, reasonably
detailed statement of the facts accounting for such adjustment, (b) promptly file with the Warrant Agent and with each transfer agent
for the Common Stock a copy of such certificate and (c) instruct the Warrant Agent, at the Company&rsquo;s expense, to send a brief summary
thereof to each Holder of a Warrant Certificate. The Warrant Agent shall be fully protected in relying on such certificate and on any
adjustment or statement therein contained and shall have no duty or liability with respect to and shall not be deemed to have knowledge
of any such adjustment or any such event unless and until it shall have received such certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
13. <U>Fractional Shares of Common Stock</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company shall not issue fractions of Warrants or distribute Warrant Certificates which evidence fractional Warrants. Whenever any
fractional Warrant would otherwise be required to be issued or distributed, the actual issuance or distribution shall reflect a rounding
of such fraction to the nearest whole Warrant (rounded up).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company shall not issue fractions of shares of Common Stock upon exercise of Warrants or distribute stock certificates which evidence
fractional shares of Common Stock. Whenever any fraction of a share of Common Stock would otherwise be required to be issued or distributed,
the actual issuance or distribution in respect thereof shall be made in accordance with Section 2(d)(v) of the Warrant Certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
14. <U>Concerning the Warrant Agent</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company agrees to pay to the Warrant Agent, pursuant to the fee schedule mutually agreed upon by the parties hereto and provided
separately on the date hereof, for all services rendered by it hereunder and, from time to time, its reasonable expenses and counsel
fees and other disbursements incurred in the preparation, delivery, negotiation, amendment, administration and execution of this Agreement
and the exercise and performance of its duties hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company covenants and agrees to indemnify and to hold the Warrant Agent harmless against any costs, expenses (including reasonable
fees and expenses of its legal counsel), losses or damages, which may be paid, incurred or suffered by or to which it may become subject,
arising from or out of, directly or indirectly, any claims or liability resulting from its actions or omissions as Warrant Agent pursuant
hereto; provided, that such covenant and agreement does not extend to, and the Warrant Agent shall not be indemnified with respect to,
such costs, expenses, losses and damages incurred or suffered by the Warrant Agent as a result of, or arising out of, its gross negligence,
bad faith, or willful misconduct (each as determined by a final non-appealable court of competent jurisdiction). Notwithstanding anything
in this Agreement to the contrary, any liability of the Warrant Agent under this Agreement will be limited to the amount of annual fees
paid by the Company to the Warrant Agent during the twelve (12) months immediately preceding the event for which recovery from the Warrant
Agent is being sought. The costs and expenses incurred by the Warrant Agent in enforcing this right of indemnification shall be paid
by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Upon the assertion of a claim for which the Company may be required to indemnify the Warrant Agent, the Warrant Agent shall promptly
notify the Company of such assertion, and shall keep the other party reasonably advised with respect to material developments concerning
such claim. However, failure to give such notice shall not affect the Warrant Agent&rsquo;s right to and the Company&rsquo;s obligations
for indemnification hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Neither party to this Agreement shall be liable to the other party for any consequential, indirect, punitive, special or incidental damages
under any provisions of this Agreement or for any consequential, indirect, punitive, special or incidental damages arising out of any
act or failure to act hereunder even if that party has been advised of or has foreseen the possibility of such damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Notwithstanding anything contained herein to the contrary, the rights and obligations of the parties set forth in this Section 14 shall
survive termination of this Agreement, the expiration of the Warrants and/or the resignation, removal or replacement of the Warrant Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
15. <U>Purchase or Consolidation or Change of Name of Warrant Agent</U>. Any Person into which the Warrant Agent or any successor Warrant
Agent may be merged or with which it may be consolidated, or any Person resulting from any merger or consolidation to which the Warrant
Agent or any successor Warrant Agent shall be party, or any Person succeeding to the stock transfer or other shareholder services business
of the Warrant Agent or any successor Warrant Agent, shall be the successor to the Warrant Agent under this Agreement without the execution
or filing of any paper or any further act on the part of any of the parties hereto, provided that such Person would be eligible for appointment
as a successor Warrant Agent under the provisions of Section 17. In case at the time such successor Warrant Agent shall succeed to the
agency created by this Agreement any of the Warrant Certificates shall have been countersigned but not delivered, any such successor
Warrant Agent may adopt the countersignature of the predecessor Warrant Agent and deliver such Warrant Certificates so countersigned;
and in case at that time any of the Warrant Certificates shall not have been countersigned, any successor Warrant Agent may countersign
such Warrant Certificates either in the name of the predecessor Warrant Agent or in the name of the successor Warrant Agent; and in all
such cases, such Warrant Certificates shall have the full force provided in the Warrant Certificates and in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
case at any time the name of the Warrant Agent shall be changed and at such time any of the Warrant Certificates shall have been countersigned
but not delivered, the Warrant Agent may adopt the countersignature under its prior name and deliver Warrant Certificates so countersigned;
and in case at that time any of the Warrant Certificates shall not have been countersigned, the Warrant Agent may countersign such Warrant
Certificates either in its prior name or in its changed name; and in all such cases, such Warrant Certificates shall have the full force
provided in the Warrant Certificates and in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16. <U>Duties of Warrant Agent</U>. The Warrant Agent undertakes the duties and obligations imposed by this Agreement upon the following
express terms and conditions (and no implied terms and conditions), by all of which the Company, by its acceptance hereof, shall be bound
and shall not assume any obligations or relationship of agency or trust with any of the Holders of the Warrants or any other Person:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Warrant Agent may consult with legal counsel selected by it (who may be legal counsel for the Company), and the opinion and advice
of such counsel shall be full and complete authorization and protection to the Warrant Agent as to any action taken or omitted by it
in accordance with such opinion or advice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Whenever in the performance of its duties under this Agreement the Warrant Agent shall deem it necessary or desirable that any fact or
matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence
in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a certificate signed
by the Chief Executive Officer, Chief Financial Officer or Vice President of the Company; and such certificate shall be full authorization
and protection to the Warrant Agent, and the Warrant Agent shall incur no liability for or in respect of any action taken, suffered or
omitted to be taken by it under the provisions of this Agreement in reliance upon such certificate. The Warrant Agent shall have no duty
to act without such a certificate as set forth in this Section 16(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Subject to the limitation set forth in Section 14, the Warrant Agent shall be liable hereunder only for its own gross negligence, bad
faith or willful misconduct (each as determined in a final, non-appealable judgment of a court of competent jurisdiction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Warrant Agent shall not be liable for or by reason of any of the statements of fact or recitals contained in this Agreement or in
the Warrant Certificates (including in the case of any notation in book-entry form to reflect ownership), except its countersignature
thereof, by the Company or be required to verify the same, but all such statements and recitals are and shall be deemed to have been
made by the Company only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The Warrant Agent shall not have any liability or be under any responsibility in respect of the validity of this Agreement or the execution
and delivery hereof (except the due execution hereof by the Warrant Agent) or in respect of the validity or execution of any Warrant
Certificate (except its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or condition
contained in this Agreement or in any Warrant Certificate; nor shall it be responsible for the adjustment of the Exercise Price or the
making of any change in the number of shares of Common Stock required under the provisions of Section 11 or 13 or responsible for the
manner, method or amount of any such change or adjustment or the ascertaining of the existence of facts that would require any such adjustment
or change (except with respect to the exercise of Warrants evidenced by Warrant Certificates after actual notice of any adjustment of
the Exercise Price); nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation
of any shares of Common Stock to be issued pursuant to this Agreement or any Warrant Certificate or as to whether any shares of Common
Stock will, when issued, be duly authorized, validly issued, fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Each party hereto agrees that it will perform, execute, acknowledge and deliver or cause to be performed, executed, acknowledged and
delivered all such further and other acts, instruments and assurances as may reasonably be required by the other party hereto for the
carrying out or performing by any party of the provisions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
The Warrant Agent is hereby authorized to accept instructions with respect to the performance of its duties hereunder from the Chief
Executive Officer, Chief Financial Officer or Vice President of the Company, and to apply to such officers for advice or instructions
in connection with its duties, and it shall not be liable and shall be indemnified and held harmless for any action taken or suffered
to be taken by it in good faith in accordance with instructions of any such officer, provided Warrant Agent carries out such instructions
without gross negligence, bad faith or willful misconduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
The Warrant Agent and any shareholder, director, officer or employee of the Warrant Agent may buy, sell or deal in any of the Warrants
or other securities of the Company or become pecuniarily interested in any transaction in which the Company may be interested, or contract
with or lend money to the Company or otherwise act as fully and freely as though it were not Warrant Agent under this Agreement. Nothing
herein shall preclude the Warrant Agent from acting in any other capacity for the Company or for any other Person. In the event that
the Warrant Agent seeks to exercise a Warrant, and provides the Company with (i) an opinion of counsel to the effect that a public sale
or transfer of the Common Stock issuable upon exercise of the Warrant may be made without registration under the 1933 Act and such sale
or transfer is effected or (ii) the Purchaser provides reasonable assurances that the Securities can be sold pursuant to an effective
registration statement under the Securities Act of 1933, as amended, Rule 144, Section 4(a)(1), or other applicable exemption, the Company
shall permit the transfer, and, in the case of the Common Stock issuable upon exercise of the Warrant, promptly instruct its transfer
agent to issue one or more certificates, free from restrictive legend, in such name and in such denominations as specified by the Holder.
The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder by vitiating the
intent and purpose of the transactions contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for a breach
of its obligations under this Section 16(h) may be inadequate and agrees, in the event of a breach or threatened breach by the Company
of the provisions of this Section, that the Holder shall be entitled, in addition to all other available remedies, to an injunction restraining
any breach and requiring immediate transfer, without the necessity of showing economic loss and without any bond or other security being
required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Warrant Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either itself
or by or through its attorney or agents, and the Warrant Agent shall not be answerable or accountable for any act, default, neglect or
misconduct of any such attorney or agents or for any loss to the Company resulting from any such act, default, neglect or misconduct,
absent gross negligence or bad faith in the selection and continued employment thereof (which gross negligence and bad faith must be
determined by a final, non-appealable judgment of a court of competent jurisdiction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
The Warrant Agent shall not be obligated to expend or risk its own funds or to take any action that it believes would expose or subject
it to expense or liability or to a risk of incurring expense or liability, unless it has been furnished with assurances of repayment
or indemnity satisfactory to it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
The Warrant Agent shall not be liable or responsible for any failure of the Company to comply with any of its obligations relating to
any registration statement filed with the Securities and Exchange Commission or this Agreement, including without limitation obligations
under applicable regulation or law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
The Warrant Agent may rely on and be fully authorized and protected in acting or failing to act upon (a) any guaranty of signature by
an &ldquo;eligible guarantor institution&rdquo; that is a member or participant in the Securities Transfer Agents Medallion Program or
other comparable &ldquo;signature guarantee program&rdquo; or insurance program in addition to, or in substitution for, the foregoing;
or (b) any law, act, regulation or any interpretation of the same even though such law, act, or regulation may thereafter have been altered,
changed, amended or repealed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
In the event the Warrant Agent believes any ambiguity or uncertainty exists hereunder or in any notice, instruction, direction, request
or other communication, paper or document received by the Warrant Agent hereunder, the Warrant Agent, may, in its sole discretion, refrain
from taking any action, and shall be fully protected and shall not be liable in any way to Company, the holder of any Warrant or any
other Person for refraining from taking such action, unless the Warrant Agent receives written instructions signed by the Company which
eliminates such ambiguity or uncertainty to the satisfaction of Warrant Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
This Section 16 shall survive the expiration of the Warrants, the termination of this Agreement and the resignation, replacement or removal
of the Warrant Agent. The costs and expenses incurred in enforcing this right of indemnification shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 26.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
17. <U>Change of Warrant Agent</U>. The Warrant Agent may resign and be discharged from its duties under this Agreement upon thirty (30)
days&rsquo; notice in writing sent to the Company and, in the event that the Warrant Agent or one of its affiliates is not also the transfer
agent for the Company, to each transfer agent of the Common Stock. In the event the transfer agency relationship in effect between the
Company and the Warrant Agent terminates, the Warrant Agent will be deemed to have resigned automatically and be discharged from its
duties under this Agreement as of the effective date of such termination, and the Company shall be responsible for sending any required
notice thereunder. The Company may remove the Warrant Agent or any successor Warrant Agent upon thirty (30) days&rsquo; notice in writing,
sent to the Warrant Agent or successor Warrant Agent, as the case may be, and to each transfer agent of the Common Stock, and to the
Holders of the Warrant Certificates. If the Warrant Agent shall resign or be removed or shall otherwise become incapable of acting, the
Company shall appoint a successor to the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty
(30) days after such removal or after it has been notified in writing of such resignation or incapacity by the resigning or incapacitated
Warrant Agent or by the Holder of a Warrant Certificate (who shall, with such notice, submit this Warrant Certificate for inspection
by the Company), then the Holder of any Warrant Certificate may apply to any court of competent jurisdiction for the appointment of a
new Warrant Agent, provided that, for purposes of this Agreement, the Company shall be deemed to be the Warrant Agent until a new warrant
agent is appointed. Any successor Warrant Agent, whether appointed by the Company or by such a court, shall be a Person, other than a
natural person, organized and doing business under the laws of the United States or of a state thereof, in good standing, which is authorized
under such laws to exercise stock transfer powers and is subject to supervision or examination by federal or state authority and which
has at the time of its appointment as Warrant Agent a combined capital and surplus of at least $50,000,000. After appointment, the successor
Warrant Agent shall be vested with the same powers, rights, duties and responsibilities as if it had been originally named as Warrant
Agent without further act or deed; but the predecessor Warrant Agent shall deliver and transfer to the successor Warrant Agent any property
at the time held by it hereunder, and execute and deliver any further assurance, conveyance, act or deed necessary for the purpose but
such predecessor Warrant Agent shall not be required to make any additional expenditure (without prompt reimbursement by the Company)
or assume any additional liability in connection with the foregoing. Not later than the effective date of any such appointment, the Company
shall file notice thereof in writing with the predecessor Warrant Agent and each transfer agent of the Common Stock and mail a notice
thereof in writing to the Holders of the Warrant Certificates. However, failure to give any notice provided for in this Section 17, or
any defect therein, shall not affect the legality or validity of the resignation or removal of the Warrant Agent or the appointment of
the successor Warrant Agent, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
18. <U>Issuance of New Warrant Certificates</U>. Notwithstanding any of the provisions of this Agreement or of the Warrants to the contrary,
the Company may, at its option, issue new Warrant Certificates evidencing Warrants in such form as may be approved by its Board of Directors
to reflect any adjustment or change in the Exercise Price per share and the number or kind or class of shares of stock or other securities
or property purchasable under the several Warrant Certificates made in accordance with the provisions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
19. <U>Notices</U>. Notices or demands authorized by this Agreement to be given or made (i) by the Warrant Agent or by the Holder of
any Warrant Certificate to or on the Company, (ii) by the Company or by the Holder of any Warrant Certificate to or on the Warrant Agent
or (iii) by the Company or the Warrant Agent to the Holder of any Warrant Certificate, shall be deemed given when in writing (a) on the
date delivered, if delivered personally, (b) on the first Business Day following the deposit thereof with Federal Express or another
recognized overnight courier, if sent by Federal Express or another recognized overnight courier, (c) on the fourth Business Day following
the mailing thereof with postage prepaid, if mailed by registered or certified mail (return receipt requested), and (d) the time of transmission,
if such notice or communication is delivered via e-mail attachment at or prior to 5:30 p.m. (New York City time) on a Business Day and
(e) the next Business Day after the date of transmission, if such notice or communication is delivered via e-mail attachment on a day
that is not a Business Day or later than 5:30 p.m. (New York City time) on any Business Day, in each case to the parties at the following
addresses (or at such other address for a party as shall be specified by like notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to the Company, to:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intelligent
Bio Solutions Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">142
West 57<SUP>th</SUP> Street, Floor 11</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
spiro.sakiris@ibs.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Spiro Sakiris</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Arent
Fox Schiff LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1717
K Street NW</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
DC 20006</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
ralph.demartino@afslaw.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Ralph De Martino</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to the Warrant Agent, to:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continental
Stock Transfer &amp; Trust Company</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
State Street, 30<SUP>th</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10004</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
mmullings@continentalstock.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Mike Mullings</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
any notice delivered by email to be deemed given or made, such notice must be followed by notice sent by overnight courier service to
be delivered on the next Business Day following such email, unless the recipient of such email has acknowledged via return email receipt
of such email.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
If to the Holder of any Warrant Certificate, to the address of such Holder as shown on the registry books of the Company. Any notice
required to be delivered by the Company to the Holder of any Warrant may be given by the Warrant Agent on behalf of the Company. Notwithstanding
any other provision of this Agreement, where this Agreement provides for notice of any event to a Holder of any Warrant, such notice
shall be sufficiently given if given to the Depository (or its designee) pursuant to the procedures of the Depository or its designee.
To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or
any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
20. <U>Supplements and Amendments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company and the Warrant Agent may from time to time supplement or amend this Agreement without the approval of any Holders of Global
Warrants in order to (i) add to the covenants and agreements of the Company for the benefit of the Holders of the Global Warrants, (ii)
to surrender any rights or power reserved to or conferred upon the Company in this Agreement, (iii) to <FONT STYLE="background-color: white">cure
any ambiguity, (iv) to correct or supplement any provision contained herein which may be defective or inconsistent with any other provisions
herein, or (v) to make any other provisions with regard to matters or questions arising hereunder which the Company and the Warrant Agent
may deem necessary or desirable</FONT>, provided that such addition, correction or surrender shall not adversely affect the interests
of the Holders of the Global Warrants or Warrant Certificates in any material respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In addition to the foregoing, with the consent of Holders of Warrants entitled, upon exercise thereof, to receive not less than a majority
of the shares of Common Stock issuable thereunder, the Company and the Warrant Agent may modify this Agreement for the purpose of adding
any provisions to or changing in any manner or eliminating any of the provisions of this Agreement or modifying in any manner the rights
of the Holders of the Global Warrants; <U>provided</U>, <U>however</U>, that that (i) if any amendment, modification or waiver disproportionately
and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group of Holders) shall
also be required and (ii) no modification of the terms (including but not limited to the adjustments described in Section 11) upon which
the Warrants are exercisable or reducing the percentage required for consent to modification of this Agreement may be made without the
consent of the Holder of each outstanding warrant certificate affected thereby; <U>provided further</U>, <U>however</U>, that no amendment
hereunder shall affect any terms of any Warrant Certificate issued in a Warrant Exchange. As a condition precedent to the Warrant Agent&rsquo;s
execution of any amendment, the Company shall deliver to the Warrant Agent a certificate from a duly authorized officer of the Company
that states that the proposed amendment complies with the terms of this Section 20. No supplement or amendment to this Agreement shall
be effective unless duly executed by the Warrant Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
21. <U>Successors</U>. All covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall
bind and inure to the benefit of their respective successors and assigns hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
22. <U>Benefits of this Agreement</U>. Nothing in this Agreement shall be construed to give any Person other than the Company, the Holders
of Warrant Certificates and the Warrant Agent any legal or equitable right, remedy or claim under this Agreement; but this Agreement
shall be for the sole and exclusive benefit of the Company, the Warrant Agent and the Holders of the Warrant Certificates. Notwithstanding
anything to the contrary contained herein, to the extent any provision of a Warrant Certificate conflicts with any provision of this
Agreement, the provisions of the Warrant Certificate shall govern and be controlling.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
23. <U>Governing Law; Jurisdiction</U>. This Agreement and each Warrant Certificate issued hereunder shall be governed by, and construed
in accordance with, the laws of the State of New York without giving effect to the conflicts of law principles thereof. The Company hereby
agrees that any action, proceeding or claim against it arising out of or relating in any way to this Agreement shall be brought and enforced
in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably submits
to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and
that such courts represent an inconvenience forum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
24. <U>Counterparts</U>. This Agreement may be executed in any number of counterparts and each of such counterparts shall for all purposes
be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. A signature to this
Agreement transmitted electronically shall have the same authority, effect and enforceability as an original signature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
25. <U>Captions</U>. The captions of the sections of this Agreement have been inserted for convenience only and shall not control or
affect the meaning or construction of any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
26. <U>Severability</U>. Wherever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and
valid under applicable law, but if any provision of this Agreement shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Agreement; provided, however, that if such prohibited and invalid provision shall adversely affect the rights, immunities,
liabilities, duties or obligations of the Warrant Agent, the Warrant Agent shall be entitled to resign immediately upon written notice
to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
27. <U>Conflicts</U>. To the extent any provision of this Agreement conflicts with the express provisions of the Warrant Certificate,
the provisions of the Warrant Certificate shall govern and be controlling.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
28. <U>Force Majeure</U>. Notwithstanding anything to the contrary contained herein, the Warrant Agent will not be liable for any delays
or failures in performance resulting from acts beyond its reasonable control, including, without limitation, acts of God, terrorist acts,
shortage of supply, breakdowns or malfunctions, interruptions or malfunction of computer facilities, or loss of data due to power failures
or mechanical difficulties with information storage or retrieval systems, labor difficulties, war, or civil unrest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
29. <U>Entire Agreement</U>. The parties hereto acknowledge that there are no agreements or understandings, written or oral, between
them with respect to matters contemplated hereunder other than as set forth herein and the Warrant Certificates, that this Agreement
and the Warrant Certificates contain the entire agreement between them with respect to the subject matter hereof and thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
30. <U>Fees; Expenses</U>. As consideration for the services provided by CST (the &ldquo;<U>Services</U>&rdquo;), the Company shall pay
to CST the fees set forth on <U>Schedule 1</U> hereto (the &ldquo;<U>Fees</U>&rdquo;). If the Company requests that CST provide additional
services not contemplated hereby, the Company shall pay to CST fees for such services at CST&rsquo;s reasonable and customary rates,
such fees to be governed by the terms of a separate agreement to be mutually agreed to and entered into by the Parties at such time (the
&ldquo;<U>Additional Service Fee</U>&rdquo;; together with the Fees, the &ldquo;<U>Service Fees</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company shall reimburse CST for all reasonable and documented expenses incurred by CST (including, without limitation, reasonable
and documented fees and disbursements of counsel) in connection with the Services (the &ldquo;<U>Expenses</U>&rdquo;); <U>provided</U>,
<U>however</U>, that CST reserves the right to request advance payment for any out-of-pocket expenses. The Company agrees to pay all
Service Fees and Expenses within thirty (30) days following receipt of an invoice from CST.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company agrees and acknowledges that CST may adjust the Service Fees annually, on or about each anniversary date of this Agreement,
by the annual percentage of change in the latest Consumer Price Index of All Urban Consumers United States City Average, as published
by the U.S. Department of Labor, Bureau of Labor Statistics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Upon termination of this Agreement for any reason, CST shall assist the Company with the transfer of records of the Company held by CST.
CST shall be entitled to reasonable additional compensation and reimbursement of any Expenses for the preparation and delivery of such
records to the successor agent or to the Company, and for maintaining records and/or Stock Certificates that are received after the termination
of this Agreement (the &ldquo;<U>Record Transfer Services</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTELLIGENT
    BIO SOLUTIONS INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Spiro Sakiris</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spiro
    Sakiris</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONTINENTAL
    STOCK TRANSFER &amp; TRUST COMPANY</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annex
A: Form of Warrant Certificate Request Notice</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANT
CERTIFICATE REQUEST NOTICE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:
Continental Stock Transfer &amp; Trust Company, as Warrant Agent for Intelligent Bio Solutions Inc. (the &ldquo;Company&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned Holder of Common Stock Purchase Warrants (&ldquo;Warrants&rdquo;) in the form of Global Warrants issued by the Company hereby
elects to receive a Warrant Certificate evidencing the Warrants held by the Holder as specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Holder of Warrants in form of Global Warrants: ___________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Holder in Warrant Certificate (if different from name of Holder of Warrants in form of Global Warrants): ______________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Warrants in name of Holder in form of Global Warrants: ___________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Warrants for which Warrant Certificate shall be issued: __________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Warrants in name of Holder in form of Global Warrants after issuance of Warrant Certificate, if any: ___________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Certificate shall be delivered to the following address:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby acknowledges and agrees that, in connection with this Warrant Exchange and the issuance of the Warrant Certificate,
the Holder is deemed to have surrendered the number of Warrants in form of Global Warrants in the name of the Holder equal to the number
of Warrants evidenced by the Warrant Certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
___________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
1-A and Exhibit 1-B: Form of Warrant Certificates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Schedule
1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Fees</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monthly
    Warrant Administration Fee (per Warrant Issue) </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$200.00
    </FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXCHANGE
    OF WARRANTS INTO COMMON SHARES</U></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per
    Manual Exercise of Warrants (until established on DTC WARR System)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.00</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><U>SPECIAL
SERVICES</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services
not included herein (including, without limitation, trustee and custodial services, exchange/tender offer services and stock dividend
disbursement services) but requested by the Company may be subject to additional charges.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><U>Out-of-pocket
Expenses</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
customary out-of-pocket expenses will be billed in addition to the foregoing fees. These charges include, but are not limited to, printing
and stationery, freight and materials delivery, postage and handling.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing fees apply to services ordinarily rendered by CST and are subject to reasonable adjustment based on final review of documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>8
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intelligent
Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEW
YORK</B>, October 2, 2023 &mdash; Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the &ldquo;Company&rdquo;), a medical technology company
delivering intelligent, rapid, non-invasive testing solutions, today announced the pricing of an underwritten public offering of units
(the &ldquo;Units&rdquo;) for gross proceeds of approximately $4.0 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladenburg
Thalmann &amp; Co. Inc. is acting as the sole bookrunning manager for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwritten public offering consists of 7,272,727 shares of common stock, par value $0.01 per share, of the Company (the &ldquo;Common
Stock&rdquo;) (or shares of the Company&rsquo;s Series E Convertible Preferred Stock (the &ldquo;Preferred Stock&rdquo;), in lieu of
Common Stock), 7,272,727 warrants to purchase shares of Common Stock that will expire on the five-and-a-half-year anniversary of the
original issuance date (the &ldquo;Series E Warrants&rdquo;), and 7,272,727 warrants to purchase shares of Common Stock that will expire
on the one-and-a-half-year anniversary of the original issuance date (the &ldquo;Series F Warrants&rdquo;, collectively with the Series
E Warrants, the &ldquo;Warrants&rdquo;). Each Unit consists of one share of Common Stock (or one share of Preferred Stock), one Series
E Warrant and one Series F Warrant. The offering is expected to close on or about October 4, 2023, subject to customary closing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Units were priced at a combined public offering price of $0.55 per Unit for initial gross proceeds of approximately $4.0 million, before
underwriting discounts and commissions and offering expenses. The Company intends to use the net proceeds from this offering for general
corporate purposes and working capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the securities to be sold in the offering will be sold by the Company. In addition, the Company has granted the underwriter a 45-day
option to purchase up to an additional 1,090,909 shares of its Common Stock and/or Series E Warrants to purchase up to an additional
1,090,909 shares of its Common Stock and/or Series F Warrants to purchase up to an additional 1,090,909 shares of its Common Stock at
the public offering price less the underwriting discounts and commissions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Preferred Stock issued in this transaction includes a beneficial ownership blocker but has no dividend rights (except to the extent that
dividends are also paid on the Common Stock) or liquidation preference, and, subject to limited exceptions, has no voting rights. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of Preferred Stock is convertible at any time at the holder&rsquo;s option into one share of Common Stock, subject to adjustment
as provided in the Certificate of Designation of Preferences, Rights and Limitations of the Series E Convertible Preferred Stock and
subject to the beneficial ownership limitations as provided for therein. <FONT STYLE="background-color: white">The securities comprising
the Units are immediately separable and will be issued separately. </FONT>The Warrants and Preferred Stock issued in this transaction
do not contain any price based anti-dilution features. The Warrants are exercisable beginning on the date the Company obtains such stockholder
approvals as may be required by the rules and regulations of the Nasdaq Capital Market to permit the exercise of such Warrants. In the
event that the Company is unable to obtain such stockholder approval, the Warrants will not be exercisable and therefore have no value.
The Series E Warrants have an exercise price of $0.55 per share and contain a one-time reset of the exercise price to a price equal to
the lesser of (i) the then exercise price of the Series E Warrant and (ii) ninety percent of the five-day volume weighted average price
for the five trading days immediately following the date the Company effects a reverse stock split. The Series F Warrants have an exercise
price of $0.55 per share and contain an alternate cashless exercise option pursuant to which the holder thereof has the right to receive
an aggregate number of shares of Common Stock on a one for one basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities described above are being offered by the Company pursuant to a registration statement on Form S-1 (No. 333-273219) originally
filed July 12, 2023, with the Securities and Exchange Commission (SEC) and declared effective by the SEC on September 29, 2023. A final
prospectus relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC&rsquo;s website
at http://www.sec.gov. Electronic copies of the final prospectus may be obtained, when available, from Ladenburg Thalmann &amp; Co. Inc.
at Attn: Prospectus Department, 640 Fifth Avenue, 4th Floor, New York, NY 10019 or by e-mail at <U>prospectus@ladenburg.com.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>This
press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale
of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state or other jurisdiction.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Intelligent Bio Solutions Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intelligent
Bio Solutions Inc. (the &ldquo;Company&rdquo;) (Nasdaq: INBS) is a medical technology company delivering intelligent, rapid, non-invasive
testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing
through fingerprint sweat analysis, which has the potential for broader applications in additional fields. This hygienic, and cost-effective
system is designed to screen for recent use of drugs commonly found in the workplace, including opioids, cocaine, methamphetamine, and
cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers
in safety-critical industries. Additionally, the Company&rsquo;s biosensor platform has the potential to test for up to 130 indications,
ranging from glucose to immunological conditions and communicable diseases. The Company&rsquo;s current customer segments include construction,
manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, <U>visit http://www.ibs.inc/</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of the statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,
Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and
uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.&rsquo;s ability
to consummate the proposed transaction described in this press release, the intended use of proceeds, develop and commercialize its drug
and diagnostic tests, realize commercial benefit from its partnerships and collaborations, and secure regulatory approvals, among others.
Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such forward-looking statements are reasonable as
of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward looking
statements. Intelligent Bio Solutions Inc. has attempted to identify forward-looking statements by terminology, including &ldquo;believes,&rdquo;
&ldquo;estimates,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;expects,&rdquo; &ldquo;plans,&rdquo; &ldquo;projects,&rdquo; &ldquo;intends,&rdquo;
&ldquo;potential,&rdquo; &ldquo;may,&rdquo; &ldquo;could,&rdquo; &ldquo;might,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;approximately&rdquo;
or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are
only predictions and involve known and unknown risks, uncertainties, and other factors, included in Intelligent Bio Solutions&rsquo;
public filings filed with the Securities and Exchange Commission. Any forward-looking statements contained in this release speak only
as of its date. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this release
to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Contact:</B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intelligent
Bio Solutions Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>info@ibs.inc</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valter
Pinto, Managing Director</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KCSA
Strategic Communications</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>INBS@kcsa.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cheryl
Billson</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comma
Communications</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>cheryl.billson@commacomms.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>9
<FILENAME>ex99-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intelligent
Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters&rsquo;
Overallotment Option</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEW
YORK, October 4, 2023 &ndash; Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the &ldquo;Company&rdquo;), a medical technology
company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of its previously announced
underwritten public offering of units (the &ldquo;Units&rdquo;) for gross proceeds of approximately $4.378 million prior to
deducting underwriting discounts and commissions and offering expenses, including partial exercise of the underwriter&rsquo;s
over-allotment option to purchase additional shares of common stock and warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladenburg
Thalmann &amp; Co. Inc. acted as the sole bookrunning manager for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwritten public offering consisted of a total of 2,232,221 shares of common stock, par value $0.01 per share, of the Company (&ldquo;Common
Stock&rdquo;), 5,728,723 shares of the Company&rsquo;s Series E Convertible Preferred Stock (&ldquo;Preferred Stock&rdquo;) that were
issued in lieu of Common Stock, 7,960,944 warrants to purchase shares of Common Stock that will expire on the five-and-a-half-year anniversary
of the original issuance date (the &ldquo;Series E Warrants&rdquo;), and 7,960,944 warrants to purchase shares of Common Stock that will
expire on the one-and-a-half-year anniversary of the original issuance date (the &ldquo;Series F Warrants&rdquo;, collectively with the
Series E Warrants, the &ldquo;Warrants&rdquo;). Each Unit consists of one share of Common Stock (or one share of Preferred Stock), one
Series E Warrant and one Series F Warrant. The Units were priced at a combined public offering price of $0.55 per Unit for initial gross
proceeds of approximately $4.378 million, before underwriting discounts and commissions and offering expenses. The Company intends to
use the net proceeds from this offering for general corporate purposes and working capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the securities were sold by the Company. The securities issued at closing include 688,217 shares of Common Stock, Series E Warrants
to purchase 688,217 shares of Common Stock and Series F Warrants to purchase 688,217 shares of Common Stock, which securities were issued
upon the partial exercise of the underwriter&rsquo;s over-allotment option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Preferred Stock issued in this transaction includes a beneficial ownership blocker but has no dividend rights (except to the extent that
dividends are also paid on the Common Stock) or liquidation preference, and, subject to limited exceptions, has no voting rights. Each
share of Preferred Stock is convertible at any time at the holder&rsquo;s option into one share of Common Stock, subject to adjustment
as provided in the Certificate of Designation of Preferences, Rights and Limitations of the Series E Convertible Preferred Stock and
subject to the beneficial ownership limitations as provided for therein. The securities comprising the Units are immediately separable
and were issued separately. The Warrants and Preferred Stock issued in this transaction do not contain any price based anti-dilution
features. The Warrants are exercisable beginning on the date the Company obtains such stockholder approvals as may be required by the
rules and regulations of the Nasdaq Capital Market to permit the exercise of such Warrants. In the event that the Company is unable to
obtain such stockholder approval, the Warrants will not be exercisable and therefore have no value. The Series E Warrants have an exercise
price of $0.55 per share and contain a one-time reset of the exercise price to a price equal to the lesser of (i) the then exercise price
of the Series E Warrant and (ii) ninety percent of the five-day volume weighted average price for the five trading days immediately following
the date the Company effects a reverse stock split. The Series F Warrants have an exercise price of $0.55 per share and contain an alternate
cashless exercise option pursuant to which the holder thereof has the right to receive an aggregate number of shares of Common Stock
on a one for one basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities described above were offered by the Company pursuant to a registration statement on Form S-1 (No. 333-273219) originally filed
July 12, 2023, with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) and declared effective by the SEC on September 29,
2023. A final prospectus relating to and describing the terms of the offering was filed with the SEC and is available on the SEC&rsquo;s
website at www.sec.gov. Electronic copies of the final prospectus can be obtained from Ladenburg Thalmann &amp; Co. Inc. at Attn: Prospectus
Department, 640 Fifth Avenue, 4th Floor, New York, NY 10019 or by e-mail at prospectus@ladenburg.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale
of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state or other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Intelligent Bio Solutions Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intelligent
Bio Solutions Inc. (the &ldquo;Company&rdquo;) (Nasdaq: INBS) is a medical technology company delivering intelligent, rapid, non-invasive
testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing
through fingerprint sweat analysis, which has the potential for broader applications in additional fields. This hygienic, and cost-effective
system is designed to screen for recent use of drugs commonly found in the workplace, including opioids, cocaine, methamphetamine, and
cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers
in safety-critical industries. Additionally, the Company&rsquo;s biosensor platform has the potential to test for up to 130 indications,
ranging from glucose to immunological conditions and communicable diseases. The Company&rsquo;s current customer segments include construction,
manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, visit www.ibs.inc</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of the statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,
Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and
uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.&rsquo;s ability
to successfully develop and commercialize its drug and diagnostic tests, realize commercial benefit from its partnerships and collaborations,
and secure regulatory approvals, among others. Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such
forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results
expressed or implied by such forward looking statements. Intelligent Bio Solutions Inc. has attempted to identify forward-looking statements
by terminology, including &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;expects,&rdquo; &ldquo;plans,&rdquo;
&ldquo;projects,&rdquo; &ldquo;intends,&rdquo; &ldquo;potential,&rdquo; &ldquo;may,&rdquo; &ldquo;could,&rdquo; &ldquo;might,&rdquo;
&ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;approximately&rdquo; or other words that convey uncertainty of future events or outcomes
to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties,
and other factors, included in Intelligent Bio Solutions&rsquo; public filings filed with the Securities and Exchange Commission. Any
forward-looking statements contained in this release speak only as of its date. Intelligent Bio Solutions undertakes no obligation to
update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect
the occurrence of unanticipated events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
Contact: Intelligent Bio Solutions Inc.info@ibs.inc</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor
Contact: Valter Pinto, Managing Director KCSA Strategic CommunicationsINBS@kcsa.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Media
Contact: Cheryl Billson Comma Communicationscheryl.billson@commacomms.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "J IX# 2(  A$! Q$!_\0
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M'I@D\ \ $GD*&8XK]AO^"0O_  1_^,/_  5*^+4NR35OAS^RW\/-7M8OC/\
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M1_PA_A;_ *%CPY_X)-,_^1*Z6BOSLW.:_P"$/\+?]"QX<_\ !)IG_P B4?\
M"'^%O^A8\.?^"33/_D2NEHH YK_A#_"W_0L>'/\ P2:9_P#(E'_"'^%O^A8\
M.?\ @DTS_P"1*Z6B@#FO^$/\+?\ 0L>'/_!)IG_R)1_PA_A;_H6/#G_@DTS_
M .1*Z6H+A]D9;. ",G<5P._(Z?B5!Z%A4RDHQ<G:R5W=J*W2W::6_9W=DDW*
M*9][\DG)OT2U;\D8/_"'^%O^A8\.?^"33/\ Y$H_X0_PM_T+'AS_ ,$FF?\
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M^0H_U,X4_P"B7X4_\13AK_YP!_K#G?\ T.,U_P##AC__ )ZGI_\ PO'XY_\
M19OBI_X</Q7_ /+FC_A>/QS_ .BS?%3_ ,.'XK_^7->88'H/R%&!Z#\A1_J9
MPI_T2_"G_B*<-?\ S@#_ %ASO_H<9K_X<,?_ //4]/\ ^%X_'/\ Z+-\5/\
MPX?BO_Y<T?\ "\?CG_T6;XJ?^'#\5_\ RYKS# ]!^0HP/0?D*/\ 4SA3_HE^
M%/\ Q%.&O_G '^L.=_\ 0XS7_P .&/\ _GJ>G_\ "\?CG_T6;XJ?^'#\5_\
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MQ7_\N:\PP/0?D*,#T'Y"C_4SA3_HE^%/_$4X:_\ G '^L.=_]#C-?_#AC_\
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MO_Y<T?\ "\?CG_T6;XJ?^'#\5_\ RYKS# ]!^0HP/0?D*/\ 4SA3_HE^%/\
MQ%.&O_G '^L.=_\ 0XS7_P .&/\ _GJ>G_\ "\?CG_T6;XJ?^'#\5_\ RYH_
MX7C\<_\ HLWQ4_\ #A^*_P#Y<UYA@>@_(48'H/R%'^IG"G_1+\*?^(IPU_\
M. /]8<[_ .AQFO\ X<,?_P#/4]/_ .%X_'/_ *+-\5/_  X?BO\ ^7-'_"\?
MCG_T6;XJ?^'#\5__ "YKS# ]!^0HP/0?D*/]3.%/^B7X4_\ $4X:_P#G '^L
M.=_]#C-?_#AC_P#YZGI__"\?CG_T6;XJ?^'#\5__ "YH_P"%X_'/_HLWQ4_\
M.'XK_P#ES7F&!Z#\A1@>@_(4?ZF<*?\ 1+\*?^(IPU_\X _UASO_ *'&:_\
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M8KEC8HHHKWSA"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+3M'TM'DBLK*)69G\O&[@L << @!< $%0 3P%"H.@^XI[ !54C.2><''8'T
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MDUNSM;6ZFCMIHM,N;^U^QOBO:_!?Q-\)/B#\</A/\//AIX'TCX@>+OAY\/\
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M%7QOKJ0:)^S9H4-SXI\*^/;$O*^L^(/#6COJ,>J?"31- 0-)=ZFGV[P&T_\
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M$>CV>KCP+X$\%F[A\.R:1>W$']I?VC"DFI2BUB'G-,_Z<?\ !#?G]A[_ (+
MX_Z(-:_^J:_:-_Q'YBOYG;7_ %$7_7*+_P! %>[]'7P7X-RWZ1?TAZ%#'<>X
MG#>#O%_ .5<!8/.?%#Q(XBP&68#BSPDCFN?T<=@.(>,,WP6=3QF+S;'U*6)S
M;#8G$X&I5A7P=6E7P]&I'@\2.+\XQ/ / KG2R2E4XPRSB&OGE;"<.9#@L37E
M@.):V%PT:.*PF6T<5ATJ,(PJ.GB.>LM:LJCU)ER2Q(P=S=L9&<C&#COC/L13
MZ**_T<BN56O=7T6GNQM%*.FZ2CHWJ[N^R/YXDTVVERK2T4V^5)))7>KLEN]7
M?7H%%%%,04444 %?J?\ \$S_ /CV^/G_ %W^#G_HOXO5^6%?J?\ \$S_ /CV
M^/G_ %W^#G_HOXO5_&7[0K_E#?QQ_P"Q%D/_ *VW"!^R_1\_Y/%P3_V&X[_U
M39J?SE_M%?\ )Q7[0O\ V7?XR_\ JQO$U>1CI^+?S->N?M%?\G%?M"_]EW^,
MO_JQO$U>1CI^+?S-?Y[Y9_R*LJ_[%F _]5N0G^@2V%HHHKM&%%%% !1110 4
M444 %1.ZKG<0 >KL2%48Y!(!)/!;:!R.>M#NJ*78@*O)W,H4!=V2Y8A54 9+
M,0/<8S7];G_!!?\ X( ZC^TG=^%OVSOVW?!C6?[., T[Q%\%?@?XCM)8;_X^
MW'F2W-CXT\?Z->VUO)I_P2$'D3:-X<O5EN_BTMTDFLVVF^#M+A'C?Y7C'C/(
M^!LGKYSG>*C3IPBXX;!PE#ZWF6(U4<'AJ,I)RYYI1J5I)T*-.]2JU"W-K1H.
MO)*WN)WE+I%K5)V[O33_ (;S;_@A1_P0'US]M*_T']J[]L;PUKGA;]DG3;B'
M4?A[\.=234- \3?M)7L$B3P:E=*5M-2T;X)0N(99=6MY8YOB=&YL= F'AE[C
M7;G_ $6=!T;2?#>C:-X=T'2M+T'0]!TNPT71="T*QMM+T31=(TJSBL=-TC1]
M+LHH+/3M+TVSA@L]/L;2"&UL[2&&WMXHHHU1;MG96=A;6MC96EM9V=G:PVEG
M:6L$5O;6EG;HD-O:6UO"B16]M!#''%%!$B111HB1HJJH%L #H /H!7^=O'7'
MN>>(&;_VIFM3V6&H>TI95E=-OZKEV"G-N,(15D\152C4Q-5)>UK:VC",8GKT
MZ,*5[*]TM=+MI:-V[=%T]7<6BBBOBS0***\U^)'Q+\"_"?P?XA\?_$KQGH/@
M+P5X9MKB]U[Q7XIUB#0]!TFT@W,SW.HWLT5NKL!MB@C+7$\A6"UCEN"D+72I
M8C$XC#X3"87$XW%8JK##X;"8.A5Q6+Q.(JSITJ%##83#TJ^)Q-:M5JTZ5.EA
M\/B*TJE2$84:CDHD5:E.C2JUZU2G1HT82J5:U>I3H4*4(J\IUJ]6<*=&"2;<
MYOE5G<[V=Q&SL1D@;U&,@[$!/5<*>,#!Y)&<=:^#/VU?^"CO[,'["?A9=7^-
M/C&:?Q?JMN\GA+X2>"HK'7_BGXL?9,R2Z?X=EU"PM-%TAS%(K^)?%NI^'O#8
MEBELX=6EU%H+2?\ G>_X*#?\'$VM^(CKOPL_8#BO_#VBS-?:?K7[2'C#2YK?
MQ!?P@RVGF?"3P1JR2+I%E/;E)[;Q?XVLX=:0/*;+P9I=W;VFJW'\O/B7Q1XG
M\;^(];\7^-?$WB7QGXN\27KZEXB\6>+]=U/Q+XF\1:C*P>;4-:U[6+N^U35;
MJ23]XUQ>W4LA9B<*,"O]0?HW?LS^,>.)9=Q9X[5\P\/N&:LUBZ/ ^$MA^/<[
MPRFIP_MC&^QJT^"\+B*,E1CA:N'S;B>6$D\3AZ&3RM4H?S1XB_20RK)'6RO@
MNC3SS,J<72J9O5BI9-A*ZE*G+V2]R>83I.\Z+3A@J\DG4<J6_P"HW_!0/_@L
M%^TO^W1<:GX)CN[GX(? !Y[J.T^$G@?7M12\\4:=<1FW7_A;'BJR72KCQNL]
ML[O)X9^R6'@FWEDC:70]5O;*'59_R=PG[O9%&H0%<J%4)QC;'&BA$7IA4"JJ
MX &!3@ .@QTZ<=!@?D.!Z#@<4O\ ^O\ 'UK_ &U\/O##@7PKX:R_A+P^X8R?
MA7(<NE3J4\'E>&G3GBZ\:*H5,;FF-G7GF6;YG5I)^VS'.,PS7$UYR<JKA!0P
M]+^+>(.),[XIS"KFN?YAB<SQU9SE*MB*U11ASMWA0H4^6CAZ%.+Y*.&I*.'I
M02@HN-[E%%%??GAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>
MO?L\6FAWWQX^#UCXFU^Z\)^';GXC>%TUGQ/8Z,WB.ZT2S&H++<ZE%H*7FG-J
MYM(T:5K%;R)Y5#/''<R1I9W/D->J? ;2[[7OC;\(]!TZRO-7O]<^)/A/1-/T
M>QFBAO=4U+5M:@TZQL-/DNMUI%J%[<W,-G8R7"-#Y\L2R@1%R/E^-(QEPGQ+
M&IB'@Z<N&N)H5<;>BHX*C+AS._;XVV)A4PSJ87#K$5J'UF$\.JE.?MHRIN2.
M_*YN.88%*B\0Y8W"1C1=2K3C.;K<L$_9-2<^>:]D_LS]Y:L^^-'TK]JWQ39^
M/9/V@M#U;XN^ OC-II_:8T'2I/&NC0Z/\:=2T?4IM*LH?@5X<\,7=^NC?$#Q
MM>?%S1-=T*U^'OA2#XFZ-H.G3V3>&;WPO>^,])'U1^W1^P/XP_99_P"":OP5
M^)7Q,M?#/A3QIKOQ?\*^!](^''ACPU<Z1K/ASPOXWM/CO\7KZ\^,VO:MXA\7
M:MXK^+P6U\'^&]0M8?$FL:'X%MO#U_X9T/Q'XLT.72Y]-_H'_P"":'_!)GPO
M^S9:?#KX]?'FUN?&?[2.D?#CP?X6\(>&_$^MV7COPM^S-I&F>%-.T"^\/_#B
M^&C:-IUUXQU.*VN)/%WC[3= TB5[K5O$&C>&[>RTO4M7U3Q'XC_P<NH+?]@?
MX6B)5A_XRX^'0 @/EH ?A-\<E(14"B,,,AD7 .XY'S$5_C?D_P!*6AQI])_P
M?\-O#+^R,)P<_$_(UG^<9'D^*X>RC/:N59#QCEE#!Y%DCS'$8-9?4R[*^'X9
MQG\<+0Q.<XC"U\-EE##\/?4L97_L#&>&%3*O#?B_B+B*6(JYK2X<QL\LR_,,
M:LQKX!5,3AZ]+%UL9R1K\LZF+G5I9.I/"8"I?%2C+,*E62^M/^"%HQ_P2Q_9
M8+C.ZT^+H?(!4X^//Q/ SG&W+<COD_05@_&[_@NA^PE^S[\8/B'\#_B#J'QA
MC\<?#'Q-?>$O%$>A?#&\U;2(]7T^.%[A--U*+4H4O+4K.H29(DWF.8%1Y;$]
M#_P0RCW_ /!+']EI,#!M?C!P?N\?'OXED9&""1SMR#C)QWS^,7[;G_!!/]M_
M]HO]KK]H;XY^ O&?[,5CX+^*GQ,U?QAX8L_%_P 3/B?I?B*#2;^WL88(M;TK
M1?@AXCL++4%-LYDCL]8U.%(UB6.[17FB/\UY-PG]'[C#Z6GTDLN^D;QK4X%X
M/P_''B/C<CQ]#/:W#ZQ'$3\3<TI?4YXJAPWQ-6J4OJ$\1-0>$H)**_VA.].?
MZ#B\UX[R7PN\/*OA]DM/.LQJY1D6&QN'G@:>-5#+)<.X7$PFXO&8"44L95Y>
M9XF.[6D;,_7/X6?\%X_^"=/Q>\::%\/[+XD>,_!&K>*M4L-!T74?B5\./$'A
MOPU+JVJW,=GI]M?>(HEU72]$AN;J6.+^TM>ETS2+=B3=W]O&"X^3?^"S_P#P
M2/L/VA_#_P 0_P!KKX.:[XZO/COX.\,#6]?^'FM^)==\7>$/'_@3P=I<EU>>
M%/ .FZU=:D_@+7],TNVO=9\/^'?"?V7P?XAU<ZA%/X;@U_6U\1P?G/\ "7_@
MV9_:EO\ Q]X<_P"%_?%O]GWPQ\+(=0@N?%EQ\*O%'Q%\=>/;[3K659Y-)T'1
M_%'PH\ >';6?4E5K)M8U/7YXM)2ZDO1HFL20QVA_K=_:$^+7@/\ 9N^"'Q,^
M,WQ'OCI7@CX:^!M;US4)FGD>:=[>P72M)T2PC<J+[4_$&H/I^CZ3!(Z2S:KJ
M,*-(HG_=[\=YCX4?1Z\9_#'B#Z$_B1G_ !WG>8U7E/%F25JCXCR?-:&8YYP_
M@<!PE',7PKP_7S*/%.%Q>98;$99AL'''X/&4\DS+ YWA,9AL+0I/(L/Q3QWP
MGQ)@/&;AS Y%EU&E]9RW%1<<LK8?V%"I+%9I"%'-LTIK$933C'%X*O4K4I3J
MRJ8:-"3;J/\ S#OA/\6/B%\#_B)X+^+OPE\6:CX+^('@36(M<\+>(]+=8[FS
MG2%HIXIHY%E@U'2M6LIKC2=:T*]@N--UG3+R\L-3M[JT>:SN/ZG/V</^#F[2
M;32],T/]JK]GC6I]6M+>UM]1\?\ P!U/1[R#6+G9Y=SJ-S\-/&^L>'!H;3'%
MY<1V'CS5K?+2_8K6#;!:-\:_\$$/^"?GP5_:F\=>-?CE\>+[P)X_T#X+WUGI
M?A_]G;4)M$U=]<\2ZG!YL_C?XH>#[Y9/[0^'^E0W9T_PQI-Y:3:/XB\2-=3:
MJ5A\.R:9K?Z+_M?_ /!MM\/O'FJZ]X[_ &.?BA;?!W4-6N[B^A^$?Q'M;WQ#
M\*X)[F2>:2'PUXLTPZAXT\&Z),\D+0:;)I?C6/3US%I@L;&..R'][_2:\5OH
M/<=>+V,\'OI \/YKA>(>%,IP6$EXH8#!9UED,DQV=+^U?]6WQ!D.&?$M?!8/
M#8K YH\TEP[Q'P=/&9A+!4:TJV#S+'TOP[PXX5\9\DX3H<6<"YAEU? YGBJN
M(_U;J5<#C9XVC2E.F\QJ8?%7I?6ZM2,J+P]+$X'&JDHRG5]DX4S]D/V5?^"F
M?[%W[9FHR^%/@A\9=+U#X@K:B\;X=>+--U?P+X]^SO;27<LFDZ#XGM[)O%,=
ME:P2W.IS^$;[7[6QA@:2\N+>%E>OR*_X+W?\$TOA3XE^"?C;]MOX6^']"\"?
M%SX6S6/B'XKP>'=+CTO3?BWX(U?5XM)U;6-<L+&**Q/Q!\.7^JV_B(^+KB&2
M^UO0-/U?1]9N;F8:'>Z-Y#_P3W_X-_\ ]HOX!?M0_"SX^_M$_%_X,6GA_P""
MOB6'QWX:\.?!+6O'/C#6/%/B:QANX-/L-:U+QG\._AO;^&M 5[U[G59;"'Q'
M=ZW!%)I7V/2EOI=4L_TV_P""Z7Q]\%?!S_@GQ\7_  ?K>JVT7C/X_P"F67P>
M^'?APA7U'6[_ %74K?4?%VHI:HXDM]*\-^#[/6-3U+5&C?3[2]DT2QED6XU6
MSBG_ (*R3!<%^$OTO_"++/H@^)G$'B'DO$6<\.8'.'"6(J8;ZOF>?_4^)N$L
M9C\+E7#U#B;(%PE/-L_Q^9X[A^-#AR>%CBG6_M;+:6:S_=,=6S?B;PFXKQ'B
MQPW@<BQN P.95,)&<*4+XC"X&57 9G@U/$8F6!Q53%25..%I5ZD:DVZ<%*G)
M<O\ GQN%5RJC,1 *G@!=V&VG&,$'!]N?:N\\#_%;XJ?"Z75IOA?\4OB1\,9-
M?LX=-UZ;X=^//%7@F?6[&!Y98+'5I?#6J::=4LXGGN=EI?FYMD6YG"Q#S"*X
M*,8+C((*RL_.0) NT[0<D#C(P< C@FOMC]F;1+Y_@O\ M'^*?"OA;X':[X\\
M/Z_^SYIN@:G\=='^!VI>'-"T7Q1J/Q:C\3IHUQ\?#'X,M=;U2;1M C=8)'U6
M2UL)(+="(BJ?] 7'V:Y7DW"]7%9WDV"X@P+S;(LM>6YE#*)X&M6SG.\!EF%Q
MN.>=Y+GV!PWU&OB7C<3562YE5=/#1J8;!XC&XNDE_!>08+%8S,J5'"XZK@*T
M,%BJBQ6%IU:E:='#Y?BL=5M3I5:=9XBO3HRII1J1:G-2EHFG\D^#_&GBWX<^
M(-/\7?#WQ9XL^'WBW2/M7]C>*? OB#5_"?B73?MEG<:==1Z;KN@W5EJM@EUI
M]Y>V%W]DO8'N=/NKFQEW07,Y:OXH\3>(_&>N:GXH\8^)O$?C'Q/KDZW6M>)/
M&FM:GXG\1ZS<I;PVPN=8UW6;J]U34[HV\$43W-]=W$K1QQQEBBH!]<?M'^%M
M3M?A3\%O'OBSPE\'-)\>^*O$OQ*T[4]>_9Y3P WPTG\&:-:>$?\ A#](\8O\
M&KRZ^$.C_&"WUE_&.H)H_AA;76+GX?WN@7_C& :A/H\@\6L-&TF7]F[QOXDE
MT^R;Q#9_M!?"'P[::Z\"R:K9Z#K/PL^.&JZKI-M.R%ET_4=1\/Z/J%W!Y@1[
MS2+"0QL5++X>1\79!G6$RWBVCD&%HYAF>=4^!JE?#XC)<?BZ#CG&8Y3/#K.Z
M>08#,L5D=/$Y?+$4*#JY94E";]GDN7U,/4I5>K$Y?BZ-2MEJQ53V&'PSSJ-&
MI6Q_U64HX>E5?M,NK5*E..)DIVG4J3F^9/EDJ5HG'>*_B?\ $_Q[H_ACP]X^
M^*'Q-^('A[P7:K9>"]"\<>//%'BC1_!]DMG96 L_"^DZWJM]8>'K86FGV5J(
M=)M[.,6=E9VK(\-I;I#E^$?&GC3X>>(++QA\/?%_C+X>^+M-BN[>P\3>!/%.
MM^$_$5E!?VLMAJ$=EK?AZ^TW5+:&_L;FXM;R*&\B2YMIY()U>-V4^R_!_2-#
M\,_##XK?'O7_  UH/CG4/A_XN^$/PM^'_A/Q7IW]L>$E\;_%FU^(GB5_&WC+
M0VD6W\4Z=X6\)?"?Q1::1X.UJ.3P]K'B?Q#H>I>(%N])T1O#^N=3H&MZ7\=_
M!7Q7\.>+_!/PWT'QI\/_ (9ZY\6OAYX\^&WPZ\#?"2Z?_A"?$/AVZ\9^!_'.
ME_#C0?"GA?Q1X=USP->>)KWPO>7NBIXNTWQGH7AK2+/69/"NJ:[INK<^*X@R
MC+O[5RK"<&87$\)97FN'R+B2<%PSA\#3Q&>2R>MFT:'"2R6@\WP5*MQ)D&)X
ML]C@Z53&8O,,5C/JV88G*,S4G2R^OB/JF*Q&;8B.:8RABL;@$ZF/K5<1A\-3
MQ=1U/;TZBA0E4>#DE3E%RBYPE4DK21\T:[XD\2>+=<U+Q5XN\1>(?%_BC6KY
MM2UOQ-XLUK4O$7B/6]08KOO=9UW6+B[U35+IO+CC>ZOKF:X:*-%+MM4UZ'X!
M_:!^/?PGT>X\/?"OXZ_&7X7Z!>:A)JUYH7P\^*GQ!\#:->:K);6UB^J76E>$
M-?TG3[G4I+&QLK2;4+BWDO)H+2"-YC'%&B>2AP^YP  SR' X R[< !44 = $
M4(.B$H 3Z=\%7^'$7Q=^'4OQB;9\+D\3V7_"8NZ:M+9K8.LL=M+K<>@NNNMX
M9M]4?3IO$Z:$DVM2>'!JYTJWN-0CM(Z^]S[!Y-1X9KT\9PYA<\RS+,O6)H<.
MT\DR;-XXA97@JV)PF!RS)<7E%?*:N,BJ'U;+*%'+<)"%6<(8185.-*MX^"Q.
M-CFE.I3QV(P>+Q&(=.KC88K$TZ\98EQ564\1AL1AL15<E)>TC&M%UVN62>B7
M6ZY^UC^U9XHTG4M \1_M4?M*:]H.L:?>:5K6A:M\>/BWJVBZWI&I0FUU'2]9
MTK5_%UQIVI:=>6[-#<V5U!-!<PO+;S(89I W ?#SXM_%;X17FI:C\)OBG\2_
MA3?:S;6]GK%W\-/'GBWP"^KVMH\TMI;:K/X0UC2;K4+>TEN+F6SMKN2>"WEN
M9Y(U5W)/T'\:=*^,4O@"YU7Q7\.OV8]?\"P^+K2/3/C3^SAX1^"%CI>AWT\5
M]]F\/RZY\ WTJZM=%\1Q8^P:=\;O#2^(VFL88-/^PZN;X3\!\$]%T&R\*?&'
MXR>*?#.D^.8OA!H?A.T\*^#]>EN_^$9U?XC_ !#\:)H/A[5/&^GZ9<Z=?:YX
M*\+>&M'\<:Y<Z!;ZG:1:UXNM_ FD:R+SPI?:Y87GYUEF9\%RX-S+'T>#>#J>
M#QN;9?@Y\.\.T^!<PPN<9I7Q>4Y9E&$Q\*'!'#F4QQ53'9KAZ6)AQ-PYA\9D
M>$H8C&UXPPBPT,9]%BJ>;_VO0I3SS,ZE:A0=:EF6-K9OAJ^"P*ABZV*J4%5Q
M^)Q4J#6$G-^RQ?-4=2'LI4DY15R?]LK]L"Z@FMKK]KC]I^XMKB)X+B"7]H'X
MRW,4T,JE)(I;>Z\8R6T\;H2KPW$;PR*2DBE"17D_P^^)_P 3?A-?W>K?";XE
M?$CX3:KJ&FII&HZQ\-/''B7P%JFH:2L\-TFEWNI>%-5TJ\N=-%Q;6\HLIWD@
M$T,%T8_M-O'(/HSP'XNM/VB)?%OPN\<_#WX3:9KMW\._BWX]^&OQ#^&WPJ\!
M?!G7/"'C'X7_  W\3?%W^R/$%K\,-#\*^'_&?@7Q1X;\#Z_X6U'1/%.C:UKG
MAVZUC3O%'AS7()M%DL-4\V_9LT30_%GQ9?1_$ND:?K6E)\(/VJ-973=3MA<V
M/]I^%?V5OC5XL\+:B(I 4^W:)XCT+1M>TJX$.ZRU?3+*\@>)T$B.GBN%,ORC
MC&CC?#S(<EGDV6X#&\0\/Y?E?!.,P6<9/CJ%+%X*M%9;P=DV6YOR5G7PM?"9
MYE57^S\QP%2D\%553!YA45>&:8G&9-5I<08_%QQE6I#!8[$XC-J6+R^K2E55
M2:PN*S#&5Z4Y>S?LY4\0X5*4U4Y8R4K;1_;0_;%9"K?M=_M0R$GI)^T1\;"N
MTD$J0?&3<-C )#;2 ^UBH \D\"_%+XG?#'6M0\2_"_XF?$CX9>*=1L+C2-1\
M2_#WQQXH\%ZYJFDW=]::E=:;J.L^&]4TO5;[3[R^L;*ZN[6[NY8+BZL;"_D0
M7EK$5XA2S(NXDDJ"<DGDCDYSU]\U]!GP[X?;]DO_ (2YM'TU_%B_M,KX7/B%
MK5#J_P#PC!^$=SK)T,7A+L=.&JI!?_9,1K'.$F\QG<0Q_29WDO!O#6$PU"'!
M_#<<-Q-G66\-8S"X+A?A#"X'$O,WF=:C'-\'2X7PE#-\KI5<FE.I@,;&O#VT
ML+B*$(5Z#J+S\+C<YS6>)K5LXS)U,NP.,S&%6KF695JE-4:5.-6&']MCL3&$
M\33J*C.4N5.G'EE)IJ)X#>WE[JEW>ZCJ5[?:GJ6I7MWJ.IZEJ5S->:EJ.I7]
MU-=ZAJ-]>3RRW%U>WU[-/>7-U--)///,\\TCN[&O9/AO^TG^TA\&M(N-!^#O
M[0GQP^$N@W5S-?7&@?#/XO?$?X?:/+>7+*]S>/I7@_Q%I>G2W-PZJ\]Q+;&>
M:0;W?(&.WNO"GAI?V'= \=KH.F+XTNOVO/'W@Z?Q2+)/[<E\)Z7\"_A9K5EX
M>?4?FD?1[36M9U+58=/+1)#?7DUY&LTCN%Z_]B;Q<&^,'@WX:ZQX%^#7C#PK
MXBN_'>JZG%\1?@G\,/B+K$MQ8?#;Q%J=G!;^)O%WA;5?$FG:7;:AHUAJ-OI.
MGZM;Z=%=6\VVT7^U-3:?R.*,_P ES#@CBW,,5P/E_%F6<$YIQ3EV-R'//[ J
M87$K@N%"6-Q6&AF^0YWE=.$Z>(HQRVG4RN.*H.*A&MA>6,GUY;EF+P^>9-0I
M9W6RNKG6%R[%+'X2.93K4'G$*TXT:OU+&8+&58_N9QQ$J6(C&:DFX22<3Y6\
M:^.?&7Q'\0W'B_X@^+?$WCGQ;?QQP:CXI\:^)-?\7^)+^&W&((;G7?$E]J&J
MW$,!+^3%/=2^69)6#,7&.T\"_M#?'_X6:0?#?PN^/?QR^&OAN2_N]5D\/^ ?
MBW\1/!'AQM2O(K>WN;]]%\*>(M+T^2_NH;2V2YO7MVGN!:VPE;_1X\<WXQ\>
M:K\1;ZQUC6=)\ :1<V6D'3$@^'OPP\ ?"W2KB..ZGO1>WNB_#WP]X=TJ^U%F
MOGM?[2O+274&L[6UMWF\B&&-/1/C#HFBZ-\,OV3-2TC2[/3=0\6? /Q3K_BB
M\LH/)N?$.N6_[5?[17A.UU?5G5R=0U"U\.^'=&T&*[G6.6'2-'TW3E$EI86L
MB^MC*61K#<)9#G?!^3QPN<XO'8?"Y'6PW#^<9+DM;)LEQF:^U^K8WA>>!G"G
M@L).CAEE^4Y>J'M+23IQJ.IS47C(8S,L=A,UQOMJ%/!JIB_K&:83%UGF&)I8
M6TZD<9/%S]E5J7<<1BY1G3BE"<5RV=X@_:O_ &IO%^AZIX7\6?M/_M$^*?#6
MNV<VG:YX=\1_'+XM:]H6MZ?< )<:=K&C:SXKO-*U.PN$ 2>SO[6XMI5&)(F'
M%>=>#/BC\3_AO:^([#X>?%#XF_#ZR\8V*Z7XMLO OCKQ-X1L_%.FK;W5JFF^
M([7P]JFG0:]IR6NH:A:+::O'>0BUOKVV*&*ZE5O=WN_#_P %?@M\&_%.B>$_
M!7BOXI?'_1O'_C35-=^)W@7PM\1?"_@+X=>#?BEXE^$?A[POX*\&^,[#Q!X.
MF\3^)O$OP\\9>(O&/C+7O"^J:OI>E3>#=(\*OIUM-XM.KYGCT:#\2?@9:?&^
M'PCX1\ >._"WQ8TSX-^.[7X>^';+P?X)\;Z=XN\$>(_&'@7QE9>!]%6W\+^$
M/%&D?\('XJT3Q7;>%;+2]%UN"_\ #=Y+H^G:W;ZKJ.L_,X7,^%7;+:/A[D^&
MX/SKBI\,T\9A<NX'I8+'\1Y=B<UP6#QN,X5PO"M*<,LJ9YD&;Y#A,_Q.$S'$
M_6,'A*ZPF"RO,,MQ2[ZM'-)5%B:V?8ZMF^%RZEC9X66-S1UZ& KX>ACFXYK+
M&XF4(TZ>+IU*M&E*%-R<GRN3<G\X:)J^K^&M5TOQ!X=U?5/#/B'0[VUU31-=
M\.:G?:+K6C:I82K<:?J.DZQI4UGJ.EW]C=1QW%K?:?<V]Y!+$AAGC&\-K^+_
M !GXR^(?B'4/%WQ#\8^*_'OBK4Q9KJ/B?QQXFUOQAXEU"/3K&#3--2_\0^(K
MN^U>\6QTRUL]-M%GN9$MK"QM+2!(XH54?4GP0T3X)ZE^S[\3X_BSHUAITWB7
MXW_![P!X<^,\,=TNM?!;4-8\ ?'G7M.\17IL;74+[7/AQ=Z]X:TC3_BSX6M=
M.N+^Y\(R3>)_#\4WBOP;X;M+A_B'X/KX!_9$^,\_C7PAHUA\7/ W[:7[/GP]
MFUY8M.OM2M?"WB;X'_M3>)M1T_0?$6GO<6FJ^"/%]UH'A/Q5IM]I5Y=Z'XHT
M_3_"VOZ??7-G!8,>G%>('#&&XCE#%</5*7$67\69+X?9?FE? 9,\=B\'GE7+
MXU\;DN;XBABLP_LS+,9C:&%X@R:KF5/-\)BY86N\!BL)C<'F[QAP_CYY<YT\
MQ_V*OEF*SG$T80J^RHXC!QQ%6.#J1YVW.M1I^THXFWU=QFH)N<&G\U^$?BC\
M4? .D^)]#\!_%+XF> = \:VRV'C70? _CGQ1X3T7QE8):7FGBP\5Z5H&KV%E
MXCLS8ZEJ=FUKK-K=V[6=]<VC1/!>7*OP\1^1%565$&U=QRQ!8NS<=-SL[D8&
M&=@!@ GZ<_9\'ATZ'\34L;CX%P?&EX/"7_"M%_:)M/"-WX'N/#-O=>(#\1K'
MPU_PLW3M3^$$7Q1OKA_ W_"/7'Q833=%'AB+QA!X:UFV\62Z=!<\M\?](^(V
ME>,]+7XG_##P3\+O$EYX4TF\2#X<^'_#GAOP5XSTS[7J-I9>-=!@\ W][\+-
M4BOVMI=(NM8^%D6G>%;N]T>9;S3K?Q1%X@>;V\IS_*H\?9SD&&RC+\NQ^(=2
MOC<?4QN48#-,[E@\IR_$X7,(Y3'AW!YQQ#A:6'QE3*89[5XGSN>6PRZO@JF6
MY5@E1<N+%X+$RR/"9A5QE?$T6TZ.&C]8KX3 *=9T)QYU7E#!U:KBERXK"X>E
M67[O!5\3--GB%%("#G!_#T_IV_F<X-+7Z6K]4T[O1^NC^>Y\Z%%%% !1110
M5^I__!,__CV^/G_7?X.?^B_B]7Y85^I__!,__CV^/G_7?X.?^B_B]7\9?M"O
M^4-_''_L19#_ .MMP@?LOT?/^3Q<$_\ 8;CO_5-FI_.7^T5_R<5^T+_V7?XR
M_P#JQO$U>1CI^+?S->N?M%?\G%?M"_\ 9=_C+_ZL;Q-7D8Z?BW\S7^>^6?\
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M<;.%AJNC?$#XL:5?QLNG_"&Y?^S;SPWX(N4FN_BM:>;?>)K.Q^'TEK9>//\
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MCX9\1V*F19)[9=6TBXM;Z;3[T V^HZ9-++I^H6,D^GW]I<V%Q/:R_OG\'/\
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MGM2T45]5N>>%%%% !1110 5^I_\ P3/_ ./;X^?]=_@Y_P"B_B]7Y85^I_\
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M+:2:98HI@=6^X0_)&4^89#%6Y'&%(.X] 05Y8%0V2>&%-\TT<2[@F9'5 &)
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M+1)OIV6R\V^8G!W Y&1CG(]1BN-\:^-O"'P_\,ZQXT\<^+?#?@KPAX?MGO\
M7?%7BW6],\/>&]%L_-6,W.KZUK-U9:9I]OO>-!)<W40+LD:DNRK7Y4?MZ_\
M!9+]EW]B&VU;PC%J7_"[_CW;V\D<'P>^'NLVDJ:!J"$(%^*?C2,7.C_#ZWB8
M 7&EO!J_C1U='@\*7%I*+X?Q5_MJ?\%%/VF/V\?$=OJ'QO\ %EJG@/1+J2[\
M(_!_P5#?:#\,?"EPQC3[;_8LMU<W_BGQ"JHZCQ-XROM=U:R2>ZM=$DT72KJY
MTV;^J/HZ_05\7?'KZCG^;83%>''AIBTZJXKSK!5J&>9U@IQIM1X+X;QGU/&Y
MEB,6GR87-LU>29#!2=2AB,\Y:;J?C?B#XV\+<"K$X+#5%Q#Q'14J:RO+:D)8
M7"5Y7BO[5S)REAL%5C;F67MU,;.W*N1R5OW\_P""A/\ P<31VTNJ?"[]@6V2
M\N$-U8:S^T9XT\+>9I,1VPK%<?"#P7K1,FJ2"0R?\53X_P!"3266*3^SO"^L
M6DUEJTW\I/C3QOXX^)OBK6_'/Q'\6^(?'OC3Q'=_;M>\7^,];O\ Q%XEUFY7
M(CEO]7U6:YO)5B0B*SLQ(MIIEJJV5C!;VB+ .750@PK,Z\89L[B,8&2<DX
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M1EWY8\M_P73_ &Z/A7X3^$NE?\$M/@-X8US3+?X:R_#/2?B/=ZMH^JZ7X?\
M"7@3X:>'=%UCX:_#_P (7>OXUCQ5<WD<?A+4[KQ9;QR>'UTC1GL+/5M:O=>N
M&TSVW_@UW#'X6?M>A?O?\+'^%0'U_P"$+\0CKTZ\<\5[F;U_$_#?LT.+,RXS
MSCC"%;$^(&28_P .<RXASO%U.,JGA;F/'F4RX0Q>:9I@,^>8WS7!*MC,)&OF
M\IRP-9RI*675,K4<L%#ANM](S+8910RFI*CPYBL-Q!3P.&HO*I<187*9T\R=
M'#2HO"Q=+%4Y3DZ%&,55NU::E,P]2_X+9_\ !([2M3U'2Y_^">OC&2;3=2U#
M2Y98_P!GS]DL12W&G74EM,]N'^(T<K0RNI-N94CE, C,\4,YDB7\2_\ @J7^
MV-^R_P#MB^/_ (/>)?V6O@-J_P #-$\!^"_%VC>*M$UKP)\*_ EQXGUC5=<M
M+S2KVVLOA;XD\1VVHP6EI:7EJUWJDEE?6\SB.WMC!-/++^S^J_\ !0K_ (-]
M[36-5MM3_84MKS4;?5]3M]0NA^RG\)I5NM2AO[E;V\623QBCRK<7 EG6Z:.,
M3"7SG0-,!7\[/[=WQ'_9V^*_[4_Q)^(/[*'@-/AA\"?$'_"#P>!/!47@[2/
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M$JV;6$=E<BV<S3A%7=^P7[:?[:7_  1D^&'[4GQ<\"_M._LC6WQ-^._A^_\
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M\6M9U31;,VT(_M6+2/#CPW#_ &Q6D_*O_@O-^R1IW[,W[:=UX[\$>'+7P_\
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M<6&F:/>Z2UE>_77_  ;!;A\#_P!JO:Z*P^*W@ !WV$!AX,OCN(7>A(;Y^"Z
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MR,=/Q;^9KUS]HK_DXK]H7_LN_P 9?_5C>)J\C'3\6_F:_P ]\L_Y%65?]BS
M?^JW(3_0); 2!U('UJ*618@SNRH@P-[MM0;L]\$]5"X WN\D<<2R2,$!*ZQ1
MR3.P1(E:20[E!"+G).6& =A )*@D$#D5_=/_ ,$%O^#>N3P>W@']N/\ ;R\(
MRCQQ:OHWC7]G[]G'70J0>$)8UAU+P]\3OC+I;0F6X\9HRV>K^#?AQ?3QP>#6
MG-]XUL;KQ8+?3/#/S/'7'61^'^32S;.:\'5J\]/*LLA.G/$YMC(:+"NBW>CA
MG*4?K&(K+V4:*<KMN,)[4:,Z\DHZ13?--IM*VMM-;NUEV>KT.>_X(%?\&^ES
MI]UX1_;=_;_^'UM%?+;:+XM_9T_9O\6VKR7.C7$S->Z=\5?C9X5O(!;0ZY#:
M'3KSP!\.-41I- FN[S7_ !YH5IXDBTK0]!_MX*E8T#$LZD MG!8\ M@Y SU(
M)]N]4;JXM+2.6\EDBM888I9KRZF:*WBA@MUDFDGN9Y'B1(8PTK-.[A(QYDA8
M()&'\W7[>O\ P<)?!WX,#5?AQ^Q];Z+^T#\3;>2:TOOB/?S:D/@CX.N4N7@D
M^Q3V]QI^J_%?4[<IS;>&;O3_  A$2[IXSU"YL[W2(?XRX<X/\9_I0<>3P/"7
M#68<39E&=.,EA_\ 8^%^#<MKSFL/'-<\QT8Y3D6"J_O(PGBJ\L1FN)IRIX+"
M8NO^[I<?$O%G#?!.62Q^>9E2R^@E)T**M5QV,J+5TL!@8R>(Q=:3:BE2HRHP
MD[5\1A]S]ROVC/VHO@'^RCX'NOB!^T#\3/#?PR\,D3Q:;+K5P]UK'B74(8A*
M^E>$?"FE17GB?Q9JRQ%97T[P_IM[=10GSYA# LLT?\:/_!0#_@OC\<_VC)M?
M^''[*[>(?V=?@G=F33KCQ*DMK8_'#Q_IQ2>&8W_B71]3OXOAOH]X'$T&F^"=
M03Q0L;,NH>+&M[ZYTB/\7_CW^T-\;OVH/B/J7Q8^/?Q%UOXF^.=4B^S-JVM?
M9;:PTG2S)YB>'_#/A_3;>QT3PUH5JQ)MM)T73[.R$YDO)EN+VXN+J;Q\DE=I
M)*YSM)RN3DDX/&22?S-?[/\ T9_V=/AYX5/+N+?$^>4^)_B!05"O2PF+P$*_
M W#&+C*->?\ 9F38JDJ>?9C1J)4_[2XDPV(HX>I3CB<OR+!XA4:J_BGQ$^D%
MGO$SQ65<,PK<-Y#4G*G*KAJ]2EG>/HQG:2QE>,N?!4:NLOJ&#JX5M24YXV,T
MXMC$R,\TI+R222S2RR.TDTLLQ1I9)IG)>:1V4,\AVO)*9II?-GGEE*C&!CIC
MCZ48&,8&/3M2].E?Z40C&$5""Y(1]V$(Z1C!)627?\+:)'\Z;^OHMOZT]$%%
M%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "OM_\ X)K_ !O^''[./[=7[.'QK^+^M7/AOX:?#OQ5
MXOU3Q7K5GHNL^(I["VUGX6>.O#%E*-%\/6.IZU?K+J^N:;;O'I^GW4R13R3&
M(QQN5^(*!P21P3U(X)XQSZ\<<]N*^7XUX4P/'/"/%'!F:5L30RKBSAO/^&,R
MJ8*=.EC(8+B'*<7D^)JX6K6H8JC3KTL-C\3*E*KA<1!5)1<J<HJ49>EDV:XC
M(\VRS.<)"E4Q658_"YCAH5XN5%XG!U56H.K&+C*4(SNY14HMIV4HO5?JU_P6
M>_:E^!'[97[8^E_&7X >);CQGX(@^!?@+P?/J^I^$_$_A.[37=+\1^--1O=-
M.F>+M&T;4V2VLM<L)5O$M7L)'=[>VN)I4:.OR?6*.)$$85%^<%5 "@L >B@#
MDX)^M2[1DG R>I]?FW?^A$M_O$GJ2:, @@@$'J,<'C'(Z=./IQ7C^&?A[EGA
M9P'PCX=9#C,=C,@X,R;"</Y97S:K#$YKB,KP4\?5P\<PQ%##X/#5L3&MF-:<
MJE'"8:BVH\E"GK$[.),_Q/$^?9GQ!CJ<*.)S7&SQN)H8=N.'C*I"2G"E&;DX
MI3DY0;;:BVI-RLS]_P#_ ((3_M\?LM_L,W_[44W[2_C[4? L?Q,7X++X/.G^
M!O''C0ZDWA$_$R?7DF/@WPYKJ:;]F3Q)HRK_ &DUH9C<21Q!Y(BA_.+0?VQ/
M$GP(_P""@GQ"_;!^ FKW5Y9O^TA\;/'^DV\T6HZ59_$+X6?$#XG>(]9NO"/B
M#1[Q]-U"'3O&?A;4K02:?JD$5UHVM1:1JDMM:ZKH=MY'P\"1O()!DP9,$CS"
M#N!?GYR&^8%LX;D<\TW8O'RC@Y' X).21Z$GDD<Y .<@5\!@/HY<"8;C[Q;\
M0<Q>89]C_&WAK)>$N/,CSFKA<5PWBLCR;+L/ERPV!P,,NH8S#3QM*E4EBZN)
MS''<M2I#$X2&#Q.'PT\/[L_$+/GD'"60472P=/@S,<5FF49AA.>&8+%8O6;K
M5)2=-PIZPI*$4U3E)3YV[']'/_!9/]KK_@FS^WK\+_ 'Q9^"OQ*U;2/VM/ 5
MOI%J/#NN?"CXFZ'/XQ^'?B":UD\0?#?7O$\GA%?"3>(/!&HWIU[0->;7)]%+
M6?B7P]I^J7<7BNQNXV?\$+?^"B?[)?[$'@']I'1/VD?B5J'@35/'_CKP#K'A
M6WL? 'Q \9+J&FZ'X:U?3M1GEG\&^&->M;'R;J]MX_*U">UED#F2-&C7<?YS
M6=W #N[ = S,P&.@ )/ Z =,<4U<J"%)4'[P!(#<%<L <,<$C)SP2.]?#R^A
MYP'5\!,7]'/%\4\>YCP!5S?"YI@*^/SG*JW$>38?"9_3XBP^1Y;FTN'*E&.1
MX/'_ %F> PF+RW%5L*L;BZ='$4,/6^KT?<CXO9[#CFAXA4\JR.CGM/!2P5:C
M2P]:.78MU,-#!5\77H>U]H\56PL(PG.,TO:>\U**2?\ 7E=?&?\ X-B;N[NK
MNY\%^'I;N\NKJ\NIW^$7[5P,UU>3-<W<\@CTM(S)//(TKD(!O=B  2*_&+_@
MJAXN_P"":_BOQ'\$C_P3D\/Z?HVBV&D?$9/BXEAX2^*?A9+O5KB\\&2>!9I$
M^*%M!)>-#8VWB58_[(#PH+DF_#'RX(_RJ/)R2<^N3V]>>:4$@, 2 V=P!(SD
MDG.#SDDD^I)/4DUU>'/T4<K\-N+,FXLP/C/](+BB62T<=0H\.<<>*69<1<)X
MNGCLNK9:OK^32P6&6(E@X5Y8G R]O2>&Q=.A7IRYJ2BL^(_%7&<295B<KK\(
M<#9<L5*A4GC<HR*. S"E5P]:-:$\/BZ;]I13E%*I&.E:G>E4_=R=OZK_ -G3
M_@IQ_P $B?C/^R]\*OV8/VU_V:_#GP?TOX3Z*FF>'M,M_AUXO^(WPWL[]Y3/
MJNO_  [\:>!&\0_&GPKKWB:Z:ZU7QA/JD46J:MJ6IZ@^M>+?%<D]UJ%S[EHG
M_!3C_@C+_P $\_AO\0W_ &!/!M[XP^(GC:"WG7PUX3\'_&JS3Q#KND6^H_\
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MD7<HNVL(X()(D:_>U:< ?E<&8!@&8!L[@"0&SR=P!PV3R<YY /44@)5=BDA
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.?\ Q=?Z"_\ PQ1^QI_T:3^S)_X87X5__,I1_P ,4?L:?]&D_LR?^&%^%?\
M\RE'_%2W@G_HUW''_B0<%_\ S.'_ !+9FW_13Y-_X;\[_P#F@_SZ,O\ \\I/
M_'/_ (NC+_\ /*3_ ,<_^+K_ $%_^&*/V-/^C2?V9/\ PPOPK_\ F4H_X8H_
M8T_Z-)_9D_\ #"_"O_YE*/\ BI;P3_T:[CC_ ,2#@O\ ^9P_XELS;_HI\F_\
M-^=__-!_GT9?_GE)_P".?_%T9?\ YY2?^.?_ !=?Z"__  Q1^QI_T:3^S)_X
M87X5_P#S*4?\,4?L:?\ 1I/[,G_AA?A7_P#,I1_Q4MX)_P"C7<<?^)!P7_\
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M_ABC]C3_ *-)_9D_\,+\*_\ YE*/^*EO!/\ T:[CC_Q(."__ )G#_B6S-O\
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MG#_B6S-O^BGR;_PWYW_\T'^?1E_^>4G_ (Y_\71E_P#GE)_XY_\ %U_H+_\
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M_P 5+>"?^C7<<?\ B0<%_P#S.'_$MF;?]%/DW_AOSO\ ^:#_ #Z,O_SRD_\
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M<_\ BZ_4S_@F?(?)^/R%2A67X,/\XZAU^,2_PEAP8SW[]..?ZR_^&*/V-/\
MHTG]F3_PPOPK_P#F4KYE_:I^!GP3^#W@'1[OX1_!WX6?"V[U[Q=IEMKEU\.?
MA]X2\$7&LV^GZ/XFEL(-6G\,Z1IDNHPV,EW=26D5XTR6SW-P\*HTTA;^>/I8
M?3DX6\7OH]>)GAQE_ O%^0XSBC*LKPE#.,7G/"6*H8"6%XEX>S.5:>&PV$G5
MKN5/+IT8TU'EYJZG-J-/7[7P[\%<TX+XSR/B:7$&6XG^R\16G&CAL#F,:LY5
7\'BL*DI8RK.@HI5Y.?-%RLER6EJ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>inbs-20231002.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaaH2bP9z5Z8SekhvWB3bUlKjyEiqHmrICib+46WMSEA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:INBS="http://ibs.inc/20231002" elementFormDefault="qualified" targetNamespace="http://ibs.inc/20231002">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://ibs.inc/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="inbs-20231002_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="inbs-20231002_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>inbs-20231002_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>inbs-20231002_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://ibs.inc/role/Cover" xlink:href="inbs-20231002.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://ibs.inc/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140449614778592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 02, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct.  02,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INTELLIGENT
BIO SOLUTIONS INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001725430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-1512711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">142
West, 57th Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">11th
Floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New
York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(646)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">828-8258<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">INBS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="inbs-20231002.xsd" xlink:type="simple"/>
    <context id="AsOf2023-10-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725430</identifier>
        </entity>
        <period>
            <startDate>2023-10-02</startDate>
            <endDate>2023-10-02</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2023-10-02">0001725430</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="AsOf2023-10-02">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="AsOf2023-10-02">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="AsOf2023-10-02">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2023-10-02">2023-10-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2023-10-02">INTELLIGENT BIO SOLUTIONS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2023-10-02">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2023-10-02">001-39825</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2023-10-02">82-1512711</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2023-10-02">142 West, 57th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2023-10-02">11th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2023-10-02">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2023-10-02">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2023-10-02">10019</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2023-10-02">(646)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2023-10-02">828-8258</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2023-10-02">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2023-10-02">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2023-10-02">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2023-10-02">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2023-10-02">Common     Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2023-10-02">INBS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2023-10-02">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2023-10-02">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2023-10-02">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>16
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M-@1([38W=B=&QNF&PE(:(\/T<,,9K%A[ WR_DM(<3NP>1;;%U/\74$L#!!0
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ =8M$5YE<G",0!@  G"<  !,
M             ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" !UBT173P<8UK@$  !N$@  &               @($."   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ =8M$5Y^@&_"Q @  X@P   T
M             ( !_ P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !UBT17
MEXJ[',     3 @  "P              @ '8#P  7W)E;',O+G)E;'-02P$"
M% ,4    " !UBT17JL0B%C,!   B @  #P              @ '!$   >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ =8M$5R0>FZ*M    ^ $  !H
M         ( !(1(  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ =8M$5V60>9(9 0  SP,  !,              ( !!A,  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  4!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ibs.inc/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>inbs-20231002.xsd</File>
    <File>inbs-20231002_lab.xml</File>
    <File>inbs-20231002_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "INBS",
   "nsuri": "http://ibs.inc/20231002",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "inbs-20231002.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "inbs-20231002_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "inbs-20231002_pre.xml"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 25
   },
   "report": {
    "R1": {
     "role": "http://ibs.inc/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2023-10-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-10-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://ibs.inc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001493152-23-035706-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-23-035706-xbrl.zip
M4$L#!!0    ( '6+1%?*@Y=;<[(  "+<!  )    97@Q+3$N:'1M['UK<]M6
MMN5W5O$_8+KN[:*J8$62[3B),ZF2;3G1C&-[)/EV]4>0.)00@P ;#\GL7S_[
M=5[  2DY<CN4.55S.Q9)X#SVV6<_UE[[Y]\N?G_SRWCT\V\GQZ_@?R/\?S]?
MG%Z\.?GEY^_X?^'3[^3CGU^\>_7/Z/SBGV]._O??YF71_!0='BR;Z");J#IZ
MJVZBLW*1%#'_(8[.597-_P8_A)^^O^OOGD>+I+K,BI\B_.K!WW[Y^?6[MQ?N
M4Q[-DT66KW[:]/Z_%]-Z^?SG[_#W,*WWG0$UZE/S*,FS2WA5E5U>-<^C__P8
M?W[QR\FGJVR:->/1X?[AS]^]^&5PP/_IT?%Z/*JS?RM^[<8E_<P1/H_<O9BI
MHE'5?8X:%ODP?OKD27QP\&0\.O_M^.SD//(>3^]OJJ2HYV6U^"EJETM5S9):
M_>V7<AZ]+!>+LHC.FW+VT<S]_C?JRRZ#/#T\25@AO;4/;5Y/XV='/\#_?PP[
M?Y54\&3847P4_-<);&UQK:HFF^8J6E9JKJI*I5'-._W0EN*A;O&S^.C9$6SQ
M,]CBD[-3.-PGT3^2"K[>U-'DY!-\-:L3W&+X=62^'1EY>'A+PBIK/"))WHN.
MW[YZ>'/\=L3Y]4Z</7%^B%/<5FFFP9^^O3AY\^;TUY.W%^/1B]-WT?F[-Q\N
M3M^]/8].W[[<W])9W7I+IF6>_O5F\.'MJY.S?YR=7IR^_74\.O[U[.3D=]B@
MK9S+?\+Q("?P?D7H#,;Y;M:44U5%1W%T='#T>,OF\&46_CY'^"9)53%MJ\OQ
MZ.(JR>$G1?3W9+%\#L;]?G1:S/;_RJ,_KL>CYDI%9PK<CQK.3=)DUPI]%/CK
M7WG@YPH<IR0?C]HB5=5-E<&)AZ]G\R@I5G%4) MPI+(B^OG#+^>S*Y6V8*^<
M_OS=AU^B*U6IIOPKS^W[)P?CT>MLWEQ%Q]>J:%4</?GY_,/[7YJKG[_#_XU>
MYV59_96G -\<C_Y95A_CZ.T_X6\'AS_^E8>[%6HF4W!8DR*-?H5SFJN%*G[Z
M*X_X/W%G_M'6339?R1\S4 7XT(/]IUEQGU.YN%*B:&IXK4ICT.N-RF$,\+[H
M159&YV7>-EE9U*3QXRB)9N5B":H(=-"LK)9EE32@D.@9J%JC/+FA4- K!?\%
MCE,TF95YKF:H?O-5=)/!X<_ X:K;:9VE64(!(]A\D(#Y/,LS>!RJNV*6MVE6
M7,;TB[)MHCQ;9*C%2YA6DN<1C#!K\,=I5L_RLH91@-N6JGI695/6D7P!7&8U
M> ?XP^@<'H#RU41)'4T5/-\?1UFYP\!I;%H/?,7?\_1?;?D<-/)+7AM4QW^O
MZ(][,>GEZ0K6K9AGU:*FV2>7E>*!3)JKK'8><:P_<1\R'M&ZX<MJOA\B]WJ(
M)G4[NXHZ-X9>PBAP#TY@_JF:9[#GL YY>;/7G<H'YV'.4/B@J@1>EQ3AK[L#
MWWQ?D;-]<Y7! XW%$0T8'!&L5 *25(!- A.H_#G!L]P%^N MD#\Y?S6< :,D
MXEW;X. B%-^B])]4XD?P>4+B-1[YCXHC"G:J8@;B P-:M'F3+6'*WC/J*Q3@
MJ4+1K=1E4J6P1OAF'"5\8]'=+IALBP*.HX*UY-]?)3AIG#&L\7BT4$F!NPW?
M=5X&3GUA'DL'#04QS5B&:]7@^H-H\9/OW:3[*EKM 2GHTV8\ J%G%=V4)8I(
MT@S+.4HLBEWR$80F6K;3/)N!&@.11-%@ZS=ZSW\^5[.V8A4*,E.7("CPOP%E
MD8)"@ALZ ZV97DN(#%Z2EO"C?3BKP2?R0$#&LP+^ O*ZXG& %,M!E=')=+IC
M75;93#D"FLEY>U^5]1*ND[:.SMOEDLR%9B>W?[&IB-S.VXK495=^5V4+]SKH
M,-#F T*'UP+^V1-ON=.-D* ZJY-<^W712[ #\.]6$.F^LNX3?NG=DFT!*ZSP
MV&0&UDR:@-Z.Y*J%X9N[^.O(UW] NF J_^O1H^AUIO+TI^A]<JF>PP/^U>(%
M!C^,'CT2&,//KT[_1P^#9_)H6C9-N?@I^AZ#L%-8/569O[W(D]G'Z'#_*4RV
M+O,LA9E<'+]X<Q*]/'GSYOWQJU>G;W_]WW\[^!O]^_S]\4O];WF'/ ]MQV19
MPUCT?SV'_4F;*YS5P7^'@D,79_H9E(&<);E>YJ9<^NN>JSG]XI7^A?-HNV 7
MKQ"\<8;_!V< _PMK$5B6::62CX^F"B071K.DM92E@C?3.L'+WONK2/)@W_7>
M?[JS-]_AYO!^/"#Y^W)1TB\[F>.SB].7;T[&H],OK!J^2 #^U<GKT[>GE$?8
MQA3" [HG#_</8>@??GF%OA@;Y>B-H+L#QA:;Z=I>8@M>>VTJK]4->2ET*;JW
M50SNW5XT2Y;@+^?PLE1^2E<O^S0-^S$W6:WT$\<C\2Z,7R$>11U=PH5,PR W
MDQ\F5_%+U+%ST+*-8J\? PGL;/=]3+JO)U/Q->>@T<L;<E#IB?J]QI6IN^8?
M3/(<(PGP<%BX>P\2/2"CC_\OCO7K3,J&,VB[O !"QWNU?JL$;EPYPWW76_YX
M_W#R<>_!FF(/:,]U!,W;=MSGFHUKL//1A<.=QDCB>S#M*:H'_\WA%?X+*:PX
M2K,*OHS^8P7B8/[57%5E>WD5E87"3Q8EJ4(4&B7AO!A#'4U5YC7]M-;_S%'9
M35?R1PY=SAB+*-_@89(4RE#00[;*#Y4H!630<^"02MU4K0F$GF&4Z\G!4R<N
MZK@;<";N78J_]N8_;(E^4285R Q><"1^I1<3C5BT<9>G^$6\"%/]/>.:<FAX
MM_';,"F[\6T-]DM=CT>ODE5_RU%CI<G*#0J?)TU;P=_@Z7#X$](R_#']HY!8
M-^H;!)PE>31-BH]D3V$D[6768*",!HMI1E(U2=M<E15:<B"#%:C/?[49!M)
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MSZCG&8-6;A)X2!I'T[;!7Q1E!)8:S"N'%1&S\O#@IX.#*-E?[$<3<\W3O=_
M?I@L?ZUP@:+)$<'JBI1A=7O>>IJX&R,D:=E1_\)Y1/NI88M )56>X=OA\>3]
M:LP"05? T5W"*^5>Z*(59$-W+L\63:I_;/UCX1[@SXW@@0ZGZ*\<Y\M+!+\T
MSMT@27\M:H5JR+;!EQAP$[X)(5]EBW4[''U9++*ZQC.YD[5MF%1?UJS.O"\Y
M2_8FV?7]1XN_]M+]A>3A5A""H^>"MZA_PL'(#CV/_B?)6_SX6T,8A!+5'NK
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MCQV@>BBB*UCTDV@=%%UR+]1Y5N#M7EE;GQN;P?,@D[HF@\L_-!$<9MYKJ;P
M)9:K2]5KF_W-,Z&LAX<\W<%#[A4>\G0'#_GJ$K_UDQI4T]$Q&VXFXQ].^"<I
MC"QM%YTR+*.M+W3WU>[C;'-+[RM8S>DJ:EMJY7^-$08U5R8VU/Q5?YY<ZH)7
MIY")_ZC+L#K7Q;HT_$O89)CY+@^_A9-RA1M=F8(JZ=Y+SKKM8UA $,C_8"+8
MI?V5272WB U%#AJT$LHNJ8U4#!K([9E;$GIN2D++:CSB+K#F$%BJ;:_JEAO<
M'SW9F;U;,BE'Y,J94FFX;ROZQ3-I!YXGV2(&?R<C5YT*.QEN0,7&YBE.V^HA
MZF+X.2JP) \\!ZE#DMQY7CP>D8]%* O!9<.7*4.A!*>^6*!%D4KIKP+Q+7;4
MW-LQ*5<.^]K.+<)#J$[NZC?63/JJ#*NPG1!LPZ0"0@#67;M<YF&+SK_^:O-%
M?=/9QU#$+U^A7J(KS+FG;,VXN1:Q3%@XT5FZQJ/ Q;>3J6V8E)6I=IIGLZ'\
MI<B3KO*Y5CE(5;A[,YKJ5O+P.YP%<;ZR$XUMF)01#??.0'=2+HU;R<=U4F5E
M6Y/%8F*  ]0J8*##UYALQNLB42!GP2(Z?W0835Z#PHG>EOOCT>/'CQ\=/7M\
M=/CC'FLM#?SL&?(Q@\H=1H/$C,5!K3OM)+KZ$=U/YY]6Z8+=Y8JZXYDXWW<5
M<4IUA8K=47T[<YETY>=VILA!([%*85E""R^\># .?+9X+-R7@[7X]PA4V=W[
M6SPIYR!R&>-X=$R\3$E^+QEE+*]6.X=T*R9E90$.]W@$-EH_D*>M-X]4U^K4
M4&"B;^$1 0R)"ST..SU-E=&?I*M CD!E-RB/<W@3]\7!A\'_QDP7M3*EP$C[
MBW^SI+].YRA-/-@?I&1PD)ZJP1KE!,MW3)6TYE^BNB$J'  UZ Q[)]/;,*FN
M3*^[L<(=J.YH4/#7J5K )1AC$]BU&[ ^G[I5)=Y-W9%1'=O)+!6;6PN'PCE5
M,ZKJ;QM8$LHV@1@KS<\?B!'R&C@'F$KS[W2"=\*_#9,RPG]^\G(\.E-@_=T/
M3FQ'FK(]D[)"$/*^W?!>W]\>\+%-+=X'1)MS;(<!J=^$2*S'+GR_PR[<*W;A
M^QUVX:M+_-9/*J $;]=[Q+8<>;QK.?+-R4I%<G(2"<8^ZE==6*&Y%6>NRZ'N
ML.6:-WP;%^C63VI81&Z7V7" J8ZHF/H^PZYO>5#$"_N@R_N0X*1/+T8I%A^M
MFC%ON5/AH0L+>[(G[L!4><V&W<;$[(UR7,6XHG0HA%1%QP['HZS67893)X0B
MS0'8Y4@B33)OC@7<[N LPV3G^IME <YNDL^CR=/]IWO12B4P<PH):0+S-9"L
M\>C_[*A1MG52O4/V^HOKX=<[/;Q5DQH6D3OIX==?7@]?;U+#K_^2:ABUKZ^%
M#S]'"__?G1;>UDG9(X;R-1[M2K5VTJ"E@;6-S1CW+V3&C<K'Z#]+KL^0YDKB
M ;Z29S-2=&&'6N[IMTF=)O_"-A'4".7WI/JH=/WHBF"JR-=;ZAK1/=91QBR0
M_C7=3C',^*5;]71M@YU)L$V3\B4T$.H.V0$#-N-=K_U>K6#OTM]5UV_)I*P8
M:;K!51"<O[+=K59=M6(:4!%0OG*U7!PE>5U&IFU4L9(.9XQ^D/\>?C0:69BW
M1<4W$U7:L0<U[LSK5.6]T=;1][M4E3<PO1RYSYFZ]/"_=W*[#9,R<GM1)0@V
MQ-ZQJP"P 61DU6D96X%L9$NX5>6G^G8%%Z)<JH)A_OS13A:V85)]6> =#>-<
M1,/,X7(L;W#[%_3EVNW36?LBTPFP&);D*H)GZV:O(C(NDS.UZOI7BW5')286
MT;#[Y_E)=+R J<QP:H.VGO?1KWDY7?O)N<*+7@NRE*G@"OZSK#[JZE737GZB
M867:BN2:47=MP"0M83*[2WPK)N4> $W!"PI1.'B#\4._6^QZHH;8<P\,2-MC
ME^C6,GN_09+TT,?(H1Y]6-H_R\/_IZ1B4O?/NEDO,^.D>FH4'[+$ZM(&/ TU
MAB629:^9"G:=P>;(E+W\MI*7ZZ$=SW;0CGN%=CS;03N^NL1O_:1\)3^G>-1E
M$,W[LL1N6O 16@:DG0U1Q-^3!9R "V1!LYVEJ<$M=O9"%*Q/&=%M0DV:%!GG
MN<USDJ856!#4)_F0 <;2@3!Z? #??)V7914;2P3^ZY]XC Z>/#I\^OVAU>HV
MGK7V_=^$:M[Z21E!M:C)$(_G<#FDI2CA7Y&8^"G1G21LPZ2,)+!!Y_3*N9]\
MRI.=&&S#I(P8#+H#882#I*4U7Z:Q\R/NSRC9X2FR?KBP;F2MC['CI92@=ANK
M=.[/-41'KW;IW&V=5%_F=@G=G3RX\G#OV*I=_G2;)M45B%MF4/M@4M.O:P>M
M@[=.RSR]^\S\^>BXBS^=^YW,\=G%Z<LW)^/1Z>F][U-H-O<Y]I]?_/+^P]G+
MWX[/8?S';U]%Y\=O3G[^[L4OVS:1+Z-9OLKA %L AO[A%S%"49E\8;GZ*YWZ
M;5-EDV1O//JPE%0=VG6LQ^MV^H?#?F.Z-[J\UN@%9$7LNQ:&>;56>:X]"MO1
MZ#!^^N1)?'#PI&=92'(N#G)]]SA9X\#]XX)GY[K!@'XQ/.19?/3L"![\;,BJ
MH?ZQ?73NGWUN;#O1.G B9ZDT_!C[*E^K"LOYF8 '\1O42@$OW<1S[N).[K:V
M%6Q^J/"G!R:Q7_ 8'GZM0YCM8<-@%17M8LJ-B@<D=(+?LA:;J=_N6O![SC$M
ME\3?R2Y=@<01^/RV(XWP"L0^2:]CL ;(XV=(T<-:[0<I0.LDJ)NA'A BYVM_
M6IS&([=Q]NE.CK9C2E0]:*Y YVIU+BGIR'$K=76?2FA(;(.%F'N;2AZY#L8)
M77"'17C-?\&J/HT= PBNXA37GP*N"55Z7V>I+O/.B@<E 9^!D?AAAY&X5XS$
M#]\81F*GDS?HY.N]D%?R%U;)P9I,/X;H4)_U]#B[-OW'!N.3W,ICW8.=U/F0
MJ3/TQB"!4O=NL;/U.H3?[G*)UM\M7R9R^I>Z7+;='YU,X7A>>$&.3MMFS98?
M8+=F>9'B6WS& KLWW^,A!0D;,O>'LH![^]$%A7P6TZP 40S,!HN#Z>3$_)\=
M(TL7$/?5EJUTQI-P\'UO</JEPZ.3PV<>!/]3SB@-#H]\\L.S[[&RCT?7??JF
M@E8XV?",@X,?C_@9H6D%OF!GUWF?_O.:I6;1&5CBCII:O]C]T=QZK6UWIW5+
M,[CNH+?<I>^,NOO:[L=K7CD>_:GM^";33MLVJ<D,U.>[(H!;Z05,6?2D1).Z
MVR9M31S!((Z]RDV#U+S.$C *0-(THC*.LL5"I1F\!>R%Y#K)<HSMCD?SMDAK
M2X705;.F;UE8A9K\IXZ%^^-M2F8QKJ7NCTJAXT#D!(G<A7P>61O"/1'6O0@^
MX>( >-ZBMI77+L&K16X\UC_4I!/.3NQ+;J!.FJR><[6 #B_/RFM5F+QO,$%@
M$2(UO0B_>+3_Q._UP(,O9S [_?9R/L]F;+N>_'I.';%HF7A6I':H;5O=0S6=
MJ24L'0)^:>WXV8NV:3&FSA%WOMUZ[+P1ZB(6)7@]"5)69)HBNN2BB27_R@Y3
M$>LO:VWGTB[,"E7D?.DU<TC_.UKQG3S+NQP>V%%_F/HK%?//B.'L8U'>Y"J]
ME).J\SQ721/W6DO@+]Z6#<C/I-YC9\U@?B>H*]2<[NB-/61A%%8%3F$8T6_,
M#'.WIW3IIP^/?CHXB):+:**AZ]%++"%N8%7VM*![>ENS7 _-2O@@[&!=GAM;
MT4S_9(::66OU3J!::T@)CD=]_/0=%\/QTPHS';E?9'EAJ9^L7R(.S+MK9!6X
M^T=C61&&AFRC5SR;%7_ACH.G&J[NMZA P6T]'-U6=IU)B[*\RJJ46K'@AA8P
ML%F65"8!F=7FBM@5+VP+QN%H_XC &T( #:)N;)QC2VWOAT5VZ(Z_K&02NN.U
MA!^DO04=3S)-"-J+E:3PWX_0G6NX=C1<,@IF:]U4V925,6%$DMQ8-D-,XKY!
M1NQD&)8 K7F)+AIQE$4E2UO7)**_>JZ_AY7H8DMB"8,>Q@<_'L0_'ORX+HD^
M'G5?%,AZAD F_;#KQO<Q(\R:^.UX=(>1]U8H2(!';=/"<5%ONMW()W\XT+A-
MQU[D"M?#I]L(!8E#1HF^K;T7X8B^ TGLC%G;TJ%8  5W\3?A.$KL>$GYMW&I
MK$_$_;A+Q-UK(N['72)N=YWV0OVG_=LQZ9= L)J+P6;?TY>O&^'E0,,RR6PO
M75];9DX<BKEZRK2=:4M::C:Z :A%FS?9,L\LRYY-!_J/E_<;!8Y7%+8(NM-0
M;=IK_6@']/=MANO>EMZ )SZLU-ZDO4&3L:*?YT<8@[?I+?(C#TRL'^99G4E<
M1K95FYM^ERL07(>K3QLV^C ;N>R$%1.F"0)O?>($+_9TDSITB:.):6('_G^I
MOS#WCKH-/J(:R8APJUD](B;TR9.G>TC953LQD1,3"T'YW8^."R\^?I,)Y1M,
M@9U_LNZGN?1ZIX&8TXV?]0?B]1T+*[7PHG @H;/88NIWE]5T'[O,J!\?/+ZL
MDEQB+)T OB7T]%^H$U(+9'"8$D1]GB%''EJCN"+XY"E[-T5V>=405P-Q6Z%1
M7)4%-BBFG(#N@%:KAG[%4=QU^G/ F VIU48HL/@?&-5"-9KJR ZW= .]E:P(
M!-"]#NS63# A@ECR89V%8A%*VKF2@20_%7/\-3=E-#G:B^8M?/RBA4<0A<4K
M7^I2"2[1>O .P1B=@#Q'[AP6:XH:I5P;V&F6IU>DNY>]R/]XQ*%__,1YUQ+L
M4S@<MK5NI18EY7&FFA+);F_D[N[>GQOB/MS\DGDW>X??W+QO:0G_!Q>?<QRA
MF"GGN@*;R3LWY>75^04B4[.[L1]]"!5A:@O$G9H\#?PTI?4")\QF&"G5>0Z/
M]#1F5[)3#T*%(AI\LZ$TQ*-0'1R!]>OO?N[&(_0#LWG&AY\V2:_-15]]HSJ:
M(85K[NZ8&X;N:,%E5AFGUM>#.*U&%?(VUO2[0.<6A/N.]A]3H%,B[#J4Z47#
M;Y]O[J6J)]BBVW"_[OFU.O=>D?. A.%K6XT(?S\.L6B$$86QV()#^MOV:B=_
MQ7*>=X)P!EM3:5 8V$BND"&( 67SE2(\6 FWC\==I3] ,?T'&)-IE=P@_SI\
M ;Y5IAE<]_6J;M3"W%1(9=T2<R!K-:D]\_3U0]O?!RJTMY+:/NBU+W71/0@=
MF 4[J?LFI.Y68N<31/Q9A6F>U9=-</=W&O$_D6<X/-@E&NXUT7!XL,LT[)1K
MO^AGHVY]_;!TZP/;Q(<IF8.":4@NUHM>&8JHEP4Q7!BBPP[0H?-M$50WTFEB
M8D1>V"$JQ'/AD!F>X _C )(CV5P^9])<3_</_KL'?F&[>CSJFMJT-MT$7]TR
M=2.%JWKPP. B8CMJIZ-,YVSIX70Q-]CE(*.>A@C[4ZHV<>'PNMZF1/K['YX-
MUK$U.OHG+;VP1P15E^BPI90QA>+ %,*]H3!F0=UP&AB0@+!1:^!/A:6F'C S
M']J)>Z!J9*WSL*FI@D>$W/LP;4%<3 <$">]C5BXC+"OIA(>VH ]52@;%1&&A
M;#$SFF0N1.R(6I[-U+))G ^'<=(VO7BN9B 8TGJ+&=QUK^#&(J=SL'0J]= 6
M^L%*SZ#X).#;7<)57BZS0E([VKA]"9=IK7+-Z1]N!AA')@?)51U(OIQGBZQ)
M..\&Q@1B4Q@O4+<5BN-XE*NFP0HT_VH;)EY^'2)>9B&_I:V?1%-$^CY*RYM"
MSU;8Q7KCBWAX?":ZR\'XA(6FAZOY@('769<%V",K6R6&@<*PG=>IS4.3X,Z+
M&.DU7+L_-,SPD /C'(_\@3ZTH_ PSW?V:?ATSY!^=58N,!]]OQ*#8&<PCP5\
M7 ](D+U77F/GQLH<IV,0]P81()CY]C',9.#+G6-1%V[)$Y]\]T3+B4VE$IMN
MJ4U*X:$)PL.4[D_APFBI]U^SR20^G@F,/[%IG7<$LG'*F:UQ%+Z8QB,Z$VX+
M9^>*^C5T13VTW7B@(I99&?-:R&X2H7Z_NH>V-@]UPS]WQWN="!_:VCS8#<^^
MU#UB'.;;W21<![WN)ODM>)/@6Q_8MCQ46;O^4J+V\BI3\^AU5H Y#O)T!Q/&
M3PP,"-[I-]O>:$.F_W"7Z;_?3/_A+M/_%].:7PE^_,1MDH'\* *BMS!DAP/*
MUO!0?* '-S8MFX=J]_5[!G*T6/.!:KI27:"_;3#@X/RGBKK%JV:'9/[+:GO3
M4R#!JI-D9N)6"ZS_P3O4!+!NKA32\J3FGC;. ?P$%%3-[ Q2[(.%0Y43ZD*!
MP-])ZK[?@&(\2G+06.DJPMPY5VE041B/(VM6/6[!IFJ5T(I5R)76C;F92KH[
M#@3[G"?$G\,IZFC2%KFJ:XF[)9'4D<QX^I+(WGMHLO% !1XEGKCDK+:,.S1U
MIG-F5S:L92@U?*I"@Y'IJ5Q"K.#9<  34Z7 TS$_?VBK_%!%1VM+4]O7*0H4
M:6%&Q1##(1$<]N+U#VVE'NCV7V_>_22ZY@A88NGGAM.V;\BA[*#8NB$TCUE'
M.Y_C$7N?<1_%0H:;"*)&L^0(KJ)+VW1;.=P_V@7AMV=2$RU\9X24DTI3@IQ0
MQL\816H^U^Y L3%%V'C2T@O&#$9BQB.-&RC*J 9W,B+G&]P",(T*JKBFFE@]
M%JP8MUB^-1,PEZ-&/G)_,Z0*F2F%#ZX%SPAC%ZHRCT^??UO GC1T(,K*+HT>
M&M9HPOJJQ3)/'.@7(CBEQ)\61ZY[N+SU4A)E@[4(]+>IVYOAO<-0$I[U)'3G
M8ZZ9N4S8Z2K%/A5TA IRZ.Y !ULW*08NBF#YA!R47G<CC*]/WYX=!XK@'=$!
M[T;!UH.GDZN$X2T$'*"?"L:'O+B%1OBBG*FB3IC1 VG[;DB^T$A-5O2?07 #
MX7^EC[=<7.$#^]!V[*&*H399.^ASCX7"HL^-0.0KIX39JJ]DB;U'%),\H55!
M^I3EY*)*2+W^GE0?5;-+R&S)I#3^T?BN;AKFSI:!8(=^BB;9'D=&>E<@7.<F
MNI2D2+VLHME54B !>H7\U-<J+Y=D%&3%=9D3^4^")H")= []/M.4ZA*$9)^\
ME B6U$%,A<(FPEOV6EA(YR9IA%TU='E!3$ IU\8W>"TT'< R0.M*!X8D/(6%
M&G8$6<<17&,"X<):[O?G$<8J<+78&D!V^TRB#-H8(D:</+G!O\*S\5+!.%EW
MQ1W#I[D"8Z-1&-Q*+A,TE'P7AMF@CN>(DW:PS?IS3B? JA"E-;-YMA6-:JY2
M*M5"BXM@T3-C(<71M$RJU"PM;-LB*V0)$+3)T/P;";<E1=06\^2ZY&8#J9IE
M_)2JS64:L%TI1:21I45+ W+WLSS@?Y'MZ6UX')5+5>F0CR<7=OL]V<D*IJ#Q
M%B$&=PN1XV&VG=OO+6^N:SV'36#+T.W0!1W/FH!M3*J^PCWJ/XS:%(A)[$A!
MS_A]SC1_X.UNF@^78)A>!=IH3N +*47/2$[J=KG,)9HF514R.(FS^O'F6K^B
MEO.$Z89.V(V^8[I?4=AW-H,U),/(9#/L:HU'>KG(V@;WM]951VTN,>'&9D<(
MU:E'2&[[8%#<&/ T/B]DV-\LOH@WO9X+H@J522!]< L*T6?.%A1R?LT61-X&
MZ/77'I/9 /@)V(T83C?+S]$,,V-T2>C\+C+*^O 1QQ_Z7UF_4_"  DS9NDX(
M4XW']R,SV3O;;@K#X <Y4;+I7B)9-6L7#+:MY5BPC,"GH#[PLL$$14P\6B#.
M8"SCL=BEZ*/#HUV*_GY3]$>[%/V7M:.G",W_DZEAO=W^>;S?TWA\=G'Z\LW)
M>'1Z>OJ%FQSP=.YS\#^_^.7LY/W9R?G)VXOCB]-W;\_AKGS[*OK'\=G9\=N+
MTY/SG[][\<L6SDJ+V)<>_'](Y3_>/R0DR%D@D_V/H4PV@T1.^L:J]D->9?4,
MG+<6[DV=%S!\3Z'//,XQ16E/CHE*HU=K.'$.?R5!5'?,GG_%> (Q#@R18J-L
ME7IJAV'3\KK>@/+^];)D[Z967M0T/#D_F2L#\Q !]5!@3)[;B>:-1_:CGIN<
M6"#.^NJ[6B T]0XK\Y<UNZA-"O8';:=UEG(3(SYBQP@GT/)*2!0N$I-_N#_H
M.M0$IG);PCD=6B,X]?#2P#&F4IMUW_<%O;Q!AY='DZ_8L=7_BLFST19VLLP:
M<L*P<L.XZQQ7@!\A0T/=&*$>C\S4,#*B!(V#,6IF+%Y%;S)5,#NL^QXGN5.V
M#5KTJ33Y$S:-SD#D##EOPW6[AOU/";MK'X=_1Z+B%=&ZHR=0/$KJ&ET.:EP(
M7Z&!PB.7F I;<@ "%5<&8@$#K]#EJ+FSXY1#X=QJM;)$(+7Q[?:CTPYZ"+Z
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M7C/ <K'(&I/GH7,'4@KS).ZOI*E+=4VA.@,MC[GJ44\A-I9#Y=7-S!S;B6J
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M)E3J!#Z<K*@I\N[F@W6=_SV$F'W3-M#BI1MYD<_&(UN"3B";A=(D @GH<A-
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M.Q>:70BZTX1@C]5:YS--K&*Q&]B5C]G\M'2::TT&Q=2E;C -UP=%;Z+9EZF
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MK6AR18YQ3HS'-E$Y[('(P\FS1<8K!&Y\LL<%R^SHS95A8' ;J9HA=@D8 A
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M=6,#VSJL8HSD0M80?'$J 3L\65SIQ UM]X-]2,_NS@!8(;9MQ]/J(KVJ*:4
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ME$+ID'PR;NV(QU$"?T.*<[-/<<XWQ;GYQ%*<?0[S:^P;(G;HH-^==2-H^'&
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M'8A:L.&-B4 V-R5J_<B9:B4X)4*UO-1FVJVQ9*(FHG6%&G2HDVL/^9T@.'.
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MB"AD!-_VN@HMA'!'Q:I_@:&*6B.ETD T5D,:JSJ%@&BTLOGS\<</OQ2CGW^
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M.CMIC'97YV1W1DEPK)W"2Z>*B+M$O@%1LC>U+E(T=X)QG@ S%8>([S#N7*5
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MXN<7O[\\L%^]>/S[RW^6],7VSH8&OB -/ $:.,?3=\X-"")IZHNBA-]-HKJ
M#ZHFA0?BW5WZ_ZBZ@+.ND#0693I-RQ)^5]7%^'T<Y46>XA=7%VI\$2%)%$U=
MU4D^4?EL<]9?\JR?REE/BRPKKN X(CA$<Y6O@#U'DR9;1LFD6-1PHJ,E,891
MD903/-*)*M-Q791T\'6+:%J7_95^Z% _Y-[Y#=__DN+ZSU_!:MP_BX<#/#.6
MQVJ<U'1O5>ZR\,!!+\KB4DW@A:#2 .<?9TE%!*%JCVT0.XC>Y\55'B55ET^,
M@>84K#>?#0?P=(>YQ-&WNSN[>]$B*:/+) /^ ZH3?Q<30TI&&9!R6<RC&I:+
M;(K^K6#2R('*:%X 05>P!VGU>0YN0V_7H;<N9^@*'" OF"%2),B-* 7Q,<I4
M=4&TF#?S$:LE(H7@]R,\]W'63.!Q(( T =%3-?@/.GY/4 T'0H$X-#P[51]H
MW$4!'!!U57DWT'HL3Z7Y& ;!WY.[U/ _*P8[;Z3!X2=_-[#9=+N0R<91IN:J
MYC^ [DODP'6IQLR":U21"]A">'I#L7>"8E6M]6.DBS+51]^E8B"6I@2V!#HR
MJDR6&]9+9( )L,NT2A081P[1,3UY=!;[- &D (2"E $;4X/=7<'W68*,$P=*
M'!(G*F[S6=;#@%*S3/-<_.VS^(<G/\+_/W6(./"\/-Z2 </!1<*;8I>HU<08
M%\L:1O50Q/S_>/0(#*,TFSR/WB6S]&=X_.\&#PL>BQX]DCC6B\/C/_0D>-:/
M1D5=%V#W?X_.@%%1@H5L/GN5);"_>SO/8&&@A:D)K.-\'_UN!T=OWKS;/SP\
M?OO+?WRS^PW]??9N_T#_+>^0\<:PU\FB@KGH__HYNE*3^@+7M/N/D%/L_%2/
M<8G"?YQD>DOK8N'O<99.Z8E#_80,_?3I/^QNG1^&?O'=VE^TQWA\?HK_P$V
M?\-V!G9V5*;)^T>C%*_3<] .\#ADMV'RM-4PWW?^01#YV'>]\T=WCO<QGB\?
MZ7T@U\]TO^R^W6.>_O;D3^#GY\C97Y^<'L71JZ/H^#PZ/3H[>?/'T6%,#JD>
MWNXYL$0!)OT7?T[**# #?"():1S"2O'WXP2TF*(<#M(/XXLDG]%#S-VK=-P
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M3"*Q!:/QY@T'3C:6U#BLJE5<KO;<H>_T9'@S>^IYM")P[A66IABQ5&:USHI
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M&.XG*929&F/Q!F3U%1PBJ\2ZSD#,NM12>VJ,R4$YXCJG@6JT4M40V,.:\G%
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M<EETXSJT8STP!?*>D[C0N&5$^^CQ=<EBI!M3F'QK;*49]O@+T-M-!]:E5 (
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MFL)LN<*K!O]N4L=3:F;Z403 .V26HITEDL9$[=PI<1O95BI()/T%)T#A$\+
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M*_AFO(.IG\85Z':OW"*\BOL.\YW_"O9#.@U7G YJ'!V.I=:B*0>BVT[1)E#
ML:]%4\D%@VRI?<F[PJXE#.+4P"2+F6BYSKJ^M"N59924CI%"4UFR3CY@!DVR
M)- -N51UQ\2:DR%VA@-0>:9IRB-@ !2F/;-5G'1-HZFI.&M+34E9.OT5Q4#]
M=V^\L)]IVFZ!0[<?Q?-[MY(U!R :--H!SU=::3=='ROE)!1;UA(K@;>VP$-D
M%W"[CAB#8D_N>?3_;O*_WBVZ7]OQX,_[;4"RMH4HYOE/; &O%33Q@#=J0PE
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M'P51@VQAQQ# \."5M 9E*,=[._)'>K4^44,G[_+R8_1V#E\)I> 20<T&V[0
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M;:CZXSO!VL5#FL U@LVO*20EAL^6.VW,LMP(U"Q7"HBQPZ&'1/>AS-&B.6G
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M=U2"3UB"O]1!""\"BU='(*[)]>1&8S3H)+>1P_QCCXPZ4;ETZT3"WA29!M>
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M<TJJ%T$.!P4LA]QN D/\WD!7CX)3:0WD:>BZ\3,%SN99204F4\T3&:C&EIZ
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M'AOTM#=ZV:Y^V5LV9E!AHO[.59H5MLV3X0TRE[>_ZN[3&K$6W_JBJ"I4P<]
M[#B5^4892CG5H$ND72U_&(5(IF?T8D;%,%H: D@DV$+GX^ZTSC*D%)@'@B%0
MQ@+5S2*F3NJ(IP][)WLPD*2^UY(Q3>WL$6G"%U(DP\=9<YEE[0;T_?(5A)]=
MH(<9TK=:K>:>.LH]=W4CV(J2$+0)-^.B0J6TD*(2.]4S6%+#]A"&/_"-+''@
M7W04S@_;!_WSKZ?=9QOM.&>[P-__A_LI/?SQ,==9$RB']F]AH[:J'CE4(%@3
MPP&"3;BVEKTPZRLKZ^QE3(@=+%%2K"\F"B++8(YZ"5LB"^DUV\)U\HH6G$W5
M+GC$M-8$H%\JUHTOE*0%G.WT-B\6SFTEN8>,HZS*75*//*[G-(@+W[K2-C6H
M:B0'\[-SO V__G;P+DHYOXHFSJ0^SL[RLJ3#$2;A H/X=K&&";O9LZ)(0:B=
M&8W@:B[!$?BD+O*LYN!_QI>]8SV>X\:F7 AZ2E\QQG" @#U 4X?$:HP:*MX@
M8A WP3+6V3E/(J]@&40#1SC?_V0UP@=P]ZPQL,/J4J .+$Q[GS*NY2;5JF#F
M&*;!Z>@+G9%7]6$:8P$;23F+SG& >K0]T@80#EVX%VR*&LL+\?;BJ:F>8]/]
M.;@"R1"\WNMKF%%=**C<$50\,*((9"SY5UG8I*EX_GD78<YZVM"Q[KO.0GW#
M]9F1NT;!<C(7F$=B6.28=)KE:?EC:OO*M(4E=E6C4J-'V*J+=.3'( 2"R+CJ
M*8)&BB^G%U.X;4(N%'&R+&TC3XQP!&VTT=,86#RA@W51.@X;T%:2Y6A-=QU)
M0M^,[V[BV-N,T@1B.#W(V<Q$QU"6O:JC[E.7$E!48C8O)Q01NH5>?-*D3G9N
MJ>%/MD-$3EBW'D <:S2^_A/Z2^D*MRH7:2?;ZJ\ '\T3<GSQ71BY5:TZ3_+*
M$@Y6X8P3F)NO_L%DQI7^]/6H)&8RT2T;S=M8QDOF(D,B^L/Q P:0S8S35QVZ
M@Q"O3?*1RAPIF@Z7<5'JSO;L<1P.'(V^=U?=*WFE4N"9":MF&+L 50$ND;\4
M4TH0; 9K+":-DI5W_#G<\,8Z6*,,V'0U WG8;;X$72V=Z,UU?#DCEH?FFO1Q
MI!6W3;."O>' H+#Y 23CK%_I?6Q=*^NH3U.+283JMI8-QN_#YM>"0_;^%5$5
MV][L "A3)V7:G65]K6V+.0!'*A6U'3'RH16\,.3%HMXEO,-JLF#Y %9;5M>.
M'=:]0%T_.R7&JYHLH6VAN80.!!YU.&AM*_PM^(R<Y[]7.;EAZ81Q4<AM1S;$
M\(?>XP,16C R<S5X%SG62?XJ-TJKUR14+OFCUYL8[QU"S9&NL%)!Z!FP0UM8
MYVS-RCE+GM(0"/(N;Y]8MWRYSD['E$)/L5]LGY1JL$<]"F?=;[-E\8?WM]FR
MMY(M>W^;+;O-EOW:=W_SER7]2EY:]YO4 AZ0$6X_=263L4J#+HBF+V9"'N")
M9)"YG]V_![3>G'.@F+1:#14\'#A8P5> *C]<,T/'P_X6Z!W"2W$2O-A/FDA@
MAP.6G@?2<3?>"+9+]SR^$VFY^<N:CJ1QKT:_9<OD-K'/MBT ;WA9T@#00M?A
M.?HY3,P%?SO/RNQ"3+D@R0GXD<GG<OT K-0'IEK(NL)>FF XSE'/[G: C<&*
MF25Y@3U,F>[:6.9A"I;%;')0CW1"(>?\$?LS7YI*6\OEPJZJ9 2X R?1N,ZS
M*0'T>[YTM.EUQPP3D;5C;6_*ABQ+]\JT[.X 8X:6VH T'0:(679!3X$ %<"6
MO9L:E0X\ /+B TGA54"?T,BT._ K_#$TNVHL3(#$<LZR*FOT$G-F+H;Z+")!
MR44G=99F,\\I'0S%(4WKV)<\R$5S7M6P8Q*M3$S_&LJPMAD1X1LUP@$FGPBR
M$7L1Q]C8?<P>9%:")"O?+=)%;2GP&SNH1K7^=RT0-1@[DQ 7<*:D,!XS%X\L
M<$P8)<CTO6EGK&#PIQNZK[V!.JW$J7"J=<Y_6%7AU3!57"AD2IFH*0IR7ZJ%
M7M*;@9$2ZHW37+OJ+C[2;AE;>Q3WU7_8J(,N*&@=(A4$N84>[1X[?84=1UVD
MZY/3154LRD:0N_/2_A,N"^RC5.D7.9R/W=++7,IYN":"CGTZ3?+6"8>H#1:P
MH2L6IXOT-7R[D4E!(*FAG05Z:/A[()$TK3&82!7:-GT8+(+(8&%I2?,^.T-L
M]- M1V$CK$EKH@?[:)? S86?4^ZFYY=V8K@"08"!0UV6(]F9[)\2"8D<8IHC
M'I(5KAC8P.263VY,LQ,ZBKL*&0R%P-ONH?G%'HN+,3*G.4[<P0R(2-!F<(:C
M(*8=<@6TU"K&4TWU*Y%<@^S$%5-6<;1ZRMU@#DCKRZZ-U)@2?@T78=M;)J'+
M@F(I3+37NPXO*47@)$>'9A% )*+_'?LX6W]S:^ORQGV+=.U:;R\[T4VZR_JZ
M7D0('!T\0XJ=3+JY7$"_WJ83->:S-O%I1X,-X!W%@DX6T\Q8/W6[.@CWY#8'
M[,G.R\BB3IB^Z0TG7#K8%LE4_P8C4,#=;137PMZ(M]MIOT94:VZNR<CA^02M
MUW@=G.9#TS4+U)T+-.^AKA)YLV@$H%::'"@,(P U@_2@3HV[DD*24Q,)R9?A
MX*@.JP4)O28N;058%Y]5.2+/)F56+11F9V%-LKO/'7V6?,,#=!/.= <V2@V:
MX(%7&%'[V^Y_N0U<3(R',%)]>A6USMN8=MX29FQFY<3)\]%Y'US-XO>&"4!(
M93NX8@"XR]E99FT$^65F&B:B0\@"->']^H1] G&';"_%;<3!1AP>;",.MQ)Q
M>+"-.&PC#E_[[F_^LL[8?_JKL64<+]R+I1:)[$TX\?M6=O=E]+.<HU^2^F/6
M6"VSRV1KJ$%>@99&ZDMBE#9N]9@C^B@I),R0 7UD(6WF\*61E)J%WC@-KLS5
M6+@":2\+FAU+5'PQ#<@A"Z=N5*?CC77!4:H+C@(CZ3L1?W>GF<HCTTSEU'%:
M"&EMFZELT+*DF8H^1M @"LDA1KT[2.8AW9N-9YNTN X":4W.$2D?XS>,V.8V
MXQ99+#G052']YLA+%FMC$=E31PLVG98++*=$<$%TD4U-?P7/HD'W#G:1.RNY
M!^\9@P+YO8UUCBTE0PER4&M,WR_G%N\E39-@W^U(TJ+214&)7)-%T\I/EBG1
M/,CB K6I+C/.6>)4>+7 Q>0ZR#&GHIFE-8.;Y)/3"\8XI6:<(ZH=.?IQZ03+
M&9QF0Q-TE^138Z9*$J>D^7?8>Y1SBPNBB6K#.HE*H#I31EOKORJ]/YAQ9?QZ
MM+<9F^#R=T4!=>L'8V^',<6E-XCX"MU_*X2A#4UJ)T4:_:D."I3M1<' X]H!
M1X]4X4(D!=N8D3UEPV#]P2PJO9A4NVI:G4-,P(QZW8,>7A38Y*.W;EV<$F'Y
MNDM''N*F/D6FE_.E0E4834YSWMZD_%Z6T:(LT.'IO!SAF?2BHK 88+HHJ/Q8
M-)9NX%S8E[7&-H4=-=#%SL.16X'C% :ZCCAG*"%#U+*<T^9+J>$03#(A?1\V
M[-4+8H>#*1O.I[;;I-D(OQ "SX@+]*6XTU8C$_@(TI, D!@$= ?K*XQ6:BYZ
MGEQPO9Q+CYR$L96O&[(L:6CRQIZ@VY[,A^W#&ZQ19<^*:@RRC,GWO*X69^?1
MX>E+$UJRQ45I1JAU!)3GOU)W<26?>$KP9-(U*Q50/I)[AD^3^$ 7%69T$Y<3
MMZ=N983&O\)"ZTX1VRM*372"F/220CQ:("B1(0XWM_S$H7O71<]7 ,04W\7U
MA*IGDQ$47LYE1C17G>3P:"<9Q8)>X@E:KR\N!;0N'&&C.Q%%9HN3-G (L^E.
MT3D<K)"=0051UOF<!"_XJ"/WI#MJMCR?,^;+Z==(UQLN_):E*Q<!3CD=U350
M>71,8O30>$@#K='\ @4I>6:T0]AYT+I-T4F^,IG#( 59%S(K6]\)4[S"B_IP
MZT6]%2_JPZT7=>M%_=IW?_.7)=U<PK0)[7&PTNV )+@.^$ERA8_H0PH+1[&U
M!,3 H !4B%[@OX]E:-+H9(?A("BG[IJ8A:_L,&4EBJ[-)=:8&!R#>LM5]*=?
M*J[#^-[<L)?LDMRH_#WB1\@(/)7,C-(2LVRR)6/*K<FX1X*92SN]PX-:D\=T
M,+RKA8FN<C;^7\Q$(DU/9[K'.#@E:DZ:!>6MN7%4;;9^)Q+Z[CAZ'QM'[R^Y
M0E\%!_FW+MX-6E:B\_YU)SW@%B<V?3+Z0)U)=-P'-!_LF=DT!:=% \=[F:CS
M#H]P6F5LLTH>AFN%B?DDJ,*2S(DP[KI;M\%GKLV<$C>ILZ?85.?'^*P+?FPS
M*CS\U'2TDP/;MM:%R<% <,R.GSS<BWYSG=CBBS,Y8YC69M>H\=,""P7+YK5(
MP70H\JGI2>MR96V]$).U,YZ,HLI[-^53B3.VN[.I+).XL__9Q4C\AR2YRDI2
M5UBHNML[)KP-DZ8$EG?# RNB! _6(! ^6SZP(<L25]3K2L%#H(U,08,ZS-!+
M/M%>]5\0I<MD0KOQ/$]]F51 1NQV0%5*JV%9#NL+6Q%,#8B) Y^ 2<\^HHOM
MEU30_!J>7^K/;^;-S\?MK&U>.%A]8+Q02J'&Q;#@ ?Y=C1D%B &WB+:=\3G0
M8&804_8U',^LE,)S ^"R JLF;P0!T&B/>B1G-K&NIT%^R@&U3.(-JI%0#MW3
MJDP%=B (B^%'$D\P&T1^'F>#6IM#WFW95$DHL%YR G&21H@KPCSM'<=-S#]B
MW@&%4\I4?$6<KRJH:7:FM"]%GBW"*9/'LO7Z+;_9D&6)I7>2-(L:\]WA2<0+
MP;_\3 F^^+>LF3C^\(S3[Y%JYG,$<,A2 @K4)DQCXIID11F^P$K!/*\-Z1N9
M[03$J(5"0B^5J)H7.4L\]#"!O.;R+QY((W=2TKS&*.-!6G$?"<26L,/LJV<(
MO!>F&P4,L:7D#5F6=&8ZT"4NJ0B/6RV=O8M'^+46=>K*-5][B3N2Q%TUH=4Y
MN&'!B&&R6D,G4\3)4@>)YU)"*3Z8&0;#=4I'NRH?0_:<Y&]8GM^YMF5JF)0/
M5STG@TG'E\5R:>/S[ T'KE(G@,RA<H=+Z^N>J\NL3/D!Q<_U3C2B_B@)%];8
MWJ:B.![,K#Z3*"1'>](%%U#@4/HTR@Q#G)AIN<ZBO:!Z_Z(]199.LB$5A_,4
MJ"+%0 5J"#2E^;N=D0 KZLXRGJ8EL]3!0D%-4+9^0Z2/CO-?Y%7A"BX/ KA(
M+KD;E,X;C=TJ299M;!IVIY/27O4DE,H,.9VT1\674J+$1@E-FH(7$N55KGTR
M=2:!9NVH=6$)<\PJH5?IUQA<U^N\AZ'=ESH/I/.0^A(Y,,")J5OV5L=<Z(/&
MBPY ([4O-?0X=FLML2Y3*0-6B,C2@JU&A/8)F12HNB6'O?D:J&A"4,$A8'_0
M"44S@TQ7(V&#W$8@Y4O)!/-_XD6P&<^-._401FQ5FXH=&Q6F$6ZM7^PW)=2N
MB*,^VL91;R6.^F@;1_T.XZC?U,W?]$4=D3N;/5=^=WC0,BX3:DTAF)TL&3$V
MZF9)=24FD16\= QKIZ],3V;W+)."?53R @\0_-;O(Z>SV%AO\9LK>M ' FW0
M4P?L 0BP/$31GA2L(]A*9%/#2C+2(A 8S-Z+*D_9B9=])'V./L"-J<:HV^ON
ML& 44+VL@]<JXA@+:U2H%,?# <+TDFHIBE-#YXM9?158%].$LN.4 K7+N@3K
MFIH-X!X+_@.G;M,03B*TXP+1S^@>F1UZ*CD]W)(<MC :7;MLPQH:!2$(I?@*
MU1E6%2.Z+N@\-<'AM*,E^-JSK$3 35L4/1P@JSZKB)::4 /'X(4X/E'[%L]G
M4OO-TT),GW$E32"E.$EGP9-ZA/J>K3*W:F1_QSXS.!<>\-BZ0;&8")X[J,LL
M"':;JLE3W?7'63?'^D6AI.,MLC,N)B"27JE9KF<-!8HPMQY&/ PJ@:XGTM#8
M,7>R*1X[6:'<Y<-9LJC!B< IP%",IJ <1J,TC/!2-RL0JP4]X>,J7>J,YM_A
MBJHTGWC-C CUE3<T]@VMK-3G:L@&R9BO)1N8#DIMA\UWQ]C_G91I+TB9 VN3
M^9OCWV4[DWNW2LM/),W2A0?3>3E].:.]_3P]Z'N#_# <^&607?)R]17AI%ES
M2321>[=%TE;C3DZ"5XE!BGKN$KP)_D1!M^)6;5W,&[(L@3/]!\BTFBI37B>7
M%L^4^LSDT@=[(D](8I43GM1(),"?$>)#FL2P\@"*Q!RHK3MX:KMYTO@8+!FS
M6)(!Q*DIK^U,*B?_1$G-XPKT6AF'U$DC*B'NQK^J^J/5)FUG!J>$K\ATS[DI
MT'U#:AV]3],T;0G)2]1E)+32VAI_R>TM0=27TCJHPF[CMHN.N)4L9OV.[KDW
M)HW6ZD6"ZZ5K_]B#F]?:)8/9',ETFA>H&ZC8ED/'QD,:LR=8@'MB>E])?YME
MR-HP7HT3JY:9:+B8.:A&]@0%X 3F38BNBGNZZ^:*=!3DF<JPHP[Z;A<H\E7.
MX(CRW$O1W.R)O:A8>X</?TG*<RQS+%NYD_IQX)3X5C=U<B\Z2JBH4.\/[&I>
MU]E%->&H^6(\RQMES1F9N\_5Y*R"<4BY9$T0)$+J8+E)0N-\T;AM-IC-.X!P
MVNVG^ZM:QYF(((\>9/85(?]-%DH9CZXD$W0LCXPR)7VQL?.-@<1"O:X6B8;;
MD&.%H@EL6OJ.-4Q>/M..>5TS-*<.\5+E1S4N)G$SW#V25,'VQ2:6&7Q!KGK0
M]:GZC7>-(.-*"E[ GXO,^E7M3-VC'@YZ-\-,.T)C2\J)Z"U*&=:326V+_IS;
M@U#D);5[1N6L?1M'K7,0SXUKZ2;5W.(Y7>2)FUV+PIFM6/@'0<2AJYTX,EYS
M P=%G65L7@LB&\A7(V-.,*7KRBD&DJ,"9\84HHWC)%DE62(]'12$7&R806]7
M*_A"UB4W2C AINZ]M3A'FJ6^J;C<5*"CPA"YUP.33#V]^Y=2DLQQ<%P]A<7T
M8/(4&^'2*WN. &M-(U(&6#M%_[.<$XIIW_3:F)>1LF?Z=>9-<,!D(A!S]R%L
MVZ8YQ_19UF070A-"J+D7[.\<R &6S&?C1:VLS[YR)C^5&C0WDB15:$JZD '_
ME=(WW>-,-7(RB.%6*O(7$":'L?QSN'IPU&<BSV %,%QBFO3 /-'YX=WTKOOP
MG:B$5WCW'V^]^[?BW7^\]>Y_A][];^SN;_ZR!*O_/2:?LO:F;!JN=M5./I;5
M99&E9UH]Z,@/X>YY_9%Y5SCF4U(GK4(DC>U<E 6=\\_M?#D[W4MOC]FE*WVR
M[?1UEC"A'8-268GP;)LDC@L?S;[O1%YM_K+.=)U)20H^9_X>B3;#U/NF(H-3
MB<Z<D/YE4%B+A*PJB]IJ:=5JF(X95^HX0>,$, 1R!$T6P<A-(IF/UHKX1;H"
MY9*;#V9D.;I%++;/KV"14]LUQ=DX&$7(5$^QB"B#6@^5Y)7@JH51$';YXY[A
MM897(9(J;(4R@ 5+:YRVVS285[.;DQVE1O_6.+"((SU+SC)C:/?' Q%KR$?(
M9I62@BT4;#+JL&-OT%SY\)=6JXU<I59"BAPF0UY">T>F17RESNP$)6%JNIQQ
M/J=D\LSU!\56@?81(LCV+Z0//+M8]:+2A8,J8+TX&,8QI,*FACEJQF/O)Q%+
ML%M&MB'+.G<;Y>BN4E*U*Y%R,MM-#1O:J8M2_$Z*JT;('Y!GNB[9Y/YYM.CB
MJ+6#[0CTZ..H23,+(+HC(VXMO(;3X=D6;&"/%^,?B@G\?A==&^SUP2O+$$4T
M"OF0L*#YK*1$5N/[0&QS$,K4'H <"K'V:=C>HR[B_?U'#Z+?L&W6X[\^._GP
M[GES_NP>_AF=-'66 9=Z550P_D^QXV)\\R]4N._#9P>(&H/S <-CGM=5=))\
MS.N<G9_438;'?A(I_'I/\=?_)Q^K/=A&Z]#BX_%^0^+&XOJ[? ]C,()1X_BU
M="NO\=(6-;LZD;IYXG#;43)Q]!RR@36_F5..@D/VSYA:+=AF":1+[OJ-$IR]
MU<)6_X#:)CBPV^.J^MC" :6=M.#L'1L8[%^P0P2O+HXJ;HM&PL<"Z8L*G-38
MC)G4AAUI_T[%^C@==/L*2#G)Z0 PWI]-KIQ[AMY$LR/N!IE-::=6Z'I-DXOP
M^,G#_6B^-]N+=JP[EG*I88(C*BU%98F*MTSO>BHS<>#2N(D24^F-+BRZ[KI0
M^TFHAH>=UFP])-YD87 4WI+(NMX&.+^/);>! AS8%SKUWCZML.^/ 9W20.[B
M$>:=D OR8>]D[[IWA%NB8*4M&3@"?Q!40[)?D'K%8%37W?E<16[A+<;@D'#7
M[@5@;\#UN@"@P].T 8A6=@&X3?A_BE0DT0KX_SNG7GR.N_+'K;OR5MR5/V[=
ME5MWY=>^^YN_K%R@!8RY@A+V=>ZA2;^I'*^%3H>2T!9A!]GT6DR2(,ET86JP
M?!.^K^$+@][J$J&@TE\R*<& 7\PR"9SIEC]3+QL6?3?Y!8BQ,]OS2#M*6.2A
MC(;'E0'(+_1BJ<6=,U4'?8EG-:]SNU*_)5-]%0P*>G<X]83DJQTT5Y)(T#(B
M* ,8/IJ @I%OL?<W=UF_ZY  ^Y7"< #=)=#'<T[_JR15HK-'DH/CK@OB.1#O
M>M=0^:5L!W35LM.0??OMSFL,OCT),^6M8^S*0DPWR0$N1,:] L55R:F?NDH_
M!2%-O:[1)YJ5BB^R=*4@] [/\<<.10;N04D-UP;344Q)77^V0.3D\NCY5>Q+
M%E;2D"M ,GC(N)"<,O&Z"N\B7T+7'K%2SZY"RA7!8D]>K;/2[0W=D&5]%, +
M#<W,KN\#P@Q7K;XP3HUO$/&*VV3H2"=*&G'RW74:DJ%5\83DI011R-N2E=DT
MEZ)0HJXQ-]NT<4'E3]LDZ0CH>:O+JI[65;^CZ ?S*+[SJVY<S7F;96JL82T_
MO14LC70-<1;[$8B%;5&>$.UZ"S?:BEQ?<]A>P U95B$X'5B7AGF^':!UDF<_
MJU+.\D.Q,6-ZTXJ:)4_)$I2*.N/&T+#FDJ#8<3%<#7!+/1NRK)FP[^PBZ(/S
M&](!QC3GH%SDU)F$](C>(*SKKI<D= <L7K(@$^W]M^YIY%64PS\<L,+DXT#$
M$49,\^GJ"+ ='!XYS\>YJ'<4QZ2W1]TOUVF\\EK+-//23M$O-]5.?CV2..AE
M'*I$T*G^\EEB:@2YB6?JQ.5=P5 [SY#OME]J;"_8ABRKY OV<T;.><>".9=/
ML#RQW=T6E0*M!9C\<[8P:M"W:_Y'*<D3II@Y-C:!A/!BF\6,,0F=-[(EI0U<
M5N6CB"-^]F0)?]09%?CL(6UUM5BYR?8JN1+4&PSH>.T>>Z<5!'56\W%= *6L
MYB'HM2T5.K,.L'#,^"HK5QQ:%.#2Q@'A=5=%<9OIXIUT\PV3?G^4A3YKQR=N
M<BW_N^._+W,P-[^69\?F:(Z?WXWC@27MG%!?P076,%/,XA7%G=7H1E?Y#1W5
M%1'+OVXCEK<2L?SK-F+Y/48L;_NF?X4^%AL^_4#%O7^S"N[QF^'@M^/3-T<G
M)]%O/Q^]/WK[RD^]P;Z<DX0,IK"I)@,1FXZS#@(GUWLN2MV8UL4L]5ML3O,:
M"]H18P==R514?8MM)[\2@5AVYK*OD+U=>XD>=^OE@C\0\W!XW?H#='#%'S0K
MLEQLW??=XCX#T[33>OD6M_G-WW]X<.T]O;DI"J4QXAB8?T^BQ7R>U8C)#X.\
M@(MW"L=__(^C-Z<\\Q?';Z.3MZ\_G!Z_?7,2';]Y"9?@Q7-WA206OI&S-,3W
MF#2,+W*NGSW%;WZ&CVY[BM\2Z7RCAW&C(%/+)ROG=)7AP:_\TK,&*^R>NL>3
M]>HA/*ML2TU?>EIDF\FL'"OAFY@;T8F0C":6+:%\I6F=8JK4$YG*MS:YEZ_>
M=I.&V+F;I.6#_J9)P%'1UO)7_6WKK[H5?]7?MOZJ[\)?]57][W<IU ,\[,W;
MT^.71\/!VU?1T3^/WK\\/CGJ8&B;PY8WVKFXTF%P6H%8=UP&G=Z"C5SV'?2I
M[MP?<<LCRG_"Y%2;-)LA'@1##>I"C?\G_[6ZNP:=:9V.K $H/&%8))-S&,9@
MAV*BRG"03YU><7E)>-_2UY&R7P49@ +_NH6-O-)D\7,AB?PXAN'/N#2$04**
MPDWP,@#[TH.&D\B^+&W>[N'>/6I],,)(,I^]=.Q%&'JD <I;P>)UH"WL*F8/
M>EQ]&CVYI5VXOW:ZSP8=;?^B;G()_ST<\"KX_Z/_H9ZGR25<7:IW,2TE/I24
MKTF8R>II5-7;L]R LYPZ90^4IMC5B+<7G#Y1A(N@H=_C/G1MO/6+(D&T!8(\
M9K@%M1@KIWMXW%L<R2_2[<%$6LV23_EL,>N?G(A#8BZ!J!L.6NAO#,"48N6)
MAPD13'(K>+[A!>T\1,%3<"\4ZD:BL ])NW$>(8\D,P.A[JI5C)KE@/#0@TSI
M4@N'T>FLJ"YO2URMMW<WG9GZ_U;_=Z?6NM%VG72%#<C:@;O6Z#?"*0V.3'3X
MV\'+Z  8-'8=>D.,\\O2\(:?X?8*;H]O>WS;X]LRRF_#B?G?)\?_>'-P^N$]
MNYQ_?OOZ\.C]_VSH2C?\H#BK@&KFC[G? R@<1PBV :^ZXFJM_=_&[LVSX^=.
MF07LT8%-8.4O*@8L"?<.,V4^8_\V=J,,$75MT(T0TL9N#25CW.[>;.[F'"8-
M)JK<Q![<J7WY',S&G[[[C!(O>V2MO(1MTL=&)7U\?6?E'<O\.#A!7?P7*CYX
M]?;]+]NTCV#ZZZ$-/+AAFQ;K>T\9Z@W&U<$8[F=N.V](T14'72A$R\WXYG/"
MDA:09P=V>2\ZK+B;CG)_Y28A*$:@^H)5Q#W7=A^%SY8ZNE8"%W4X^/7@]8>C
MZ/W1RZ/C7X\.XVX:,5T"!,O-8K<U&FBPS@SFH))82E-]#R>_K<4+Z[<Z=8A;
MJ5ZX[6J8+[>J;[O$ZDNO_1N=Z Y'EWEV[^J\;$;;$_NF3^Q[OE8'TFSHB_'*
M[4%^Y[=MRQ\W[<2^YVOU[KPJA5;#9)BOP"F_K[W?7I -.*0C;@F'<]OJ$G?D
M3+<7;P,.":.9J=3=!Y%(^'<<!4')[2%NQMHW9J+?SR'Y'=,%=T1GZJS.J=B>
M[#=]LMOKMP&'U'7]M*JY.J%IPP_V"V'4?!64_M7I10]@IF_GU +J2?0Z4<TV
MV^C:V4;?1$+,%VKY<._%V\-_X46Y]_/I+Z^?_W]02P,$%     @ =8M$5TQ@
MV%KZ4   E"("  D   !E>#0M,BYH=&WM?7MOV]BU[_\"]!UX!SV%=4$[=IQ,
M.TD:7,=V.L;))+FQ,]/BH+B@),KFA")5DK*C?OJ[GOO!ARQG[,1R-$ ;6Z8V
M]V/M]5Z_]>+GLU_>O.SW7OQ\?' $_P;XWXNSD[,WQR]?/.)_X:^/Y,\O7KT[
M^F=P>O;/-\=_^V&29]6S8&]W5@5GR30N@[?Q5? AGT99R!^$P6E<)),?X(OP
MU?<W_=[S8!H5YTGV+,!'S?^>!U7\N=J.TN0<_C2*LRHN?GCYXO6[MV?N&[8G
MT31)%\^N>P<]6R;_B7E*/[S\<S8L9\]?/,(!80_>W^7LB^3\HKK-R;]X]?+X
M\T4R3*I^[\G.XQ>/7KW\.BNY_7. I>A1W.(BMJM\1@LQ'PSSJLJG\MF=+^GT
M^,/)\6F_]SHX?/?++^_>PKCO#O\[>/_QP^'/!Z?'P6\''SX<O#U[4&M^6,<H
MHU=%E)63O(!7SF>SN!A%94RK3>!U*;P:7MOO#9,\*/-T7B5Y5@8G;P]WUO=*
M7K?P[F,^.WCUYC@X/'[SYO3]P>')V[__[8?='^CW]P='1_K[C??@*AE7%_CH
M[G\]#X9Y,8Z+[5&>IM&LA"GK3S^06'MQ]N'F+[B,BRH91:GN*!#=#R(D7YP=
M??&$G^[^UVW>L-^B HZDXGF=7D1%7#X+_AKN_[@?_KC_HSF+LZ/[-_63LIS'
M/*NCJ(*/WXVJ?!@7P9,P>+S[>-^=//S?A_MRE%9+^".[ZHUROY9W>T=\^/'T
MY/TSGLK^CWM/]_Z^]_3)K1#E'2I]]^X\-N2V*D<Y/7DKU/;QU-#;[7#!KT5P
MCTA>OKPSQ>#W>5DEDX5\F&3CF 9/LG4UH[[*@LY^/@&]G?7WX!KU/=BJ+N+@
MS^GXW_/\^8N/*J)?//KX\L\%?3@ ]0SNT"2!.507417""XO@,DKG<5#$HSBY
MC,<AJ$A'Q\&?H^GL.;QO)PS@D:0J^[VH+&'A9?TU/^<IZ$#>6Y(R@,U(JA2'
MF\_R+,"O@%XX+8,H&P?E?/A[/*K@!M,?TF2:5!%KJ_!L_!GTNZ2,Z5'\^RC/
MQ@G_^2(NXB2+)C!6OU?&%2Z@N@B#J(*G%T$%NXE#P)3I&?KZ&(0\JR@7--7@
M8#8K<E@USE.732^+)Q.8%OQ:7^-)!N^'+QSKU%!Q<)<,NP/?YS?/B@3^'];V
M]-GN;C#;F>X$6WCB_\R+3\%A4O$T!X%L2Y[%V_#E[6C[(DHGP2*.8/)9!K,H
MRJA8!/F$'B.MA=Y;G]P9["OL"6Y0OU>?6#"<5T&65SA&$=.FA#@W.()R5"3#
MF$@ )S^;%Z,+4*N#29%/@Q-K4 2OP)XXM?9$-@*BB(*C.(VN8%/A>(I97M#[
MZU,[S*<S.!=W0F&_-Y_A#(RR&)2D/@9;4>E21C3&&S;%">#4YW#!<.IM)"X*
MJ+=NV#9X^Q3F=%KEHT\[P1E\TZP1SF@$.B \!-O/$ZA_(Z WP@N!2O0]\&":
M!K!I\;_G0 Y"OX8JWN.HL#=E,(XG2094E<!@2%(PZ..MX0!G41^NWTN8NM(%
MCIS@.3,Y3B,PZR(=!]^$%A#.,PK*>#0OD)8NXI3^/,SS3]NP64 Q])1>GJ-X
MEI=)E</G9P5L:"!G(M<:: .()X:]V++;>G1VZ.TE+]N;)@X--B;RC?.D!*J"
M2<KU(H*UJPR]0PV87?RY*''HDIU1^)<XA4?Z/?A)KB0\J_L$RQ/&-0+R'O,"
MX2S+.?Y53H'9B]P6_>8!$/!H ?\4<8RD%.)85Q?)Z") $Y(G6J+-FHUB62?<
M%KC.LUFZV'E DN3;B\;=G:>WNR2@5+E<_=X>$NQ.@,2+5X_%!7]VD@$O80'B
MTXI>TC@MXROD,7S-7-+E2Y>F^562G<O7+J)+IO]I'&7P<0E?&S-EXEWF$?36
M[SU[4%M^MU2$L_TVRS*L[V R2=+$%Z+]'IYT21K&>Y#*)+A1>QHGP*NJE'EI
M9GZK+HI\?GY!H@7^,LV)LI!XXG$2%0G.!'2:JLC3DKY:ZJ^@, 7#A7S&\F?$
M(DD>Z/>NDNH"6"//@V1-.0=N)LH5O&E>LKQ  0#?*JL"Y0D/]F$.'/O)[E,C
MVV(D5!0DJ!(>C*H[XWC?[F@?.L6^2H#MD.;AD"SQIC(4Y6Y!.C!S,])\@/55
MI#4RO1&72PI0#D1\6I8W2B,@*#87 A2*"3KZMB)0\OE15V4"]H=/QAFH]"4*
M:G@[S(9^ H($!20:XZ"_1,6G6+CK,!G+G/+F@#1_8MBHV -1_WL>EZQHRA^R
M&#6_"H8 K8$&QZ6"/B[:M?]*G 9+_\:;.F<>H9$ "F[%>_4JS?/I,"[.@S<[
M[T&S=PY"_^(;!EO#J*QOP%&T8#7[IV?[NT'4:2* N'KR;/=QMQ$Q" -0*_$L
MWIT=_M]7.&W\X1^X'-3ZS2O[/7?3+T&;APV]BE'[PC6"L1&=Q]<<!#$:LJ:N
MV7U<;&T^L(M$/:-HF,9@ VR-6BE(Y]U^%$0-LH4MKP"&!T/2&DI#.=[HR!]I
M:#U10R?OD^Q3\&X&?Q)*P26"F@VF:0H&65Z<@ZS_#QLY^!?6*V%'1C$O'(X*
MU>G)/!N))3N1M^!?>5(#WOUI#EN&.P8*JB'_?F\&'-E8(HVIE[F9-)GD6^,!
M<7E06'.T[4B?+45CB9("^16N@ZU[MAE:S1RR5I0;]'M XE&&TBR&S4#FA>=6
M1&#>P.Q(26?Q<I[G8WP12"/A(*S9E_RN:?1[3O9)DK'LBRUW$>U*+EP^K\H*
MS@ZW"8\0K%20;$ F"]#"87MG%9*,:FYBO<@ZXY@="O%GF"RR*7@#WV]CJ<VB
MQ/ X^?)W(N1@8?]K>SMXG8"%^"QX#R3[' 8 #@JF#GSQ.9 [4>HS?)'JJ]O;
MZJH\.OE5YU:+=OZ(83D)?>EGK]((:&EOYRGL ]B%R1B69R-P;L2M'I&3=W2&
MTFHAMZ858'W)+1YB_SC2>$+?,%[89NC2>QT\ZVRA;M[SX&PQ@_<?%-$P&3T/
MWD;3F#?X;8X;N.=^Z9%^"_]B?:[J;WWQ"/:Y9<N'< T^;0]C8&,P]HP.SXU"
M_\A+O_\[[.UF/1;0N@ONYN&F,DU^NVNJDWXPS,)J+'E4C,D+=D2V2UZ4#1V2
ME31\$)GK6)]S9-1WQ%(?P++LX<]+D/AEB3[C1?/8V6I8B'(!ZC_H"U$U+^ S
M&!WLQXCL5/XS_6(<:Z!=H$,T OD;99_0/4+.5]):@6R,&HO:2#2O+D!1^ ^I
M8@4(_W_/DX(U[32Z"L@=B'Y0,$1R4*.?HX<'O??).![CI$/\X"*_BB\Y!L$F
M#U@M!7L+$S22&S,RCC[4$,;H&ASCJX8WGD\PGI-J(ML*BLP"8Q$7^326[0S-
MWR[B%.0+'.WV#(1EX^]9GFW#<6#@!.893V=IOHACXX(00X[WVZJEK''A1,'0
M3U3U9-47ISAGC0^_.KM8E,B[@R%H7W!.:3Z2H$M4<:"$+C=IN/R-\QQV-4._
M*7Q+=J8"M0QTT31'=8VY VF%19XE(U1_QV7 V3HXSP5H\-,RV$JR43HG%0^/
MYRI!/5P>*LE7OS+1@.(-MDI*VB&N#55V'!.L5#RD$5PCV/R"(DEBL&RXT]HL
MRXT<39.R!&)L<<0AT7W,$K1$3BLP.$O7BX7VP/'G$3"L<S:A>)@-#:S+LCP:
M0-\^V:GMBHEX1TNR9'V5) 2M68/;?]K=V=T+C($=$I%8=@KBHB2-IK1D!$9K
MKK8DL!&,-IN_3:-%8,*I*#6 ;^(0&%DG?P53WWA#<^NRK'::"XY!^@,%P4M;
M%&.D'X<H?.I3&7PZ'Y:)>/V%G*[R>3K6! EZ2 *G%*+'8?(@&I'> 3+.26QP
MW388R!21&@88$\CGE9-($;+^%@^K$)US(&91B2GYFQ1S#4%T\I-7$BLUVEQ"
M00.*O)/;-RG]>8SRC.Q =,O0-8%O2M(&N6KH5[X"]#N(Y]",?H6!<EE\V;%Z
MB0"'?@3_X5'=0[],*H;[O8-1U<[ '<%MA#8\C+=I[Z?])Q3@BJ;HB1R')J>A
MF*<BZ(OX?)Z*%@MFP72>GE.&0&521C9DLR[+,F3#L<W6 "R%6<'XP^P;E+,V
M]8C$?06V07F1S$*P+F#6Q"3E$1;,\\S[!&1V#C8'?__W')A9< FKFZ.*0,P4
MGDF3:)BD9/>,5+/@1UGK,!]::XF#!YE&"2AT,L1YEPF'&Y#1#2S#)7:X4*OK
M$ZQQ0[7KLBQ#M1\H$:J0/#RR2Y 6VMF>: DV#<KY,M"5?!=MV->8ZW2ZO1=L
MO4Y EK[-=X+]_?WMQW_9?[SWTV!#)^NR+$,G5N*M)A:M--S?2,/OD5YLYC(0
MC*0N-ZF&?%V19C9';*22:6H]F$@M-@K?03ABQ[R-RG'T[^ PFB7H_7.CXAFZ
M #'R#=)3A=> \QDH+=1.N&$5@7(_PU S.QQ-IG<M,/R=4.GR .WC32SV%F*Q
MCS>QV(<4B]W(C=7EAGJ>%AVIK*5YH,ZEJ48'0V1AP'G13NI6$*5E+LZGF+U,
M%#9R<V"7#(VI^Q);$Q_7N%ZJP^;1=R(#'L"R;"&2IAJV!Y3]*'%K B8,T)XK
MNJ&&=5E6DQKX!-O]YXU\8\Y:+%T?<KF<:*[+$E6^0K49FC_\C'7<?YX>!P=3
M6,H(E]:I]GI_^GN:#Y?^Y93BX2;CF#F;QJ]-9$&=G:)1!T:A+LG_[^X-:.<Y
M+&9C[*_-LMQ+0$D.8+F=MSJ##N&[2<89%DP9^A4IP?6*]IC<1O.BH.",/AE1
MF68]_"F5(M,H22FW=CPN*-T'G0D<-X?_+V*@T?U=>/)UFF.<1@D5?OHG:HJ[
M3[;WGOZX9T.FUO);^OX-L:[+L@RQ?D0/T16ZG9!MFYK)=@_5W'D8",#45X[%
ML8[DH, JCQE8!6AHBFE#=57S#4C];#@OSH,S4#IASIF6G^<[_1[6&TL1!M O
MWA2JT!9J,]- 9T,63=7;E62^LVR:CTUTOIR#.DO316E!;@L,:V*&><)E)M%H
M! 9:A)8BW2*J?Z<2JPU9K\NR#%G_^MO!^Z8)]+5KHVH%1F0!75<;-0;6O;CK
M8IVO42JU6@U4OW?'15#>YB[=5I*2=UP$%:Q0 ]7O?84B*-62E]= (<7>=1%4
ML'H-%%V@NRF""FY2 ]7O>450%[==!!6L6 /5[VV*H!ZX(#.8>W54BS8-#402
M8F9@JKHF>,E];2AK<IN'F$)6>5 S(1!/=17'64-G@]_[/1=E8^.B69MEM1-4
MAYYOS%%ZIL4*=*EK8P2NZ[+J-%&VIMT[V$6$=T4R%\>$E[WV):J!6KI202?(
M1KX8:L#XN&DT@<FB^4X(:7E$>'\3$;Z%B/#^)B*\B0A_APA9CPU"EN+5T0??
M!V-=_V5% _?HR#_A 'SN6!!"T<",_*5J#\=]JB+8D>62*C:-QK$ Y.5<Q@$_
M8U9U#5^SH'\Q+,=Q?!.^;X7)#"PR)C-,5BLM:"4_-<1RE111+Q<U.Y=MZ?$<
M;.'X<SR:XPK>'[T&!CFC)(9I4E6"7!)O8[2#_!;R8U15T>@"58B!R6S+*W&<
MF7FZ\(I1EL%KQI2& !.I(5HVO^RB_>R 393 UO)P<52D"0,B;B6#H+J"T1X/
M7 <89]]M)?A7]"3-T5V&SWO/8(9YD92)N,Y/T5& ]?BG<56Q'QOAP))\3!":
M@FI'X4Z+/3D>X!38,SYP(>TTZP)>:H%785YX4F64C$,'VT4<"G).G$YX#M8D
M9IG64##5]=3O";IG.8M'[(&7W7$2$5M.! [3JQ*F;/^HO$@<[,C110Q:S;B(
MKC)V+?HUH5A'',RSE()>%#>#[^-O=J&S(A_%8ZR1]J9GMVTT **%K4*?W,U6
ML .?P8.?MG.X@$#IJ3Q#-]<LTWAH-$TS#+)<]QEI?QJ/X4><S/D\PLL:L^-1
MRO)!T\&7VK_!G[*\B@IQTPVTJ* Y0;@P]K4XVPI#'8X7:H&$?"XTHW>2<.BB
M8M%"%E).;Q).,==32LY3O*@8M&P@JE8YGXW>]7E6P:UUQ@8>9GC9F#U]/L0G
M8[\&T25<=SH+D^QL,J3U41QKB-X,)0 ZRLD\34.Z+A88M&5YG0NHYS?! *!0
MIIQ/2P!].?_K./5F132JA'9D/9RCX'G=)P[=^/RJU$O(^^R:W*#J%@PA($^7
M=416! N8I^22108OFRL^2W+6$F?G:54YAJ8M9UIAVWF_#$PFHRKC=^$B 9\2
MKN.Z/+N&[_=D=K4W$+PA1A.!7'PL7N=.=L[9D!.# LLI*['H2?(J%(.WWRMB
MC DB=H3EG->_P@RK3);B!V;/>0;^*Y6]DN@CY%Q!+J7$ZQ9JN&*1@W"36WN#
M0($]*,)"#OA1G,PJ\_*,1@!-\-7+VO+)N4<HWS&Z_HSO.=,XDP.-BN!<G[+\
M*HW'YRSCR:\8,#(F?)>IW:@CB-E1V@1S& DT"_A*-+L(:_+(J"XN0;9?^WZO
MA@V] J'B%36O<)@%JSCGL/<9*SJB%I'((  4(C F.JK1T<@)Q@!&3N+BW37;
MV6C5M[NLFM1C660RKH(ZFN_CK6B V.=2L@QZ<AG;R$X-/1BY= 0$E(%"1L F
M[H,.GO56.;#:.=\!K+@V0JL#X%M19H_.#B6)3(H)2PP6)>4%D.<H!1V40M4.
M1OLL+G  _%AQ9$S #E;'3(B9-@:55(B@=5#SUM5VQM'A)1BH<R.^HU@+S2F%
M?F1TH)R\R$'OE=0]+$GG5]'J)[;F/": GUFZP%$I74,8#JMVE$\G,L@H?ARR
M+_SRF%5GBZT0W.G>!.'<*6^_#8#S9BQH183SX&X!SC=\ZG:7-:Q9_P;OEQ4(
MQZ!I1-%7[FGP)YCUT_"Z%@QU@[AE3L8:?G#'\ 5.^R<;I_TM..V?;)SV#\EI
M_] @-4?$G@_%O]3O>1[VX&2B"'OL/W4\;8IYP]TG,._+:4+4 0J@'5<(^D<2
MO$#;0?=4->=6 A%[ "43UN3!>280?@U#LM:Z:_A41/%@A2;D3*6&XYCJP896
M!HWK+F0PXM6'S*T*<!.&"\DQ(!M/Q$G#0:?I"(GK%?&\,D,#)C3V5:N&(=CO
MR:H\?P$FU264N#"45CNHQ"+$"&I]_[-UL/UJ$&S]8_ O_'SK8" 5<7?5U>.G
MG^J=9-LI>/OQ7V:WVL.Y76_:]%#U)UQG+\*:[[!!WQ^?= M7O.UIP[W@>?XM
MN*6YM]R 6PVFE3PW:\0]XQ -< 1,%]>,6#=7.9E2^Y8J)O>MIOJZKKWKHQJ)
MN.#,GW@:KE\7/7B@ 5[86!?ZUJRWU[4*/>-;1 D%0K#24J#;:AG01PS;BW$H
M[RVR'S=_E3NPZ7Q'_MU9G%&.\D39.Z-,V.SEBQQ>H"S>"UWA7(#G4[N:'W=W
M,;L;AOE@4"J"M[^<>@@GMI_-)!XC/JR+S)=&5^7 X,$Z$PXY]";"F?'P]"!%
MZ/%<XH2\ 5N+NR<1/)S_\&M>)6,)IBFA-#*B91*P\=DHF<&R:TG\G1GYD?$D
MJ$YB%VU<%TP<SJ;8J?-\5B%QC[H-48_GY%99A3(:9$8Y[DX$A.<B7G"-LM(0
MK%AQ@-K!()8@D_>DC6(3LO.J9.M.3GM* Y5<>W5P/DD+Q[D1+VG$%33$B/.H
M[7QS"Y<<TQ]A0&8C>1HWW<WZ';VW_9'72!-8RXG>@=B_WPVWU_2<;EV9?+5F
MRJ1A=;4,F$8?5(P:D$=5LHM(:7F.['5#DO>:)#<\;D-0M\OC_K&N/*XSOX+,
M388VER[6I+A2]W<?Y\^-D#=+[6N13O?AB2#QDT5FDE_0<^I[$]&-:!\HHLIT
ML(F:.8 [[5=%O.AWG0"^"7U>NZR3B<V%T%R>PO1)3\1B:#E9J>G';#C\3F>V
M4AL5JF&S#X;-UD^:.MSO^;BL89O3G/W25?0I5IO.:9$^@F>B$3KO8>]&]6@^
M9B>BV6-<Z7YZ&$VYY/[DZ&3!5U )%39X3[1)<*0)U%YVQNA[B<:N_[(:.4DF
M%;>6@QLHT(D3%3$1&<EX :8GAG>$W:<PX_ZR)1/:,<"79O0CMEL54T]UNG;Q
M9:QMTFTF>*>,,%+!W-IE<_(\#38UKRV-FE)K9(?LPI>/+GE.' SB$-IXSGFJ
M6Y\'*RX)8VQ?2>XM$WG]WHUD'E<=+ ;!WL[N[EWQA;W=?4Q=6"F:M4]9#M\X
M4^/I)E/C%C(UGFXR->YSIL8]O)4W.\C&:=UD+YA\=LVO>H%WO7/^P\;Q'PO7
M/F9]@NCD-@:ZM=,;#SQ;Z1Z:J2\^OOPE1F!-T*WY0JWZ7ZV@KVD56HOP%B_C
MJCKF]D]?XQY^[56)YAS<WKH2/;=;'!-HZD@+4YLJ[4?4\_QTKV9%SPAQXMIL
M15LF9/-KN0\MU3UR9:LB9M206+SD+&I]"@9F4FG$&?7+N05DJ45V,3&KPA J
M%_N8SX=12BJI?IM44US044Q69@Z;X"&2FC($'$X>PM&Q#!8K,[$7!3R,75G'
M"6BCW!$VV+()Q$>_'1RZ6<,.)!J]0-'F(C;E,<S-&C0IQ3(>*K0:I#\8V'PZ
M>..U^73<D,)LW/4Y<=QN-TJ['H&SD%/!,.^K0:,JI&;E!Y=)J_O"0*Q<246L
MZ> [=@@R<DL'0M?9D'BP3>:,.3-<G].G$#O3)Y8ZD80F;;#;"9@W\_0PZJ\9
M>JY%Y]LT6K['(+5.K:T0OP[&DVTO&#;A<$U]L478C+O6785M$>B[:]#;7RPY
M)%I\YP79:53WK)963-?>*)7AMU4:_@>6&&P9T$,V]1MH07S^@>&3Z"3P*@&8
M3]:WHFTWVS(\I4,W 78B.]4&;DA/P'&8\*C>=!C#CGA--;D ,N?V]2V7E3@<
M_#"3F@>E7^?&-LN&PR IY#L.%JVF8M27Z;\Q#+1_.=/I+%I,'>2L3O+8<CJQ
MRS48F2+)!O<8(/U+-NS8Y,9\$U "6]QY_?E3LK1+E),H24L#U2HUI7!,!H/
MDX)M[EBW-*N;;RPAY-";$!/E+%H$M>QHK.&"4Z P;YK\>YXPN-XXFD:(88][
M2JEXF(HSB[,HK1;,4>,(".Y/>^'N[FX+2W7F[W-,BZEJ<XA:,#-OFE<T"&$N
MNU1"Y/(RS)["W1<GVY\>-Q^1-P&E 1DT^> UNSRP>]'\+JU\R9<EHZOY&,<*
M;/(2O$)(!?XV2K!9O;>K7XB#X!.' 4(H@>F5B9MP[USV%AJQ=?FFF1;2/^)3
M(+(JP3+F1J(TO*OB)]2O  ,@Q5/P3+&:6Y%;DTQ_=@5^:[0!7JPU\$"X-<AW
M%;0-W0P'?7UP>H:\[KR(I@C=FB+V=U2#D2MB'+UL * Z_81W@H,RF*N2C/YN
MI\E-)]MI1S,L]?G2/C^CYT-X)=;@"BA$U,'W0B7SNE8%S' :D7;L)6#6Q4OC
M?D;8:MQ@)/B7=05^V?!P?CL[[H&:I[=HG28$OZ6<BT(8^&T3_6LQ)D]JP0 '
M6Z.)9,)U-@V&%&J&,Q8[BRH<.;@/_1Y%*RS 23T"X1D8M5*FZY2==D$-U\LN
M/(A1'<I&I@!?(*M\:P3A9!2U 3^>9]9ZKG%"1)P1?;$&=16*?N>^G;?4A9%&
ML ^ZL27%=) <R.R20(T=[LYB)_?KZBV/F_RXB9O<0MSDQTW<Y%['3>[7C5S_
M924B#3^@'EZ6!#GU@?B^(_CJ=B#( .M+;?&'BM/T>JNPO8B!0/((2' 5DS!S
MWW&5N)!7!O-#K(R:D?'@#O.ATN@ED2C28)R5$>.BH5;Q:K[8/B'0P=?6/L/!
MTH42R@J! A@A&H\3!]Y+4&=$_['UVG57P\0'S;OER]&1G>)#>%E<6<&6C(;Y
M93UGQ\F J0. +KU=TL7$,?[%K^MZE1WHGGX/'=7#(O]44Q2W&"D.:Q&U%PCM
M@S6%C8-]H+7TM5 )CXHB99(44\<A;T#<0G:I<VLUS[AS'%48L  **B?6\HX"
M"B+X'NX.+V7=JQYE;&ZC^X#=?%38-L,3J?F)(L=>9L)U7;,.*_.]&!A'03>7
M^+5:R(:AT$(Z*6Q'@IB=-,^MSP,FT-I6,I:@.1P&JW'J\NQ6CV 762J4.O[
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M^T9DTW;#.NP^.G2CA,$L"C\/K4LS#&TB4LTN;>A>JRFW9:)I9=R FQMC.%;
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M(1-:J@D)KE9HJXO5UM1?KQ>,+>KK\MZ$#L)$5-66;[$PS/;XD5,Q\8SY4FE
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M75<3TR? LS30[8*]X\XS[KQ[SB Z?D=CF]!K@':"1D]#WU_F%KM%515AM^U
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MYNA0F",;BP^'\SL%_LO.E/8E3>+Y2E/^3E2 ]5\6.U].HVI>8'8X\)Q3A+V
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M_0=E-$Q'+X(WT33A#7Y3X 8^LG_TK?H5?F,\NLJ;^_);V.>6+1\"#_RP.TQ
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MKJ$SLIBSF<Q]\1 IHW5' C24:@-F15F1'\?>&Q#/8#=,'HK2MCRT_W@;Q=]
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M#(/*'-!*B3G2.3\A%^I(K2I[N4,"3(A@;((=X+'G0$HC'+:8PT&1G]9K68E
M"T?^[[PX/^:/>;^IFRET6(9#44$2ORLI==:62@$V_DR]'6VCDK9#904 B=K
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MUZQ]^86@*,QX7N*\S8W "['BYN-RD-+5&:)4PR/D??*FNE1)$$NKZ[TJ;\N
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M96L2$X"2LEYJ'6@@OZIF"ZP3S-)24[X6V2;QBY"EHYPR\\3-[;BR(P=51:!
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MO11J)^3 %;PGIT '>,U51"C5@M_%]P.C?78"0%MB&1E^"\N6M"#F.[(+IXE
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M4'D!PAVY>R%&[7?; :"HYC"1[,>F(U2D[LTVPG8OPI9ZPO8N+:LB;]-I9(>
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MB&HYU9F>!+VXQ=24(MDQX&'?RFNDC[20P:X^EP&RFPP5)G*W@&@]2.A <E/
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M>^D$Q4P%$L2C_][:Q9;FT9 N<NLR?A:#CVO31":"S4M9X0(9_9W B-OC#'5
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M5#[0;QUF1O[4#4H3)W;&YYIJ&Q5=YQ05-EZ%T\A9QA=(G,=\G5!3VH9,>/B
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MX/80C\A9:MM1S% <^S3<IIR0Z@&(=H>D2GPM+&F$:?B#ROF,+'7T[C),WW5
M;'2S$I\5(^XCZ6GIL#P,%?3(VLO.5A9MAV4+#E7^C#K"4<FBT )]8E$'#ZMY
M1W(W2//><G\=HF&A&QW-B!@_F' ]%/]=. [@7WBP9-++36V/F,>B4-D"&Z]1
M[=THJ[!V DQ'K$ZK00]PIT2K%C*8?.Q;9UP --=1H<\=8>$"8E>*F!6]<7>Y
M':BK57=C_00C008&MTZ/@,YXRN1%\$;"79Z6,Z_=*=8_DD B&V,ZLCZAUJN0
MX\ -O;UNP'O;+.I2?^H5YV#QBFP!RUXY6@S5"YC#5QA:NW1&/N;C5-D!FH/W
MA*>M%P%A[9T9]EU+ICI?U*;X2 J;_?[4VI"@9FIH3ZZT!G.%?,&L&Y'BPW+A
M'"=R@)#G2^NPHK!!6O11N;Y^KU2;X&Q75+PKK2JIPT4ZZN)5$#(&V$N-MIN.
M_#=]+RT_;>5J\/MZ,UETV-?/]CSQ3#0!EU=<?FVX1V@C5"C#.B@F,450N%'#
M9MZ\ND7T+,Z*-L-T9B;%$Q_9/@.W7%0"8/0.VOFK->ZP?H?S#:"!O0UHX&Y!
M WO?%&C@RX05OL8 R9X$2*3B66KXCD 7^][O2KMJ8)H4M;C!*VO@5"MF^4AZ
MMT@1>?-&6:FN"JI.4Z-M&AS"!#HDH.NG,==<D/9)D%[RDK4(B2D.G9B6]\WS
M$0TL"OR6"S8,#9> $)$ZQ"Q^\8>UU\E^;^^PW.JL$$TQD@J05P&F(7? (&<@
MUD8Y7 "=S5J)M932P_W,B;SKOB#&5R;< %.XRJZZMDH;0YB._5:L#&VY")[W
MH(:]$:\Q&1H)U/O1G4XB) Q*33-T24P@IY'T0&X4CR(H5"FM;R-R<4E92&4^
MH^$7E%_>[/-[WN<'M,]_YJPP2-2;Y/HP^I\.M90R$3;(+LD=6N%XA+X+9N+H
M,604Q]JTA94#-?$,Z %8K%S:)0:["$D$U8F:1I?9%37$D ";V18BQO 3;(PU
M+\%MS<#"KS2LXK/8L<N&1%6V';!+V4Q)LG0DK&.L09)+3&-1EP\-15(GW3'[
MK-(@P>=M[M*5 VH!)--+3)\R,_PVX#RNF I12SXUU:N,.ZS!*R*!F.JN<QCB
M!'>@^=ZYDW1,+<OTJAA22V&F/JLDN@W+[G*/*:V5QT=F.W>I<FR;:0Z1,!]X
M0616$D/CS+_1J]ZMJ<;91F)E6DS?>^[X1<Q&>49&,[ST8K91+/>L6!XSO2FV
MH$I++*NN6C6)A&&,NZQ,[T)8PCTJ]0Y6[VCXR_M6.)C0<X?_*J6=@%H<NKK$
MDGZQK%.>N.-V=7'))'1.Z1':!\AKJJ<XL9#9)MU@<#LM)62_.^>E5MW7^,+4
MQ*HL<B$#Y8<27:BYLZ%KBU7!.0I"J:X066/?RSY_(_CW+/A/6/ 3(@VJ+)'O
M4#XQG3'28=WA@-F^%R!4<++:X*91:D4NS+%>;1R:48R,L)FF69HH3Z8<MT,W
M@-<,M,O)N'8XNJ]1F)ZR/T_D2KS16:!^PT6Z(DK(BJA[8]:+*[!);J-SZ=22
MVNZJDC=)*M&1-JI)YRU1LT6-QDK4QP6UH61#;O5XN&B2#3()CE+J>-7MA6U0
M;NPX8N#GF$'Z;HZ>#OHDPR*K#'.VGZ=\EFC;5O00DRR7D+__[$IM++Z&7+%5
M@91#DSF.HXDRZS$M2C# 5,,E/!%V&B7LWY9!5K;+C!A:J-5]OZ?4AP2&$AY,
MI#=RFG:UT>>UN:B-YJN<@2328M,A%8;$.1SI Z(X-9_-X8NTZ7BTN[/W\,MW
MO[2"$19Z]93DN%H=- @V=A MX%\R\=.M8@+"O/<PXP>W7)]-9/HF06.FQ]=H
MLD:_)G^D8)IV4CK>.KC54%K$O)][+9.TT^$(?/$E<QD*NRF!9Z15+T4=PMZU
M*-.#=(F]F[/::R(O(N=T);1'BFU+&/,M$*=6P!D IVX)!GI5T\=(9 ]F/>6P
MZ:A!ON^8.E)_'!77?-K,DNE8FE>CJL>#NURH'>E]K>3@"^35&B=#<PH@V5;!
MX&PXYC#%2L<EH]%T)FA:9BEFA]$1B489)EYQ,C1WZB)RJ[HH:=@8X:C++$5P
M7K6LZG0&#YPF X11.7>(,57.L-_L*IO"08_0I\U>?:A[E6D@3^#<!_\U"/E?
M.$QKN ^IMZ*IZ##)>"0?+5.",SA RY)M/-WK*!AB.*"14J(_+DTXZ$R8*0*0
M\D0N!!#W'_9YIMZ\3JLXFT_ XH.4(EYP!T$OAAD#-\QN\#U^V'_53U0C\9''
MLY78+)KM)M)\#W( A;^=WTG<+AWC_;E@FPWRR1OD@''HK].T.D222^K3)*E6
MDHHJ0P),KS.#5%E5%DT*SL_Q^46TA=]*:T_R]?@ZO)VT\]QNP];,B6.QH%L0
MY! CUE;BX<EXL^$D'2W@O-K#V^E^#9Z(K^$^K=$91'@P)2".#Y1W<$C7L2N+
MO*#&(KS].5AVO$0D[T#C'Q?2"<'<C!^H "3W"*;\ :P\+!T8!R7M8>&FIWL)
M$:U-.?CPGP2>@8U5:W?/\F]FBWI!P3CZ8L0].##@QL2A< H7>KMWB>&<Y)8[
M"&_?(AR9G> C2TTOJQO!G#M3?FBCC,:$QE7A*6O(1M18L<]"2$)HV;6,VMQ6
MTWWNF@AM]"-M#%C.)3P=2+(V)$W;&K^IIKC!V+2WY'/+N2?M"/HLJTQ+A4KC
MZU4ZW>[JE:#Z*-0:KMI3.6R":&$IVU".^#92"%'98 8'&$C78,B#FQ=S:WIC
MQ<,[/RK&C^;%\"/H.ITJ/[FDZ;N"] LA4MR=(TW'99*EI5'8?\JI<54Z8#J<
M,493X)W(0X#W^(Q[;[/-ND'W+>M-F1QKBCK'%;53(CRR*](J##DI^SB25M8#
MW%843(6O$+Y*A2&&,-FOR#%MGO@V+BX9]Y;'TH^'(9%,Y-BTI!2R_E.8IK_P
M8@1I?2@'(&)Z114D<XD4^0A#P9<I=:^@8LEJ@DEB&<:'G?,=K-R$8TE[0+U!
M=RR.7H*;ERS,!W1/<$6S8;4Y/1Z&6&/U]0<J EO9:%0U(6O[F 1<PL05UE]Y
M9I:%/2O?"=P0.=C+4:/N35L*H5+K]^QM&R%@>W!9PX;ZDN55HBGZH'F/))N,
MUC6%(R4;8?HK08PO-?C.I/,XV$:GI,3T?0F8@_$^8PJ.9.2>B0ZGN\!WWY/P
M8SF,Y\LQV*-,;4=PRY;N+(B4DW@K$IR,[^E9EF&FS:+_BEV[&Z#B^QNH^-U"
MQ?<W4/$.S_\+=*Z^ZY##Z5F_]]OIQ=G)^7GTVR\G[T_>OA:TI1^"(\3 ,%E4
M::.26A@TO*(4VSIVQ%TCHF6:E-(R!,P#N)D$YM80/O+Y*0&-0FHJD ?#%GA?
M_(#';W&:S_[CN_U/GM.['.*+E[!7+F"-3W\^.;O@X;T\?1N=OWWSX>+T[=EY
M='IV#,+\\J=V\KTOOV!&PI[04?"@R1V?//@1/OX<0[S;?]^W(,ZY--M8460_
M\;L^)(7R\$;[<OE<AK=JP#?9J%]F["].?_J^^IX'&[0O.'VPJO"!*I<[Y;I$
M,_[!C8HD1(0EZ'*Q$9'['M8%AEQNHWF^Q.".7[^])Q9C=:X.[ISD=.,^?/G]
M]7#<AV.XU^D9. ]';T0#7KP]_J_HXOW1V?GKD_=*%/W^P_D%C/I7&/3O&W=B
MXT[<T1 ?DN@\T,78F/2?SQ?]\M[I1C@?N&^P$8L'X0\\N&&MDHN[<P:^=-KR
M8).VO-NTY<$WE;8,$_0\C^N&A+G[48/?=93GZ5_]WM%SIE5O9_N)W@LN\(P*
M##W':WU>5==H_0;_V]%[\(,O^KWCD_<7IZ]/CX\N3J+W)__KPPEXPV=O+TZ/
M3];ME>ZM+N%.;8 "_!:GG55T<S<K0@KZ57*(CG*Z?D?-IM\>IDENI-BE#5SP
MGM<<JPFX;@K;;XP<2EJ/W?G=HAQ.DLIAT=V2!=0/= 45D3H6A1MRC0N#4]!K
M1=F1B+&D<OFHVUG$4H2!YX:RU]Q=<88.NRX6:\W3(?P2'YM.B^O/T]/Y2TK9
MM]FI\JX!47L[#\X!0M.6!V+XM3UF]RSOVFC/H__7_<_&TWY P_I:%V!_/;83
M;*&V$V8K&U.=>4K]F:@B)T?"K$_=A]M=&_%;$('-'OS";WKP /<@T>^97>AN
MH6"#?>+A]BVLYV9#?>$W?;P^&PH]<:9/[28[&BBE;MN.^A;6<[.AOO";/KF;
M#?79'>^[.+:D[(]:9>7<I[6U]2TS'GI;\EL0A3L%U]QO'.8K7I6G#^_$DTW#
M8VD]U&Q39],U3RD7I*'T\[7/*C_TV/**^).KT-;C938K\*5?9K,"&Y6SF>X'
M-=V-[*&TWO"8<DQ#;.;!B-O)H#*;1]9&DH92T;675_/\J@5>.4T9J'S=]$[F
M[IE.#XA;A' UI:EVOO.D]$]DYA$;(Q<7P6N]RXG*9K-&9_!K6 ?_H 53;L^T
M-+"DSZ/%',F3$JR!^3_GIS^?'5U\>'_2[[U]'?WR]LVKD_?_][-GA#\;M<\:
MKH_F86"?G.97V&P=S')DA*V7*[.6G_K/>K"GO3@U:^A4S:['.L+8S[49#*WG
MD6VORU\4S+<4KC.^Z]]<Z_58U?7>EFW+>&=;<[. G\\@0QC_YU_!S1)^OB5\
M!0;A\W[OKE;J'A;O2X*;;ZBL>+RIK+C;RHK'F\J*\H[)W^YE YW\1;V@^KV]
M1T?"44P?1'N/7JXLCJC6L:+@[Q1A/?G6%(3<^N#@W^V$X19N7O'XQBO">WQM
M:N"A6R7AEB+*\SM6(4[+!U C2#B[CJIAK2NE>!6T0\.:OD'W]*\G.TY+FC[4
MN[?G<C"C_>%NF55^A0\FTR6/U!1LC699CDVZ$XK$@UQ%6_.T--^?(C)L^V[X
MH5KTDWG7_;M]UW_;W]W=V=WMY.!XX+E^&7%@8V[VQF?;&ZQ53_[W\2]'9S^?
M\(#?OHZD+!7)72_>(BO3KV_/HO-?CMZ?G#>T[YKLC';MV[(S[F2E_]X$L)WJ
M&)-W.;%-*_5AO.[=+?$[Q2C^FE#3D)._TG*85:F7ZMQ:Y'4VC=*J3J3)!S8H
M>75Q3$(?G5.WQ>W/)=UWJNM1TZ^;CE^9G_RL!NK]O0-Z"^].CD^1\.[\Y/T_
M3X];U.:#>ZM[;?IRE\,^ESX@_5Y>U-(XUC2SO;&Y5XTU_:G3]FZ48=-5N6<<
MI8+(^+Y.I7LY\@%4IH\>_*RB,O%11G"'4;_G]@(S5VY3/W=IP]4L L=62@/;
MNQ);XSE-8"8PH>G=-Q3:;.M/W-9OW2YI_9[;J^UAO]O:;NXC[#)GVU&VMZGC
M]M2P?0;P7^HD:7:/Q4"7Z65!+:A3Z6L'AH%L+%4:,>U1[J\K6H)P5'$T+S/D
M!KGD!H 5*X^T7,;1&+0,]MC#SV=)#:^13"O3;PE^6534M@R_!T4RNK]NZAOI
M89">O_11@OW 42R,#@?7+\N3$IX0&:"<M(8D %_IZ66O3Q>.F;L2)Q5;DN,,
M-7:97F4P2NP-+LTB[UY[?YE%OR&5\/0P>LM]U)]';Y*JWF06[B&S<$\IP'O3
M*]^_?/OJ=_1;OO_EXM<W/_U_4$L#!!0    ( '6+1%<ZNLHY]P\  %)+   *
M    97@Y.2TQ+FAT;>U<;7/32!+^[BK_A[G4'@55LN,$6"HOI A)V,UM@!0)
MN\6GJY$TMH?(&C$CQ?A^_3W=,Y)EQP1V*YLE*;86XDCSTMW3+T]WC]G]]?SU
MR5ZWL_OKT?XA?@KZ;_?\^/SD:&]WW?_$V_7P>O?EV\,/XNS\P\G1\[6AR<MM
ML3$H2G&N)\J)-VHJWIF)S"/_(!)GRNKA&B9BZNF?G;<C2O6Y[,E,C_)MD:B\
M5'9'3*0=Z;Q7FF);8(GF06S*TDSXV=K>[JNW;\[;^_6&<J*SV?;7=N2Q3O]/
M>0+7]A[DL2MV=M=I04CD]$9XL7HT+F^=E=V7>T>?QSK69;>SM=7?V%U_N7?#
MC-VG0_J'>-D]?OV+.'MW\'Q-?=[:ZFW\=S#8Z'\L1FMB_^3\^=H-,NOY8 ;$
M8!7O-ZQ\QU@SP_I8N]MYJ8TX,UE5:I,[<9PG?;&?YZ;*$RQ[:G6B\Y$P0_'3
MDV@P&- ?\3Y/E9U:798J%Z=5G.E$O!T.L6$^NB%=OE61W,9!?JQ<J8>S&S[)
M-T=_=#L?WK[[C<0>B;=):6)EQ68D-@>;C\6#22K=>$>T#ERL..^';Z1+Y:=M
M<?SFY=DC\; <*_$@2S]59N? 3 J9SQY8_NU1)*28J%0G,@-WR3@WF1G-1.)'
M=3NIRO0EZX'0\STC866ATTCD)N_I_%(Z#,)\2 0#74U,)$J3RIF00?U20804
M<Q64N:C:JE=XU3-!]6A(E>O2=3MM%M[3HYH!2-&*D37.86&3*)4Z7KG ;Y_U
M1(+F&52]/Q XDPQ4]6]%+79$+),+T 7^>@F$:K?%=*Q+=4?5_%;X.9&IRN/*
MCKJ=\[',,"47#^2DV!$'IN\U6SLA$]8RZ5B;H&Q*Q,9<V"K/Z3EFR1%,AO2"
M!M3*]./<OUM^SL>JV[G6$23P)MJ5;-K/HLUGF]&SS6?"C:55_ S^:F)RX4J3
M7$2BD%9<RJQ2XJ=!?[ A"J@#CXUH+"E%\(++GA%K=#MGM$CC7AX:V]JG-?>!
M=33",5=X>X07.5QEJ6-HY*E5(-W"Y?%R"QLMO9N[8IV+3*L*&W4[GAH_ J_F
M3$^EM3*'*$H#,=ED+)UJ4=B>!W)E*:;P>T)]+K2%,>3,PA#NNB=QHK('.QOV
M9@H2@[61JW?2S@*KW8X!GM8Y8H-VKI)PX2*%1UW@IF'_CT!8*[3DZ0T1#DH\
MY2;_%L+%M]/]:IGN",J490I.YI)"QU278U[2C^]VYHQ&HK7<,O=]<223L:!8
MM:"]8, S?85GTK2%MTMZ H'2ZRMTL)CG;^8<]<5YR_^1ZX0PP1C%82.2S#A6
M"&PK8U.5#=AXXL%&)%P5?\1X'@UW %N&A&E>,,E4<YC_X5F_6W[8LS)>$E-E
M/?;"\<.X)/G,6.?X;=G9\B#.$ ;]IT_9>[(:4T35^*!A5W\&<44B5IC;]O&T
M3:I= N9!&BDP>7 8*V-85NB:&M+9W"GGM;EVW 1&\Y1]204U)D/,53DG:&C-
M!$^UFR_$0%'ERLJLVTF,+8PEGP!75, 2_*Y38R]8N0%O2YG]T.SOEI_]#*<8
MO+U3245*I5@?8@:%*473-O[SX:1^&<_:L9S I9"I]V?1 D) E(*RPYN&[*51
M85B%%$^>]I#@@)""9BY$MJJ@7^5\75C-1C38&D1;@ZU6W"/;7(@#T,-UJ.J5
MN/JUU;N=O[#\JV]>_AN)+[L=3O)6^I1,.;<HQ6L=P0_S^T[YN68+CCC+Z)=0
MF H6"9=<0N$<I7%0&YTG6962^X5MYFJH$PHO9@H_[<:Z$'&&!6!K,0 *V6)N
MH"^7&HEBZHN]3CQ4GQ-5,$PAW8)$J"Q"$++;J<=B?80_F3DHN=1I#8074#8A
MH4Q_JC2P(I%6,!<*Z)&A[ (>RO1$DTOP6_MB1R#OTK!6>^+ZHC[S&U,EPI7=
MSI=0(L&\I)6(4*B'&RNQ)GTFIL=P@,HV^4OP78BHYLOH=(%YF9*J3;C:*!D%
MD) ;CWM >^,@*;IBF4/EH)Y>I V])%7P^,Z?(-G]"4E4^B)6\.O?E%EA+J0Q
M)XXFKM2DK+5!F^I0*+!*YSBM]C%=I^3MH$/5,JL)%7OGYP$725%/J+CF(9%3
MR$LEGPDAC1"-@FGXES2NT1C:I''.-.7;K0IZ;Z"*G'F4$@-(!;P+CN'> 0#S
M4O=2[>MT8JAD6=D:8LWWM&1,RB;:,=FQ@N?A&DNP'LZIVL'2Q+2;@ZX@]>%D
MW.L:U(30(7)R%OU$SHAUJV!KQ$X(QK;* @RS:E1EB[K@*YKBP ,S\5K:"\7G
M#7B*<PV6S\2RUC$)-2L<WSFA59>U;U@@'.*K<F:2C("YN,*$J'GP *$1$Y\D
M"3M>%!<QPGI%V!?.X5*Q=Z"Z1)\*7&I%B.=1"+L-)RNPN+=/'RK#Z7):S":.
M4X18@LR65B'+#1\A>2KX&J^O%):Q,&8]U(]X)OZL(J)<0313\E!C(E1#E3.B
MD2KZ]7BN-5 5^-)D%2B<*K)YTD&8M!R%U;N=NEXWY%*RE2E# SES"T8T1&YN
MIO1JI0(JX(V$5!>"H)* \@<H7)'ID ]?!3[+0N]VODWJ^#\##,R)B$2Z,:.;
MN0YZMPI(114(5E5XCV3<<L%>/;#-.!0S.6;02*L2!3G ;K#): 1[H$WR:A+[
M<_I"V<0$76"?1C]A[?K>PRAP]*]>3[S2*DNWQ2ET:@<+?*HHQF"BZ/5"^WWW
M\/CWFHRE5N//#&J,Q:DTSUYF8$AL])^"9R0-.@4GY_LO3Q"/CDY.3O</#X_?
M_/)\;;#&OY^=[A_4O]?QPZ]']219.-!2?]J!TTC+,7$U^/>J1M#YNWH-CGN)
MS&IIEZ98%'^FACSCL)ZQL/25WOA<AN>'= _A'?U%3.$GQ+-"4K%5\J+G4_AM
MH"<2;[MS^S-3?+HHV-"\K?<Z75R]=5SK=%[^B&Y ,^\A9+_[1LLI00LN >TG
M5L<4 F)#KM<2MO#]/H*&R]GY@@\ESS[2#@&"W:L#HE,3#C>Y>&7L1)SU-L3#
M-Z8O'C]^W-M\]GAS8^M14P_.D*L/=88M_E,AFFQLUJ7.5IFWH9.<_=%G),3Y
MR&<*/BT5#\^.#A[QVU0EF22"?=RAR!5(QQ"BZ S)@6*GO;GEM^J+?80X3M>!
M)AS58RL'G@CN4%0S86$641WG$&4F#1*Z4M#P#,TYP-9MA"DOI<X8D038A@$-
M^)^JV.&X$6B07I5EL;V^/IU.^SBM_LA<]L415<*MR9'+)Z;0\RX(\R!:+ 10
MY\&30K8T)0S1;![YDES3XA-?Z/ Q)?ME"1T]G2]^2/"8,XY(_/QD .<Q!+?[
M ',55GZ"SZ\R8VS$6OG!6.0K;SZ0"]S8HJP.AZ)Z$U!"*=#N^[TYV2^RFJ ^
M4#PBY?N_^;+#/QXM[\0UB-UC> WMR$8(5,$\5.@6!:Q-+952EU7)R(U-@FS'
M*;P/0))"=A(ROG#9H!D75S/.B5I>*<<T-AD&96PX-$!FJJXSNH6D+V15[(!H
M2T/S( XD@JFN:QL!\G$JP9M'2V19WD%,345%22J,97(ZK,BRM+$>"L[='37D
M!$%WGU[3"EQ)6ZZ"8@U?DR<"?1KS12JA\\=[?_\EGWNJ][?"#PQBGSITW<[U
M]W[NURF"Z_H@[Q-;7[NK=\UEK>5[7709YIK;6^)/7-[J=J[<WEILN,58"RFU
M\[43JF^U=?$59BH+GY7S&H>V&HFSQ"K%Y:*SF0,*\MX5>7G8 #(1A;&E+[OX
MW:D> ?&/QH0OZA6%FRHN8\ILAG0V"DZU3IH+0_5>JO51UAM;(T.Q)@L^TOOJ
M>2-C2)D'LP<!CF<C#2J3*.3VKNPU8 ZHU5.N&;1"57SKW#%GO!TEZJ"P\D6G
M%'R[<!F%BQ50I+HJ2JW% AFEBD+-FP%OH8U.'=TY2 @V13A."'A2C%4)_<I]
MY;G;20"49(Q47OQ!,,]A!(167U3PH0;^WW"AFPMHKLI*9CP$"-"+]1 O^=H"
ME0OG^M)$'\GEJ5 ',UZ@"EN9F;((QK2)'*IRUDLHT)#6Z3R%[5!%!<"V$7$V
M6VBB-6@SUL:IW&%52*(<$ER_>HI4PX4V\.:^#[7Q>$ ;U<<9=3L6F)Q[NH0I
M1UF5T%T&C-232<5,,7'S*PI-9ZG"43-_J78$*1:UO"$4D=32N?IK#U3^42-"
MGZ[N5W@ 8BN6/@B"Y5=#"43)UD:[*:)0L?5%OC9+RLZOB#ZH>^*@B@#V$>L-
MQD#+?2IC1Q+F$;@-M .$XQ#N>RWG#O.#[!-Z0+5>G9-J2]],1KIQJ9%CM=,K
M';L^%&G]1[KQ/?,# ((SG4J;]DZ,N>#P=%;7&]SV_8(E]Q1MG<%[S^^)-(?7
M-,T6\TNJ1 W#D6?^R-N3J,02HOE$R3S<4#\+(7CSV?Z\1]*D8OL)=T(VMAX_
M1IAHQFX<K1C;%)OFDY[4;23ZYL8E)7&M\2?X,?)IX#O%T;29N/6TADE >":[
MI-Z"NW >3=!=?$MEFI+C]JLO<[Q:3"$&^JH9W1R<MU:CKWPUH8FP0#.9+F<
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MG#J\I2ZKDJ$3VS$9O%-X'P F)>(D%';<,&V-BZL9UTJMN))C&B-\QFIDCSQ
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M_Z>;#E_?G![1S^C][^KIY_?_ U!+ P04    " !UBT17&RG1D-PA  !\\0
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M(9S5HR$W09T@/I#SO0@/C/O,[PD3@U 6D[!-@<] *H,@\-:>UR*SN2/@+5O
M;+8-WYN4HBRNT.<>MZSP\Z/7E7"C(^_8=&V;]WP */Q-!8MV ^_Q$]P*+Y F
MMT-\@5\>AIYV ^NG 2Z7_O@'%/TTZUMQ8=TQ70]T#24-&P&([)I*EM5<:XH
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MZJD[N"U8 _F<F!#&!XFD<!_& 8+@SBA\V'9MF!T[8O9,8BS*WWEN>[_(!:<
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MHG7ER"BU2&Q-.>G4W=ZZOGC?/!U:/YD>'I]G90^MQ["VL!&XYDV._;M8*!K
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MW[+!HG2QE "1V1JE1DJN]5PU/=--0V!V&%K"1FZC4LD5BQ56PQ0<VV>7P(9
M(H1G2A<D'Z )ZP,0=!@!G 4\($:WT8>H2U  'B2C4@ 7B9,"V%'H.@QEXPL8
MJ/MJ3$'8GL)6,=IPF@'W/(TYP"(8[KY@T?1TBC#9E_& 8BA#X9G@-. )0Y.
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MG.ZHWFGC!'0!N(6OCC%Y7[VC2=(-YG%1,5T&22=^L6*X)?#-E]&Y7;K-4[?
M,JX^'@2@\>)#\8OR\J<7+V"$B)V)*L+YA?<UEAS-FST-"\>OWZZ4'HW36=<D
MGC:/3D[J[XY.FPJ\@_H9:YR=7#;K9Z<-5C^M351!S9-3%E'8!EHL<^D,Q2#.
M/825IP9QODAG'JKPY@C:@]&.!N\9E@W*O75_70%+KSIB^DU'N^MR;H77G)+:
M+,$ZY5WQ$*KZ';#I5V(1R83$LB"4WP16$R]6V9D[L.@5:0J2B?>D+2*)]]_A
ML?E&O[30WV$GW \68<47$%#+)J?UEFN-D.[7.T'7WDO314,$;Q@I S:TAF]8
M_9!^N2IN'UP!_H2C[NNDM5(_\>?P^-ME\</@V_ZGSN7ZI[/!\&NC4AJVO._%
M[_7.7XW.\?#=?X>7U]U2MWGVY_FW_WX*OC7*\N/A_L>M<OFVUCRZ>&=\;QUT
MG+/1CP_OZUM?+?>'49/-RU'IVG]WL=6R>A<'??E7^]OYNUNOLVZ^_]KY].7P
MXT#^9=???VGM__?;QX_?.U^[YJC;^+XA#_[J^J-.J7[K?B]9-]PXZU0OOY3=
M=\7C@[_.WQ]XY6[[9E#9[%A?^6V_L^DV_</3FT_'V\%%VSUK?!Q<OA?]:V?;
M- Z<KBF[UX.F_%1NWK9O/Y?_+#G']I?3X/O[DV^BL^X.MAO#(_M H>/_ 5!+
M P04    " !UBT17/4!S?R8#  #4"P  $0   &EN8G,M,C R,S$P,#(N>'-D
MM57;<MHP$'WO3/]!]6O'-VC20""97)J&*:29T%RF+QW9%J!&EAQ)!M*OKV1;
MYF*@0%L_R:MSSNYJ=Z76Z30F8(RXP(RV+=_Q+(!HR"),AVWKOF^?]2\Z'0N<
MGKQ] ]37>F?;X HC$C7!)0OM#AVP8W #8]0$GQ%%'$K&C\$#)*FVL"M,$ <7
M+$X(DDAMY)Z:X,"I>1#8]A:Z#XA&C-_?=4K=D92):+KN9#)Q*!O#">//P@E9
MO)U@7T*9BE+-FWK%MQV]AT58DAN'O41\G-[AIR&B1^DEI!/Q".%U+;AM_#KX
M?M1'SZ/QXWD]N"=??KY^PB_7,>]<X.#]A\/'7O_36>ZR)<(1BB%0Q:"B;>G\
MBO0F=8?QH5OS/-]]ZG7[&<[*@<TIP?1Y%=QO-!INMFN@%>0TX,1(UUV]'4"!
M2F6UBS?@,142TG !'\F2, \^<//-!2A>"3W,H=A ([2$$RATAFSLJ@V%K]4-
M,!7V$,*D! ^@"#+18F,!++BL I5Q&63+UP2)E=!\:X'0N3GOEU@<" ?3, /X
MGE=30T50C*B\8CR^1 .8$A7#2PH)'F 464!"/D12]Y=(8(C6"YG^A)0RU<9J
ME@J+MB4)5GU:&I1)U[7)&4'?5,! +]0<5=2UW;U@ZAJP ([:5KZ<TS%*$1I@
MBC.OQ<CXP-8#DNKDU#)CMMQE<%4I%2CZ2D^R=<*14/0LFZXR%/P"LID;0A*F
M9"_J++Y-S,)NSK!RN&9R[M  9!/7U+W1M@36=YY5V$8<#=H6IH&P32E_J+0=
MU3L&HCULF+BL1LLG53@V$I"'%97*C:!$6(*XQ*J!Y\8^#QU+3;^=<P.T'V$!
M]Q]F3F"P:^:*@LA_3+FK]:NYMMS%H5+_RX/74NDR+@&M#.^F:S._\+LLS*0V
M4/2?;7BV-ME^S:[[SE1$LTAW"6)V KL%87A[!+'F\E[E7ZR#ZT760MLZ7?,(
M;'2ZDN,B(H6Q[!W"_)/Q%S%D,CL%L5#.2')72VC1FJWJ6/?7A_,G9O8O]FJ"
MD*54\M==&F&>8G[VJ\;LL=^N$ :?%T&___NZW:,+JLY7M4#+S=74\C=02P,$
M%     @ =8M$5\G4=:?]"@  @(8  !4   !I;F)S+3(P,C,Q,# R7VQA8BYX
M;6S-G5UOX[@5AN\+]#]PW9L6&,>)@Q9(=F87&4^R,#:;9&//;-M%L: EQA%"
MDP$E)_:_+RF)LD3Q2$J*DIR+&8_X'NJE^)BDOHX__KC;4/1"1)IP]FET<G0\
M0H1%/$[8^M/HZV)\L9C-YR.49IC%F')&/HT8'_WXPY__A.2?C]^-Q^@J(30^
M1U]X-)ZS!_X]NL$;<HY^(HP(G''Q/?J&Z59MX5<))0+-^.:9DHS(@F+'Y^CO
M1]-CC,;C ?5^(RSFXNO]O*KW,<N>T_/)Y/7U]8CQ%_S*Q5-Z%/'-L H7&<ZV
M:57;\>ZX_%.$?Z0)>SI7?ZUP2I \7BP]WZ7)IY':;[G;U],C+M:3Z?'QR>2?
MOUPOHD>RP>.$J>,6D9&.4K78XD[.SLXF>:F6MI2[E:!Z'Z<3;:>J698F'?J:
MDS0Y3W-[USS"6=[MO;M!H$+];ZQE8[5I?#(=GYX<[=)XI ]^?@0%I^2>/*"\
MF>?9_EFBE":*A%&Y[5&0![L9*L1$Q4\86>.,Q&I'9VI')_]0._I+N?D:KP@=
M(:64?(#M.FO4509-7)N](R+A\25[GVLSVI-]^=T1V?_0@'J\\R8L>8;IN\S7
M(YW;OB'O.^*'./='6H[SY'U'NA;Y?[&=M2V_^?#:CRM5&Z_EIX9%LLOD!$9B
M;5)5T3$"YWO()X:R[JIV'C7JI6HTYZ+==C4SYG6F)#I:\Y=)3!)9]_14?1BK
M#WFSY7_^F'&Y$KA8I9G 4:9KRIOQ:60IGYB6E/)":%]81#V-*Q63B,NIZ3D;
MT^(P%N$/@F^LNRU;S2V%?]!5%5\<%KD+P&A#)DC*MR(B;^J5NEOH*)6.-E0J
MU)**L/'7Q>B'7(-^UZK_?)P<:G'0T7()M-T0EBUEC986-(M==;/-E.[E>ED0
MG6PQ9/:QEB"E<=S!%W+'L=KY%<5KBWVCW%476VWI/FX4!M')-D=F+U<:I$2^
MNOD+22.1/*OE?%<[&C+GG6XQV>K[FB8L!-K&8!)J6D\#^SU9)VIJ41;4^2U1
M&SN&,4#O>NCOM&W.!59Q$- ,<0C.%O4@5$5YXNB"L2VF]^29BRY\FC+7U-A,
MFK#4-4$Q8C$&HE%H42'V1,2O6WG&3@3=]T+14KKF K!JHF'(@J+#[@T$I)+[
M960I,$L3-8#U0M*6.C_= ,RV3CT,75"< .;@4Y)*[Y>4Q2.A5-T/P*Q_0+&)
M7=,"&S9Y:2N#(@:T!S*31Z R)!QL+E_4ZEPNDP8VMJ;W"4_+=A<_E3A8A$R'
M RG*PY"*\T12[39$#T,MI6MZ *LF-X8L*&+LWD!6"CG*]?XAN63Q($0JG1]
M#)MV/$I1@' TG?6A(=4^P;A*T@C3PLN5W)9V-,^B=0T(:->$I"4,"A3('0A+
M$:"9R4.\ O,O@L4P7&I*/["TK-I1J60!@F)ZZ\-$Z;U ,ML*T7 -SSBPU-E-
MV1ZSU?U90!<$*#WF6G=M"WD#%$\ST"7+DFROGJ>[V6Y61%@:UY:X8@,RIYDP
MRX-@ 3!E,E#(D-*A0NBEY_5= I:IAQC!YI@RMP38338I:&H"(L%J#*#AH,V?
M*?5"Q$R.3 +3.8O)[F>R!]O5TKEE K#9A,(0!42%W1F 12E&N1I)N1<P[D2R
MP6*_2**>J:(M=(L&9+3)AJD*" [ &D!'J4:+^<SG3++$NWDL04T>DN)Y\!Y*
M0+U;6'IL-YD!Q &AT^T0($@&H6:43Y#F+.+BF=<>=YCQK1P ]S,>PRN4GBBW
M4 UJ0A.MSI"  !OB$\"L$?JA>"8%<?4>3UX!4C5X(>XBCN6!2LM_KA-&3L#V
M6[5NZ>JPVV3*(@R()-@=P$^I_* _(!6#;EDHT$S?T-2I?VBF0Z&9!@W-]#W0
M+%]Y(-"<OJ&II_ZA.1T*S6G0T)R^"QK9\5['FIG\>"N6_-7V<#:H](),VZH5
MF(,L/%Q:WOI@40%J/:-"?&*2+ZQNQ9W@+PF+X"4S)/<"#&#:2HVA#0\=N\$^
M?JH%L8[S.M84B_+>+XF6^1EEFB;M0TRA"0^2IK'>P:50^T3BCJ<9IO].GCM/
MQ.UB+WA8#5LA:2C#0\5FKP^8(@;)(!\GUB6NZH:&]54RH]S=*\ 66X=7@&N%
M04!@<]1^!;BX>E*(7'>S8E00#(P(S6)GG6PQ5?5QK2R,+FX;:O5P_KV6&A]?
M9)7=A=X]<@8_(-"6N.IIR)SN;;,\B!X'3)F]GLM0KO-T-5YEF$CMPW>MS-G,
M;MJI)G)=$$3OFFY:T[0N=]R;OXDDDWN>\<UFR\J[/+;G!@&=JU[NM*E[W"H*
MHO>[G)DDE%K4%#O&8L%I$B59PM:_R)-/D6!;JVPB5T# !C4-;440*("V3 X.
M0J25CB&X$T1!2&1'Y"\!JL1"XO;AP3K;=XE=0=%O6,,!*X. I->>"8L,&$>U
M"%2$H#S&+S;S--T2\29X+"&>$ +- R"U]"'B!)GLA:H(],G6@D1;.3_N3Z:K
M99)1V\EE6^)L3@+,53.241X$&X IDX6\#/$'=#+]Z^IO2$<Y[OX;OA18)8]=
M[#<K3H'L4U:5*P@Z+&H.+)(@4(!]F33<<%1*4:'UD9VJ8=;2'*/<%0!66[KK
M&X5!=+K-4>O+W^AK3T/^Y2YZE*8(\$*"7>9ZZ+>9-(?_NB8(!#J,M4Y*2BG2
M6A\O)!RFK'7_(F#M;1&P[ED$K$-<!*R'+@+6WA8!>K=%BA Y+MVN:++&0'+"
M3K5K*#HLFWQ8I$&A OL#QXPJ!!UB7&>TS%.<J?3\8I/O_TI^L+02T#G+:=EE
MLTIJ:1,%P4B7LU9:RR+I7$V,E-HU%]LXR4A<F+E*&&91@FF5'M%V1;P_Q!DM
M \U7X/3HPV!HF,D63D68SF58!1Y27;J^E%X\@/$;H?1GQE_9@N"4,Q(7UU)L
M=XJZ]6Z?F.FQW7QH!A '@=,0A\"C,RIH_*2BD XKKX1Y(>D;IUN689&_2RYL
M(Q.@<TL.8+-)C"$*B!2[,X"02HP*M9\7M(OL$=4BJ_C=(;"!D-SQZ]J=IHVW
MMJW:@)CI- B]PUWF_#BLC8LH3Z]89D3]7D3R0K[@#)?>P/9"<M<O57:9-M^F
MM&D#0JC3(/C^9!6C4L5@S92WE#%B)I=::][QE+BA<I\XIF6QG3NFD@2$A\U7
M1P89@;36"PN+#:;T\S9-&$GAB<A0N67!:K')0D,2$ LV7P +N11IK1<6+C=$
MK.7T]I/@K]ECF9\5;!N@=LM&I^4F(U9I0*QT^0.8T2&HB-$I=?W LSLD%"^R
M+,(MM4@=8P.:-9AIZ4("!C+7HH622%UON>$96G+T-24H>R3HLOP9NGHF^*(>
M7[\T$D7JA8AB5<YB+&P(=8F=_^H(:+CUVR,M91 @]=J#?X>DBD ZQ#$UMY)A
M43^/RTW,,[(!WW;H#W%%T%#SFJ,^?1 T#31I,I6'-4^N\T"D(GUF,ZHGMX>7
M> V1XY6QQ:"Q,*XI@F $M 4MB^N_%> G=]YV19/HBG(,7V5I:!QGS&O;,Y+E
M'00!$=!V!:7(RX4H5WKI_\^8/8GM<Q;M[P2/"%%/6:75:-5W_6U@M%MFWM2D
M)DV#0@/B["U^ 0(/5:!:'1]J,Y;/BWGJH7&5S8U'3XM'+ _@[39+U0PJC<%7
MP3N#'-]>&-  XR9#1T1 Z VP"=UPR"-1'OH!%<&H%NWI_"P]9 $D\>?]/7D@
M0KUWL"2[[+/<T5/'&<: 6-=G;X.;8Y[,]08& >%;W4*G>BFJ5X!6ZAFQL@KT
MNZH$Y;78?K^\ONE:?I*;]2;YUPJG1&[Y+U!+ P04    " !UBT17.US*'E$'
M  #+5P  %0   &EN8G,M,C R,S$P,#)?<')E+GAM;,V<RW+;-A2&]YWI.[#J
M6E<W;:W8S=B*E='$B5W+2=IN,A )21B#@ 8 +>GM"Y"2H@L!'F]X[(4M4S\N
M_P<0Y"$ 7KQ;I3QZIDHS*2X;W5:G$5$1RX2)V67CR[AY-1Z,1HU(&R(2PJ6@
MEPTA&^_^^OFGR/Y<_-)L1D-&>=*/WLNX.1)3^3;Z3%+:CSY0014Q4KV-OA*>
MN2-RR#A5T4"F"TX-M5\4!?>C-ZU>AT3-)B#?KU0D4GUY&.WRG1NST/UV>[E<
MMH1\)DNIGG0KEBDLP[$A)M.[W#JKSN:G2'[!F7CJNU\3HFED>0G=7VEVV7#E
M;HI=GK6DFK5[G4ZW_<^GVW$\IREI,N&XQ;2Q3>5R*4O7/3\_;^??;J4GRM5$
M\6T99^UM=78YVV]90+]7$\WZ.J_>K8R)R9N]LIC(JW#_-;>RICO4[/::9]W6
M2B>-+?R<H)*</M!IY/[:UMN5RB:ZQ43<=L?; VG[HJUDGF*NZ/2RP<1$VXQ[
M9]U.I^>R_?5 9-8+VR<U<UVJ$;4/BEPHJJDPN<M;>^ @"5T9VY-HLLW(E0^H
ME&'&Z39=I!LU77_*4EN,_5@H-W78UH++^*!@[KC+(Y?;/IS3U31NS>1S.Z&L
M[9R[#SF"W+[]YWM>T-5$&T5BL\V)DPGE>?[?K>9(TJZA5EL2CS;'\DH=*H[K
MM-]>5RJ.I$JHLJRW>1$5'[32:7?<*-H+HFQ&S7C.^*Z!ITJF/CH;$M)3T7U0
MMHAZ:%[9\A-7AR$GLW*<1Q(@SRX&T%(W6$3?4QTKMG!<*L >*(%\>ZA\2[S5
MC'E[[CS0&7/U=55Q%UGJ#H;'!4\2(/@SS)$BZ!:I!:Z$R A_H NI*L ?*H&\
M?\/D7>8-"?/?&5&&*KZ&D#X1 V&_P83M<8C$^U$1H9GC P%^J@82_QWUQL/C
M$0GY>$XY=X$;$:!>7J8'8O\#$[O?YRL ?_/LKN_VT@)GOY<$B/_/UX+_Q"U2
M"]Q3Q61B+^D*P/Y$#*1^CDG=XQ"5]XU(H+1W4G#\@P_[R!X2ZB'3,>%%C8;V
MF [C+I%#D:/$G)4V4;'_2XD"0]\30Y&CA*$5%FL&/LB4.JA,<%3QJZ'(40+0
M*I,U,[\1AIFU>]+_.4LG/QZ<'K(^54$9HP2=/E,H;+=/&H1Q$Q@AOL=**&.4
M6#-D#H7SP/I1A(]$0E<?Z3H$^D0*)8T28P;MH:"^5RPE:CUF<?6@<:J%PD:)
M+,,&46@_DM4HL:[8E!53@-70O4F@[%'"2I!=E"88B5BJA=Q[7#R0F3T?UP.9
M!(?TBH30YD")-U]@':51KI+$XM*;/[=,T&ZH*4KEX#DBO 8(V'PEV'LOP]Z#
M8T>)0RMMOA+L9R_#?@;'CA*+5MK$Q#ZP'^_4HUQZ9J"]8BARE%BTPB(F\/Q*
M<Z?NE7QFQ4JH*NHG*:#H$4/4L%G4#E]<Y"&]?:N$\D8,5\O-87*^E]H0_A];
M5-U)ENNAS!$#UY#1NA\P%NWN'EKXEA(=2:!\46+54CMU(W4MK"CQ=]]#!10H
M2@!:9J9FGK?2S7W,I0@^CSU50;FB1)(^4W4/O&X-L?:>^GM?@U>PH0RKQS9J
MQOA-,6-K,)!IFHG-,QK/K)A'"L6+$OX%[=6,>BPYBYEA8O;)WB$J1G@YYS(=
M%#)*L.<W5C/A>T5=2U-[VYVOXW*;#-3==.H;>4-Z*'&46*_:*"[YD=8952_E
M7Y(*V@HH81_4=-WC#(TS.^RMN[W)H]LQXQEE3E10UB@AG\]4S6P_RT=%W Z]
M\3J=2.[?'E(JA!)&"? "UFJ&?%"/<KQ'$BA8E,BNU [2F'"SBN=$S*A_]4*Y
M$@H8)=(+F4,;>V>@L7?VPK$7)>+SF4)B6ZP-MV?4W82S&?'O) LF .^SP20>
ML%KW_KU\RX_;NZW2O!Y#^Z$<NT<*!8ZS13)DKV[46<(,38HJ#9D@(K8AU6Y?
MFR<ZKTX%;0"</91 TRB/][]1SC\*N11C2K04-"EN]4-/^+U)H*V .(=881>E
M";Y*GEE**E\(JCSG@$<*18XX=^BQA[/VLEC4O+OV%"_I"!'WI8""1YQ$#)M%
M6I]FJ*LS>Z;OB2&;&H;X^U) ^2-.*(;-HJV?5P-[X9G)\)SYD1!*&W$I;*DU
M%,CCE'!^G6DFJ Z.+4="*&3$-:^EUE @WZ14S>R@]D')I9EO]G:&8'L20*$C
MKFP-6L6!O_JQC[S8_Q8D7Z(&OYT $;O7)-9K-^+8+:0HKN0B(<I#/:2'<D?=
M6.DW6C/Y.S.G:O_^*:_,R,9MH44/U:F@K8 2KD)-XUQ;]W;R!R^M!SHH;\3
MM,P8SIZI;,)9/.22!._+#V10OHA1:(DM%+S71#RI;&'B];V2,:5N^D3OSC9
M0 3, -HDB/'IBU#@/"Z0:>HV$\GX:3RWIO5=9O)WEMKZ!1\:!--!FP9S$R?
M.-)=D/ZQT8LFU^L'.J7*+5-XI"MS;0MZ"M\4 9)#VP?UC4)@#"7-=-$^\75K
M#[BWTA;?N%_NS:OVR/]02P$"% ,4    " !UBT17RH.76W.R   BW 0 "0
M            @ $     97@Q+3$N:'1M4$L! A0#%     @ =8M$5S3,"L4>
M1P  (\8!  D              ( !FK(  &5X,RTQ+FAT;5!+ 0(4 Q0    (
M '6+1%>"7MTB45(  (4K @ )              "  =_Y  !E>#0M,2YH=&U0
M2P$"% ,4    " !UBT173&#86OI0  "4(@( "0              @ %73 $
M97@T+3(N:'1M4$L! A0#%     @ =8M$5PVHAJ533@  /OD!  D
M     ( !>)T! &5X-"TS+FAT;5!+ 0(4 Q0    ( '6+1%=)BA/X E0  #0B
M @ )              "  ?+K 0!E>#0M-"YH=&U02P$"% ,4    " !UBT17
M.KK*.?</  !22P  "@              @ $;0 ( 97@Y.2TQ+FAT;5!+ 0(4
M Q0    ( '6+1%<.\ (/,0\  (4_   *              "  3I0 @!E>#DY
M+3(N:'1M4$L! A0#%     @ =8M$5QLIT9#<(0  ?/$   L
M ( !DU\" &9O<FTX+6LN:'1M4$L! A0#%     @ =8M$5SU <W\F P  U L
M !$              ( !F($" &EN8G,M,C R,S$P,#(N>'-D4$L! A0#%
M  @ =8M$5\G4=:?]"@  @(8  !4              ( ![80" &EN8G,M,C R
M,S$P,#)?;&%B+GAM;%!+ 0(4 Q0    ( '6+1%<[7,H>40<  ,M7   5
M          "  1V0 @!I;F)S+3(P,C,Q,# R7W!R92YX;6Q02P4&      P
,# "X @  H9<"

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
